Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Gene_full_name.refGene	Function_description.refGene	Disease_description.refGene	Tissue_specificity(Uniprot).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	cytoBand	cosmic70	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	gnomAD_genome_ALL	gnomAD_genome_AFR	gnomAD_genome_AMR	gnomAD_genome_ASJ	gnomAD_genome_EAS	gnomAD_genome_FIN	gnomAD_genome_NFE	gnomAD_genome_OTH	avsnp147	CLNALLELEID	CLNDN	CLNDISDB	CLNREVSTAT	CLNSIG	HGMD_pro_2019.1
5	9036071	9036071	C	-	UTR3	SEMA5A	NM_003966:c.*6938delG			0.000979594322677327	0.999016140899957	4.2647773658593e-06	semaphorin 5A	FUNCTION: Bifunctional axonal guidance cue regulated by sulfated proteoglycans; attractive effects result from interactions with heparan sulfate proteoglycans (HSPGs), while the inhibitory effects depend on interactions with chondroitin sulfate proteoglycans (CSPGs) (By similarity). Ligand for receptor PLXNB3. In glioma cells, SEMA5A stimulation of PLXNB3 results in the disassembly of F-actin stress fibers, disruption of focal adhesions and cellular collapse as well as inhibition of cell migration and invasion through ARHGDIA-mediated inactivation of RAC1. May promote angiogenesis by increasing endothelial cell proliferation and migration and inhibiting apoptosis. {ECO:0000250, ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:19850054, ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:21706053}.; 	.	.	.	.	0.23092	0.10687	-2.892521092	0.583864119	185.92785	2.96172	5p15.31																								
5	10397474	10397474	T	-	intronic	MARCH6				0.999995976388274	4.02361172603786e-06	1.28071470223936e-16	membrane associated ring-CH-type finger 6	FUNCTION: E3 ubiquitin-protein ligase that promotes ubiquitination of DIO2, leading to its degradation. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. May cooperate with UBE2G1. {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:19651899}.; 	.	TISSUE SPECIFICITY: Present in brain (at protein level). {ECO:0000269|PubMed:15673284}.; 	ovary;skin;retina;bone marrow;prostate;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;tongue;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;choroid;uterus;whole body;larynx;bone;testis;artery;unclassifiable (Anatomical System);lymph node;islets of Langerhans;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;head and neck;kidney;stomach;aorta;	amygdala;superior cervical ganglion;testis - seminiferous tubule;placenta;prefrontal cortex;testis;pons;parietal lobe;cingulate cortex;cerebellum;	0.27751	0.13948	-0.558357437	19.54470394	27.26345	0.87856	5p15.2		0.3698	0.3464	0.3842	0.3967	0.3488	0.3674	0.3743	0.3796	0.0074	0.0056	0.0112	0	0.0007	0.0511	0.0052	0.0117	rs771645666						
5	11110989	11110991	TTC	-	exonic	CTNND2		nonframeshift deletion	CTNND2:NM_001288716:exon11:c.1431_1433del:p.K480Sfs*409,CTNND2:NM_001288715:exon13:c.2169_2171del:p.K726Sfs*409,CTNND2:NM_001288717:exon13:c.1143_1145del:p.K384Sfs*409,CTNND2:NM_001332:exon14:c.2442_2444del:p.K817Sfs*409	0.999999951944472	4.80555284905704e-08	3.20174774359551e-19	catenin delta 2	FUNCTION: Has a critical role in neuronal development, particularly in the formation and/or maintenance of dendritic spines and synapses (PubMed:25807484). Involved in the regulation of Wnt signaling (PubMed:25807484). It probably acts on beta- catenin turnover, facilitating beta-catenin interaction with GSK3B, phosphorylation, ubiquitination and degradation (By similarity). Functions as a transcriptional activator when bound to ZBTB33 (By similarity). May be involved in neuronal cell adhesion and tissue morphogenesis and integrity by regulating adhesion molecules. {ECO:0000250|UniProtKB:O35927, ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9971746}.; 	DISEASE: Note=Defects in CTNND2, including deleterious missense and copy number variants (CNVs) are involved in autism, a complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:25807484}.; 	TISSUE SPECIFICITY: Expressed in brain; highest expression is observed in fetal brain (PubMed:25807484). {ECO:0000269|PubMed:25807484}.; 	ovary;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;optic nerve;whole body;frontal lobe;endometrium;larynx;testis;corpus striatum;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;spinal cord;lens;breast;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;head and neck;kidney;mammary gland;	whole brain;amygdala;superior cervical ganglion;thalamus;occipital lobe;medulla oblongata;cerebellum peduncles;hypothalamus;spinal cord;temporal lobe;caudate nucleus;pons;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;parietal lobe;cingulate cortex;cerebellum;	0.40078	0.09362	-2.412493531	1.067468743	97.49242	2.13412	5p15.2	ID=COSM448428;OCCURENCE=1(breast)	0.0014	0.0004	8.673e-05	0.0006	0.0002	0.0007	0.0034	0.0064	0	0	0	0	0	0	0	0	rs748518063						
5	14696100	14696100	A	-	UTR3	OTULIN	NM_138348:c.*2943delA			.	.	.	OTU deubiquitinase with linear linkage specificity	FUNCTION: Deubiquitinase that specifically removes linear ('Met- 1'-linked) polyubiquitin chains to substrates and acts as a regulator of angiogenesis and innate immune response. Associates with the LUBAC complex via direct interaction with RNF31 and counteracts its action by cleaving linear polyubiquitin chains to substrates. Required during angiogenesis, craniofacial and neuronal development by regulating the canonical Wnt signaling together with the LUBAC complex. Acts as a negative regulator of NF-kappa-B by counteracting activity of the LUBAC complex. Plays a key role in innate immune response: required to restrict linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation, probably to limit NOD2-dependent proinflammatory signaling. {ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:23746843, ECO:0000269|PubMed:23806334, ECO:0000269|PubMed:23827681}.; 	.	.	.	.	0.10641	0.10279	0.459411326	78.28497287	.	.	5p15.2																								
5	14697156	14697157	GT	-	UTR3	OTULIN	NM_138348:c.*3999_*4000delGT			.	.	.	OTU deubiquitinase with linear linkage specificity	FUNCTION: Deubiquitinase that specifically removes linear ('Met- 1'-linked) polyubiquitin chains to substrates and acts as a regulator of angiogenesis and innate immune response. Associates with the LUBAC complex via direct interaction with RNF31 and counteracts its action by cleaving linear polyubiquitin chains to substrates. Required during angiogenesis, craniofacial and neuronal development by regulating the canonical Wnt signaling together with the LUBAC complex. Acts as a negative regulator of NF-kappa-B by counteracting activity of the LUBAC complex. Plays a key role in innate immune response: required to restrict linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation, probably to limit NOD2-dependent proinflammatory signaling. {ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:23746843, ECO:0000269|PubMed:23806334, ECO:0000269|PubMed:23827681}.; 	.	.	.	.	0.10641	0.10279	0.459411326	78.28497287	.	.	5p15.2										0	0	0	0	0	0	0	0	rs147812403						
5	14707406	14707406	A	-	UTR3	ANKH	NM_054027:c.*3900delT			0.167376865709729	0.829652434883441	0.00297069940682956	ANKH inorganic pyrophosphate transport regulator	FUNCTION: Regulates intra- and extracellular levels of inorganic pyrophosphate (PPi), probably functioning as PPi transporter.; 	DISEASE: Craniometaphyseal dysplasia, autosomal dominant (CMDD) [MIM:123000]: An osteochondrodysplasia characterized by hyperostosis and sclerosis of the craniofacial bones associated with abnormal modeling of the metaphyses. Sclerosis of the skull may lead to asymmetry of the mandible, as well as to cranial nerve compression, that may finally result in hearing loss and facial palsy. {ECO:0000269|PubMed:11326272, ECO:0000269|PubMed:11326338}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in osteoblasts from mandibular bone and from iliac bone; not detected in osteoclastic cells.; 	smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;iris;germinal center;bladder;brain;heart;cartilage;tongue;adrenal cortex;blood;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;macula lutea;liver;cervix;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	dorsal root ganglion;cerebellum peduncles;prefrontal cortex;cerebellum;	0.12170	.	-0.378346116	28.01368247	46.77893	1.32209	5p15.2										0.7136	0.5373	0.7718	0.8507	0.7540	0.8314	0.7790	0.8063	rs34717032	301758	Chondrocalcinosis|Craniometaphyseal_dysplasia	Human_Phenotype_Ontology:HP:0000934,MedGen:C0553730|MedGen:C0265292,OMIM:269300,Orphanet:ORPHA1522,SNOMED_CT:36601008	criteria_provided,_single_submitter	Benign	
5	14709005	14709005	T	-	UTR3	ANKH	NM_054027:c.*2301delA			0.167376865709729	0.829652434883441	0.00297069940682956	ANKH inorganic pyrophosphate transport regulator	FUNCTION: Regulates intra- and extracellular levels of inorganic pyrophosphate (PPi), probably functioning as PPi transporter.; 	DISEASE: Craniometaphyseal dysplasia, autosomal dominant (CMDD) [MIM:123000]: An osteochondrodysplasia characterized by hyperostosis and sclerosis of the craniofacial bones associated with abnormal modeling of the metaphyses. Sclerosis of the skull may lead to asymmetry of the mandible, as well as to cranial nerve compression, that may finally result in hearing loss and facial palsy. {ECO:0000269|PubMed:11326272, ECO:0000269|PubMed:11326338}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in osteoblasts from mandibular bone and from iliac bone; not detected in osteoclastic cells.; 	smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;iris;germinal center;bladder;brain;heart;cartilage;tongue;adrenal cortex;blood;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;macula lutea;liver;cervix;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	dorsal root ganglion;cerebellum peduncles;prefrontal cortex;cerebellum;	0.12170	.	-0.378346116	28.01368247	46.77893	1.32209	5p15.2										0.0080	0.0016	0.0301	0.0038	0	0.0472	0.0057	0.0141		301772	Chondrocalcinosis|Craniometaphyseal_dysplasia	Human_Phenotype_Ontology:HP:0000934,MedGen:C0553730|MedGen:C0265292,OMIM:269300,Orphanet:ORPHA1522,SNOMED_CT:36601008	criteria_provided,_single_submitter	Uncertain_significance	
5	16763726	16763726	A	-	intronic	MYO10				0.00396952046057879	0.996030479531536	7.88547499780373e-12	myosin X	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. MYO10 binds to actin filaments and actin bundles and functions as plus end-directed motor. The tail domain binds to membranous compartments containing phosphatidylinositol 3,4,5-trisphosphate or integrins, and mediates cargo transport along actin filaments. Regulates cell shape, cell spreading and cell adhesion. Stimulates the formation and elongation of filopodia. May play a role in neurite outgrowth and axon guidance. In hippocampal neurons it induces the formation of dendritic filopodia by trafficking the actin-remodeling protein VASP to the tips of filopodia, where it promotes actin elongation. Plays a role in formation of the podosome belt in osteoclasts. {ECO:0000269|PubMed:16894163, ECO:0000269|PubMed:18570893}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10984435}.; 	smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;amniotic fluid;germinal center;brain;heart;cartilage;tongue;spinal cord;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;macula lutea;liver;cervix;spleen;mammary gland;colon;parathyroid;choroid;fovea centralis;uterus;cerebral cortex;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;muscle;bile duct;pancreas;lung;placenta;hippocampus;head and neck;kidney;stomach;	dorsal root ganglion;amygdala;occipital lobe;superior cervical ganglion;prefrontal cortex;appendix;caudate nucleus;trigeminal ganglion;	0.45378	0.20308	-1.611828042	2.972399151	8073.2738	19.39142	5p15.1		0.0378	0.0234	0.0505	0.0237	0.0060	0.0382	0.0387	0.0675	0.0003	0.0005	0	0	0	0.0005	0.0001	0	rs750470332						
5	16815271	16815271	-	A	intronic	MYO10				0.00396952046057879	0.996030479531536	7.88547499780373e-12	myosin X	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. MYO10 binds to actin filaments and actin bundles and functions as plus end-directed motor. The tail domain binds to membranous compartments containing phosphatidylinositol 3,4,5-trisphosphate or integrins, and mediates cargo transport along actin filaments. Regulates cell shape, cell spreading and cell adhesion. Stimulates the formation and elongation of filopodia. May play a role in neurite outgrowth and axon guidance. In hippocampal neurons it induces the formation of dendritic filopodia by trafficking the actin-remodeling protein VASP to the tips of filopodia, where it promotes actin elongation. Plays a role in formation of the podosome belt in osteoclasts. {ECO:0000269|PubMed:16894163, ECO:0000269|PubMed:18570893}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10984435}.; 	smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;amniotic fluid;germinal center;brain;heart;cartilage;tongue;spinal cord;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;macula lutea;liver;cervix;spleen;mammary gland;colon;parathyroid;choroid;fovea centralis;uterus;cerebral cortex;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;muscle;bile duct;pancreas;lung;placenta;hippocampus;head and neck;kidney;stomach;	dorsal root ganglion;amygdala;occipital lobe;superior cervical ganglion;prefrontal cortex;appendix;caudate nucleus;trigeminal ganglion;	0.45378	0.20308	-1.611828042	2.972399151	8073.2738	19.39142	5p15.1										0.8666	0.6470	0.8516	0.9748	0.9643	0.9533	0.9641	0.9356	rs35892466						
5	17276848	17276848	-	A	UTR3	BASP1	NM_001271606:c.*839_*840insA;NM_006317:c.*839_*840insA			0.539222352506789	0.403650732596534	0.0571269148966764	brain abundant membrane attached signal protein 1	.	.	TISSUE SPECIFICITY: Brain.; 	smooth muscle;ovary;sympathetic chain;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;cerebral cortex;endometrium;bone;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;head and neck;cervix;aorta;stomach;peripheral nerve;	whole brain;amygdala;medulla oblongata;occipital lobe;thalamus;hypothalamus;temporal lobe;pons;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;whole blood;cingulate cortex;parietal lobe;	0.20195	0.13818	.	.	157.19188	2.73957	5p15.1										0.6367	0.4118	0.7797	0.6825	0.6575	0.6928	0.7466	0.7167	rs11447766						
5	32057911	32057911	T	-	intronic	PDZD2				0.999645170986495	0.000354829013504673	9.74943212086724e-17	PDZ domain containing 2	.	.	TISSUE SPECIFICITY: Isoform 2 is expressed (at protein level) in prostate and many prostate tumors. {ECO:0000269|PubMed:11289102}.; 	sympathetic chain;colon;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;larynx;thyroid;bone;testis;dura mater;brain;unclassifiable (Anatomical System);amygdala;meninges;hypothalamus;lens;skeletal muscle;pia mater;lung;trabecular meshwork;placenta;macula lutea;liver;alveolus;spleen;head and neck;kidney;thymus;	amygdala;dorsal root ganglion;superior cervical ganglion;medulla oblongata;olfactory bulb;tongue;atrioventricular node;caudate nucleus;skeletal muscle;skin;subthalamic nucleus;fetal brain;placenta;prefrontal cortex;globus pallidus;testis;ciliary ganglion;trigeminal ganglion;cingulate cortex;	0.11498	0.16206	0.251405031	69.6685539	1979.49164	8.19886	5p13.3										0.0037	0.0040	0.0163	0.0088	0	0.0348	0.0008	0.0015							
5	32242341	32242341	T	-	intronic	MTMR12				0.997884435033356	0.00211556442189225	5.44751607464504e-10	myotubularin related protein 12	FUNCTION: Catalytically inactive phosphatase that plays a role as an adapter for the phosphatase myotubularin to regulate myotubularin intracellular location. {ECO:0000269|PubMed:11504939, ECO:0000269|PubMed:12847286}.; 	.	TISSUE SPECIFICITY: Ubiquitous with prominent expression in brain, heart, kidney, placenta, and lung. {ECO:0000269|PubMed:11504939}.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;oesophagus;endometrium;larynx;bone;thyroid;testis;germinal center;brain;pineal gland;unclassifiable (Anatomical System);lymph node;heart;adrenal cortex;pharynx;blood;lens;skeletal muscle;lung;cornea;trabecular meshwork;placenta;macula lutea;visual apparatus;hypopharynx;liver;spleen;head and neck;kidney;mammary gland;thymus;	.	0.18842	0.11936	0.134171522	63.57041755	230.19094	3.27962	5p13.3										0.0028	0.0007	0.0204	0.0040	0	0.0241	0.0011	0.0053							
5	32716474	32716474	-	T	intronic	NPR3				0.00309926266837596	0.985402925257705	0.0114978120739191	natriuretic peptide receptor 3	FUNCTION: Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity.; 	.	.	unclassifiable (Anatomical System);lymph node;heart;cartilage;tongue;sympathetic chain;fovea centralis;choroid;lens;skin;retina;bone marrow;uterus;optic nerve;lung;bone;macula lutea;liver;testis;kidney;	superior cervical ganglion;salivary gland;ciliary ganglion;kidney;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.75114	0.17796	-0.003562597	53.72729417	1772.52944	7.77840	5p13.3		0.3387	0.3882	0.375	0.2130	.	0.4020	0.3191	0.3151	0.3775	0.4317	0.3529	0.3630	0.1035	0.3649	0.3820	0.3529	rs34628434						
5	32787132	32787132	A	-	UTR3	NPR3	NM_001204376:c.*681delA;NM_001204375:c.*681delA;NM_000908:c.*681delA			0.00309926266837596	0.985402925257705	0.0114978120739191	natriuretic peptide receptor 3	FUNCTION: Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity.; 	.	.	unclassifiable (Anatomical System);lymph node;heart;cartilage;tongue;sympathetic chain;fovea centralis;choroid;lens;skin;retina;bone marrow;uterus;optic nerve;lung;bone;macula lutea;liver;testis;kidney;	superior cervical ganglion;salivary gland;ciliary ganglion;kidney;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.75114	0.17796	-0.003562597	53.72729417	1772.52944	7.77840	5p13.3										0.0074	0.0032	0.0287	0.0041	0	0.0588	0.0035	0.0182	rs79712706						
5	37065443	37065443	A	-	UTR3	NIPBL	NM_015384:c.*1318delA;NM_133433:c.*449delA			1	9.20137767442571e-18	1.38152926385215e-43	Nipped-B homolog (Drosophila)	FUNCTION: Probably plays a structural role in chromatin. Involved in sister chromatid cohesion, possibly by interacting with the cohesin complex (By similarity). {ECO:0000250}.; 	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed. Highly expressed in heart, skeletal muscle, fetal and adult liver, fetal and adult kidney. Expressed at intermediates level in thymus, placenta, peripheral leukocyte and small intestine. Weakly or not expressed in brain, colon, spleen and lung. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186}.; 	ovary;umbilical cord;salivary gland;intestine;colon;skin;bone marrow;uterus;whole body;bone;thyroid;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;adrenal cortex;pharynx;blood;breast;lung;cornea;nasopharynx;placenta;visual apparatus;alveolus;liver;spleen;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;medulla oblongata;white blood cells;atrioventricular node;pons;skeletal muscle;uterus;testis - seminiferous tubule;appendix;ciliary ganglion;trigeminal ganglion;whole blood;parietal lobe;	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	5p13.2										0.0529	0.1436	0.0492	0.0085	0.0006	0.0556	0.0027	0.0231	rs768908921	297455	Cornelia_de_Lange_Syndrome	MedGen:CN239271	criteria_provided,_single_submitter	Uncertain_significance	
5	38940122	38940122	T	-	UTR3	RICTOR	NM_152756:c.*2284delA;NM_001285440:c.*2284delA;NM_001285439:c.*2284delA			0.999999999869293	1.30706909396292e-10	3.0252953193937e-28	RPTOR independent companion of MTOR, complex 2	FUNCTION: Subunit of mTORC2, which regulates cell growth and survival in response to hormonal signals. mTORC2 is activated by growth factors, but, in contrast to mTORC1, seems to be nutrient- insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'. Plays an essential role in embryonic growth and development. {ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15718470}.; 	.	.	ovary;colon;parathyroid;skin;uterus;prostate;whole body;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;visual apparatus;liver;spleen;kidney;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	.	.	-0.28106828	33.55744279	3691.63911	11.84114	5p13.1										0.0037	0.0004	0.0197	0.0042	0	0.0238	0.0043	0.0031							
5	38940365	38940365	-	A	UTR3	RICTOR	NM_152756:c.*2040_*2041insT;NM_001285440:c.*2040_*2041insT;NM_001285439:c.*2040_*2041insT			0.999999999869293	1.30706909396292e-10	3.0252953193937e-28	RPTOR independent companion of MTOR, complex 2	FUNCTION: Subunit of mTORC2, which regulates cell growth and survival in response to hormonal signals. mTORC2 is activated by growth factors, but, in contrast to mTORC1, seems to be nutrient- insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'. Plays an essential role in embryonic growth and development. {ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15718470}.; 	.	.	ovary;colon;parathyroid;skin;uterus;prostate;whole body;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;visual apparatus;liver;spleen;kidney;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	.	.	-0.28106828	33.55744279	3691.63911	11.84114	5p13.1										0.0063	0.0180	0.0015	0	0.0110	0.0005	0	0.0025	rs199955000						
5	40829780	40829780	-	AC	upstream	LOC100506548	dist=536																		5p13.1										0.4584	0.4465	0.5625	0.5246	0.7597	0.4295	0.4292	0.4561	rs35401377						
5	40830602	40830602	-	T	downstream	RPL37	dist=828			0.577671288406045	0.411363789173122	0.0109649224208325	ribosomal protein L37	FUNCTION: Binds to the 23S rRNA. {ECO:0000250}.; 	.	.	lymphoreticular;ovary;foreskin;skin;bone marrow;prostate;frontal lobe;cochlea;thyroid;germinal center;bladder;brain;heart;cartilage;adrenal cortex;pharynx;blood;skeletal muscle;breast;trabecular meshwork;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;peripheral nerve;salivary gland;intestine;colon;parathyroid;vein;uterus;cerebral cortex;bone;testis;dura mater;artery;pineal gland;unclassifiable (Anatomical System);meninges;lymph node;trophoblast;epidermis;islets of Langerhans;muscle;bile duct;pancreas;pia mater;lung;cornea;mesenchyma;adrenal gland;nasopharynx;placenta;kidney;stomach;aorta;	ovary;white blood cells;skin;	0.59796	0.11453	-0.009020804	52.8544468	4.87318	0.17976	5p13.1										0.3287	0.4010	0.2980	0.4146	0.5399	0.331	0.2616	0.3084	rs201454585						
5	41069953	41069954	CT	-	intronic	MROH2B				1.28868466121395e-26	0.0250058459524975	0.974994154047502	maestro heat like repeat family member 2B	.	.	.	.	.	.	0.08456	1.598375034	95.87756546	6887.10584	17.68880	5p13.1										9.873e-05	0.0001	0	0	0	0.0003	6.758e-05	0	rs372893981						
5	41919108	41919108	T	-	UTR3	C5orf51	NM_175921:c.*1707delT			0.00388889950519938	0.957830833511929	0.038280266982872	chromosome 5 open reading frame 51	.	.	.	.	.	.	.	0.104848986	61.49445624	180.03222	2.91542	5p13.1										0.0099	0.0034	0.0354	0.0282	0.0006	0.0690	0.0058	0.0213							
5	41921536	41921536	T	-	UTR3	C5orf51	NM_175921:c.*4135delT			0.00388889950519938	0.957830833511929	0.038280266982872	chromosome 5 open reading frame 51	.	.	.	.	.	.	.	0.104848986	61.49445624	180.03222	2.91542	5p13.1										0.0093	0.0027	0.0335	0.0333	0.0007	0.0573	0.0083	0.0156							
5	43290195	43290195	A	-	UTR3	HMGCS1	NM_002130:c.*1038delT;NM_001324219:c.*1038delT;NM_001324220:c.*1038delT;NM_001324224:c.*1038delT;NM_001324223:c.*1038delT;NM_001324222:c.*1038delT;NM_001098272:c.*1038delT;NM_001330663:c.*1038delT			0.972848684238687	0.0271444073599248	6.90840138789878e-06	3-hydroxy-3-methylglutaryl-CoA synthase 1	FUNCTION: This enzyme condenses acetyl-CoA with acetoacetyl-CoA to form HMG-CoA, which is the substrate for HMG-CoA reductase.; 	.	.	ovary;salivary gland;sympathetic chain;intestine;colon;parathyroid;skin;prostate;whole body;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;hypothalamus;urinary;adrenal cortex;pharynx;blood;skeletal muscle;pancreas;lung;adrenal gland;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;kidney;mammary gland;stomach;	fetal liver;occipital lobe;superior cervical ganglion;fetal brain;hypothalamus;prefrontal cortex;globus pallidus;atrioventricular node;parietal lobe;	0.37751	0.40200	-0.405853867	26.23260203	38.55982	1.14337	5p12										0.0612	0.1022	0.1037	0.1221	0.0055	0.2517	0.0315	0.0597							
5	43705874	43705875	TG	-	downstream	NNT	dist=206			0.99955047731355	0.000449522673957905	1.24921717048606e-11	nicotinamide nucleotide transhydrogenase	FUNCTION: The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane. May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland. {ECO:0000269|PubMed:22634753}.; 	.	TISSUE SPECIFICITY: Widely expressed with expression most readily detectable in adrenal, heart, kidney, thyroid and adipose tissues. {ECO:0000269|PubMed:22634753}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;atrium;cochlea;endometrium;bone;thyroid;pituitary gland;testis;amniotic fluid;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;hypothalamus;adrenal cortex;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;adrenal gland;placenta;visual apparatus;hippocampus;amnion;liver;spleen;kidney;mammary gland;stomach;aorta;	superior cervical ganglion;occipital lobe;globus pallidus;skeletal muscle;	0.37225	0.09181	-0.394936437	27.02878037	828.99367	5.64434	5p12										0.0005	0.0001	0.0014	0	0	0.0027	0.0003	0							
5	43706568	43706568	A	-	downstream	NNT	dist=900			0.99955047731355	0.000449522673957905	1.24921717048606e-11	nicotinamide nucleotide transhydrogenase	FUNCTION: The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane. May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland. {ECO:0000269|PubMed:22634753}.; 	.	TISSUE SPECIFICITY: Widely expressed with expression most readily detectable in adrenal, heart, kidney, thyroid and adipose tissues. {ECO:0000269|PubMed:22634753}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;atrium;cochlea;endometrium;bone;thyroid;pituitary gland;testis;amniotic fluid;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;hypothalamus;adrenal cortex;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;adrenal gland;placenta;visual apparatus;hippocampus;amnion;liver;spleen;kidney;mammary gland;stomach;aorta;	superior cervical ganglion;occipital lobe;globus pallidus;skeletal muscle;	0.37225	0.09181	-0.394936437	27.02878037	828.99367	5.64434	5p12										0.0060	0.0044	0.0379	0	0	0.0418	0.0037	0.0097							
5	50140822	50140822	T	-	UTR3	PARP8	NM_001178055:c.*2920delT;NM_024615:c.*2920delT;NM_001178056:c.*2920delT;NM_001331028:c.*2920delT			0.119242934394393	0.880756987949444	7.7656163073708e-08	poly(ADP-ribose) polymerase family member 8	.	.	.	unclassifiable (Anatomical System);ovary;heart;islets of Langerhans;blood;lens;skin;bone marrow;breast;uterus;prostate;pancreas;whole body;lung;frontal lobe;endometrium;larynx;thyroid;placenta;liver;testis;head and neck;spleen;germinal center;kidney;brain;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.35408	.	-0.911109353	9.961075725	112.79172	2.31004	5q11.1										0.0015	0.0011	0.0052	0	0.0013	0.0085	0.0007	0.0026							
5	52250450	52250451	TG	-	downstream	ITGA1	dist=965			0.00237568458237799	0.997624074378156	2.4103946635786e-07	integrin subunit alpha 1	FUNCTION: Integrin alpha-1/beta-1 is a receptor for laminin and collagen. It recognizes the proline-hydroxylated sequence G-F-P-G- E-R in collagen. Involved in anchorage-dependent, negative regulation of EGF-stimulated cell growth. {ECO:0000269|PubMed:15592458}.; 	.	.	smooth muscle;ovary;colon;parathyroid;skin;uterus;prostate;whole body;oesophagus;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;aorta;peripheral nerve;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;	0.52354	0.10542	-0.06060434	48.88535032	3525.16744	11.45196	5q11.2																								
5	52250990	52250990	-	AA	intergenic	ITGA1;ITGA2	dist=1505;dist=34166																		5q11.2										0.0931	0.0429	0.2049	0.1119	0.1970	0.1100	0.1001	0.1156	rs34260395						
5	52390026	52390026	-	ATTATATAAACAACTTTGTAGGACT	UTR3	ITGA2	NM_002203:c.*3597_*3598insATTATATAAACAACTTTGTAGGACT			9.23087390177119e-09	0.999960004500544	3.99862685818173e-05	integrin subunit alpha 2	FUNCTION: Integrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin. It recognizes the proline-hydroxylated sequence G-F-P-G-E-R in collagen. It is responsible for adhesion of platelets and other cells to collagens, modulation of collagen and collagenase gene expression, force generation and organization of newly synthesized extracellular matrix.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;optic nerve;frontal lobe;thyroid;bone;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;visual apparatus;cervix;head and neck;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;trigeminal ganglion;	0.27783	0.62384	-0.23697515	36.32342534	1299.77706	6.78223	5q11.2										0.3489	0.2833	0.4306	0.4007	0.2878	0.3958	0.3757	0.3691	rs140054322	304507	Platelet-type_bleeding_disorder_9	MedGen:C3280114,OMIM:614200,Orphanet:ORPHA98886	criteria_provided,_single_submitter	Uncertain_significance	
5	53180803	53180803	A	-	UTR3	ARL15	NM_019087:c.*1588delT			0.00886642197401129	0.804130997763244	0.187002580262744	ADP ribosylation factor like GTPase 15	.	.	.	.	.	0.61156	0.10510	-0.163345027	41.24793583	6.04468	0.22863	5q11.2										0.0075	0.0031	0.0371	0.0044	0	0.0824	0.0034	0.0164							
5	54706325	54706325	-	TTTAAA	intronic	SKIV2L2				0.725400924600165	0.274599067097836	8.30199923198606e-09	Ski2 like RNA helicase 2	FUNCTION: May be involved in pre-mRNA splicing. Associated with the RNA exosome complex and involved in the 3'-processing of the 7S pre-RNA to the mature 5.8S rRNA. {ECO:0000269|PubMed:17412707}.; 	.	.	ovary;skin;prostate;frontal lobe;cochlea;endometrium;thyroid;iris;germinal center;bladder;brain;gall bladder;amygdala;heart;cartilage;urinary;adrenal cortex;pharynx;blood;skeletal muscle;breast;trabecular meshwork;visual apparatus;liver;spleen;cervix;mammary gland;peripheral nerve;salivary gland;developmental;intestine;colon;parathyroid;choroid;uterus;whole body;oesophagus;larynx;bone;testis;pineal gland;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;placenta;hippocampus;head and neck;kidney;stomach;	superior cervical ganglion;testis - interstitial;temporal lobe;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.57998	0.15628	-1.153638777	6.233781552	85.82584	1.97798	5q11.2		0.8815	0.7493	0.9436	0.7315	0.8989	0.8992	0.8695	0.9214	0.8546	0.7546	0.9330	0.8609	0.7280	0.9168	0.9047	0.8860	rs139320115						
5	55034757	55034757	T	-	intronic	DDX4				0.998516038315595	0.0014839616379786	4.64268163008862e-11	DEAD-box helicase 4	FUNCTION: May play a role in germ cell development. May play a role in sperm motility. {ECO:0000269|PubMed:10920202, ECO:0000269|PubMed:21034600}.; 	.	TISSUE SPECIFICITY: Expressed only in ovary and testis. Expressed in migratory primordial germ cells in the region of the gonadal ridge in both sexes. {ECO:0000269|PubMed:10920202}.; 	unclassifiable (Anatomical System);testis;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;cerebellum peduncles;testis;ciliary ganglion;skeletal muscle;	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	5q11.2		0.1922	0.1039	0.2390	0.1948	0.0814	0.1871	0.1871	0.2773	0.0084	0.0095	0.025	0.0157	0.0076	0.0541	0.0028	0.0074	rs779005328						
5	55112499	55112499	A	-	UTR3	DDX4	NM_024415:c.*131delA;NM_001142549:c.*131delA;NM_001166533:c.*131delA;NM_001166534:c.*131delA			0.998516038315595	0.0014839616379786	4.64268163008862e-11	DEAD-box helicase 4	FUNCTION: May play a role in germ cell development. May play a role in sperm motility. {ECO:0000269|PubMed:10920202, ECO:0000269|PubMed:21034600}.; 	.	TISSUE SPECIFICITY: Expressed only in ovary and testis. Expressed in migratory primordial germ cells in the region of the gonadal ridge in both sexes. {ECO:0000269|PubMed:10920202}.; 	unclassifiable (Anatomical System);testis;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;cerebellum peduncles;testis;ciliary ganglion;skeletal muscle;	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	5q11.2										0.0007	0.0004	0.0014	0	0	0.0059	0.0001	0	rs577314852						
5	55235961	55235961	-	TATATGTGTGTGTA	UTR3	IL6ST	NM_175767:c.*2632_*2633insTACACACACATATA;NM_001190981:c.*948_*949insTACACACACATATA;NM_002184:c.*948_*949insTACACACACATATA			0.997842778499494	0.00215722092922236	5.71283989692817e-10	interleukin 6 signal transducer	FUNCTION: Signal-transducing molecule. The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Binding of IL6 to IL6R induces IL6ST homodimerization and formation of a high-affinity receptor complex, which activates Janus kinases (PubMed:2261637). That causes phosphorylation of IL6ST tyrosine residues which in turn activates STAT3 (PubMed:19915009, PubMed:23294003). Mediates signals which regulate immune response, hematopoiesis, pain control and bone metabolism (By similarity). Has a role in embryonic development (By similarity). Does not bind IL6 (PubMed:2261637). Essential for survival of motor and sensory neurons and for differentiation of astrocytes (By similarity). Required for expression of TRPA1 in nociceptive neurons (By similarity). Required for the maintenance of PTH1R expression in the osteoblast lineage and for the stimulation of PTH-induced osteoblast differentiation (By similarity). Required for normal trabecular bone mass and cortical bone composition (By similarity). {ECO:0000250|UniProtKB:Q00560, ECO:0000269|PubMed:19915009, ECO:0000269|PubMed:2261637, ECO:0000269|PubMed:23294003}.; 	.	TISSUE SPECIFICITY: Found in all the tissues and cell lines examined (PubMed:2261637). Expression not restricted to IL6 responsive cells (PubMed:2261637). Expressed in blood serum (at protein level) (PubMed:24629561). {ECO:0000269|PubMed:2261637, ECO:0000269|PubMed:24629561}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;bone;testis;brain;tonsil;unclassifiable (Anatomical System);heart;lens;skeletal muscle;breast;lung;mesenchyma;nasopharynx;placenta;macula lutea;liver;hypopharynx;spleen;head and neck;kidney;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.67923	0.76430	0.536463361	81.06864827	3018.2823	10.43351	5q11.2										0.0328	0.0450	0.0312	0.0276	0.0633	0.0335	0.0244	0.0301	rs58368867						
5	55235963	55235963	-	TATGTGTGTG	UTR3	IL6ST	NM_175767:c.*2630_*2631insCACACACATA;NM_001190981:c.*946_*947insCACACACATA;NM_002184:c.*946_*947insCACACACATA			0.997842778499494	0.00215722092922236	5.71283989692817e-10	interleukin 6 signal transducer	FUNCTION: Signal-transducing molecule. The receptor systems for IL6, LIF, OSM, CNTF, IL11, CTF1 and BSF3 can utilize IL6ST for initiating signal transmission. Binding of IL6 to IL6R induces IL6ST homodimerization and formation of a high-affinity receptor complex, which activates Janus kinases (PubMed:2261637). That causes phosphorylation of IL6ST tyrosine residues which in turn activates STAT3 (PubMed:19915009, PubMed:23294003). Mediates signals which regulate immune response, hematopoiesis, pain control and bone metabolism (By similarity). Has a role in embryonic development (By similarity). Does not bind IL6 (PubMed:2261637). Essential for survival of motor and sensory neurons and for differentiation of astrocytes (By similarity). Required for expression of TRPA1 in nociceptive neurons (By similarity). Required for the maintenance of PTH1R expression in the osteoblast lineage and for the stimulation of PTH-induced osteoblast differentiation (By similarity). Required for normal trabecular bone mass and cortical bone composition (By similarity). {ECO:0000250|UniProtKB:Q00560, ECO:0000269|PubMed:19915009, ECO:0000269|PubMed:2261637, ECO:0000269|PubMed:23294003}.; 	.	TISSUE SPECIFICITY: Found in all the tissues and cell lines examined (PubMed:2261637). Expression not restricted to IL6 responsive cells (PubMed:2261637). Expressed in blood serum (at protein level) (PubMed:24629561). {ECO:0000269|PubMed:2261637, ECO:0000269|PubMed:24629561}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;bone;testis;brain;tonsil;unclassifiable (Anatomical System);heart;lens;skeletal muscle;breast;lung;mesenchyma;nasopharynx;placenta;macula lutea;liver;hypopharynx;spleen;head and neck;kidney;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.67923	0.76430	0.536463361	81.06864827	3018.2823	10.43351	5q11.2										0.1637	0.0696	0.3385	0.1870	0	0.1893	0.2082	0.1760	rs370724076						
5	55528572	55528572	-	AC	intronic	ANKRD55				2.4350104791824e-07	0.899803593421729	0.100196163077223	ankyrin repeat domain 55	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;placenta;liver;testis;spleen;head and neck;brain;skeletal muscle;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;pons;trigeminal ganglion;skeletal muscle;	0.10140	.	0.158037129	64.85020052	148.38001	2.65527	5q11.2										0.1394	0.1180	0.1578	0.1438	0.0783	0.1881	0.1461	0.1587	rs142447793						
5	55528572	55528572	-	ACAC	intronic	ANKRD55				2.4350104791824e-07	0.899803593421729	0.100196163077223	ankyrin repeat domain 55	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;placenta;liver;testis;spleen;head and neck;brain;skeletal muscle;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;pons;trigeminal ganglion;skeletal muscle;	0.10140	.	0.158037129	64.85020052	148.38001	2.65527	5q11.2										0.2993	0.3472	0.2772	0.2568	0.7080	0.2894	0.2308	0.3	rs142447793						
5	58149863	58149863	-	ACAC	UTR3	RAB3C	NM_001317915:c.*2685_*2686insACAC;NM_138453:c.*2685_*2686insACAC			0.015496264062785	0.880012133928957	0.104491602008258	RAB3C, member RAS oncogene family	FUNCTION: Protein transport. Probably involved in vesicular traffic (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in brain, placenta and lung. {ECO:0000269|PubMed:12296628}.; 	unclassifiable (Anatomical System);lung;frontal lobe;islets of Langerhans;hypothalamus;placenta;brain;skeletal muscle;retina;	globus pallidus;ciliary ganglion;trigeminal ganglion;	0.57323	0.14229	-0.295622497	32.61972163	8.00432	0.29420	5q11.2										0.2363	0.2560	0.2546	0.2743	0.1671	0.2485	0.2281	0.2537							
5	58266736	58266736	A	-	UTR3	PDE4D	NM_001197221:c.*3755delT;NM_006203:c.*3755delT;NM_001104631:c.*3755delT;NM_001197222:c.*3755delT;NM_001197219:c.*3755delT;NM_001197223:c.*3755delT;NM_001165899:c.*3755delT;NM_001197218:c.*3755delT;NM_001197220:c.*3755delT;NM_001349243:c.*3755delT;NM_001349241:c.*3755delT;NM_001349242:c.*3755delT			0.983199686418857	0.0168002270009629	8.65801803613267e-08	phosphodiesterase 4D	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. {ECO:0000269|PubMed:15260978, ECO:0000269|PubMed:15576036}.; 	DISEASE: Note=Genetic variations in PDE4D might be associated with susceptibility to stroke. PubMed:17006457 states that association with stroke has to be considered with caution. {ECO:0000269|PubMed:17006457}.; DISEASE: Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]: A pleiotropic disorder characterized by skeletal, endocrine, and neurological abnormalities. Skeletal features include brachycephaly, midface hypoplasia with a small upturned nose, brachydactyly, and lumbar spinal stenosis. Endocrine abnormalities include hypothyroidism and hypogonadism in males and irregular menses in females. Developmental disability is a common finding but is variable in severity and can be associated with significant behavioral problems. {ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:23033274, ECO:0000269|PubMed:23043190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in colonic epithelial cells (at protein level). Widespread; most abundant in skeletal muscle. Isoform 6 is detected in brain. Isoform 8 is detected in brain, placenta, lung and kidney. Isoform 7 is detected in heart and skeletal muscle. {ECO:0000269|PubMed:12834813, ECO:0000269|PubMed:17244609}.; 	unclassifiable (Anatomical System);ovary;cartilage;heart;colon;blood;skin;skeletal muscle;uterus;prostate;whole body;lung;endometrium;larynx;pituitary gland;liver;testis;spleen;head and neck;kidney;germinal center;brain;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.24539	0.34543	-1.375949569	4.393724935	15.63977	0.55771	5q11.2										0.0241	0.0310	0.0494	0.0310	0.0007	0.1291	0.0133	0.0340	rs112565146						
5	58270458	58270458	A	-	UTR3	PDE4D	NM_001197221:c.*33delT;NM_006203:c.*33delT;NM_001104631:c.*33delT;NM_001197222:c.*33delT;NM_001197219:c.*33delT;NM_001197223:c.*33delT;NM_001165899:c.*33delT;NM_001197218:c.*33delT;NM_001197220:c.*33delT;NM_001349243:c.*33delT;NM_001349241:c.*33delT;NM_001349242:c.*33delT			0.983199686418857	0.0168002270009629	8.65801803613267e-08	phosphodiesterase 4D	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. {ECO:0000269|PubMed:15260978, ECO:0000269|PubMed:15576036}.; 	DISEASE: Note=Genetic variations in PDE4D might be associated with susceptibility to stroke. PubMed:17006457 states that association with stroke has to be considered with caution. {ECO:0000269|PubMed:17006457}.; DISEASE: Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]: A pleiotropic disorder characterized by skeletal, endocrine, and neurological abnormalities. Skeletal features include brachycephaly, midface hypoplasia with a small upturned nose, brachydactyly, and lumbar spinal stenosis. Endocrine abnormalities include hypothyroidism and hypogonadism in males and irregular menses in females. Developmental disability is a common finding but is variable in severity and can be associated with significant behavioral problems. {ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:23033274, ECO:0000269|PubMed:23043190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in colonic epithelial cells (at protein level). Widespread; most abundant in skeletal muscle. Isoform 6 is detected in brain. Isoform 8 is detected in brain, placenta, lung and kidney. Isoform 7 is detected in heart and skeletal muscle. {ECO:0000269|PubMed:12834813, ECO:0000269|PubMed:17244609}.; 	unclassifiable (Anatomical System);ovary;cartilage;heart;colon;blood;skin;skeletal muscle;uterus;prostate;whole body;lung;endometrium;larynx;pituitary gland;liver;testis;spleen;head and neck;kidney;germinal center;brain;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.24539	0.34543	-1.375949569	4.393724935	15.63977	0.55771	5q11.2		0.3815	0.3530	0.4418	0.3709	0.3508	0.3793	0.3687	0.3777	0.1865	0.1532	0.2220	0.1260	0.1637	0.3358	0.1830	0.2195	rs10718401						
5	58272140	58272141	AC	-	intronic	PDE4D				0.983199686418857	0.0168002270009629	8.65801803613267e-08	phosphodiesterase 4D	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. {ECO:0000269|PubMed:15260978, ECO:0000269|PubMed:15576036}.; 	DISEASE: Note=Genetic variations in PDE4D might be associated with susceptibility to stroke. PubMed:17006457 states that association with stroke has to be considered with caution. {ECO:0000269|PubMed:17006457}.; DISEASE: Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]: A pleiotropic disorder characterized by skeletal, endocrine, and neurological abnormalities. Skeletal features include brachycephaly, midface hypoplasia with a small upturned nose, brachydactyly, and lumbar spinal stenosis. Endocrine abnormalities include hypothyroidism and hypogonadism in males and irregular menses in females. Developmental disability is a common finding but is variable in severity and can be associated with significant behavioral problems. {ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:23033274, ECO:0000269|PubMed:23043190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in colonic epithelial cells (at protein level). Widespread; most abundant in skeletal muscle. Isoform 6 is detected in brain. Isoform 8 is detected in brain, placenta, lung and kidney. Isoform 7 is detected in heart and skeletal muscle. {ECO:0000269|PubMed:12834813, ECO:0000269|PubMed:17244609}.; 	unclassifiable (Anatomical System);ovary;cartilage;heart;colon;blood;skin;skeletal muscle;uterus;prostate;whole body;lung;endometrium;larynx;pituitary gland;liver;testis;spleen;head and neck;kidney;germinal center;brain;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.24539	0.34543	-1.375949569	4.393724935	15.63977	0.55771	5q11.2		0.0567	0.0588	0.0624	0.0819	0.0516	0.0558	0.0362	0.0444	0	0	0	0	0	0	0	0	rs151199228						
5	58286738	58286738	A	-	intronic	PDE4D				0.983199686418857	0.0168002270009629	8.65801803613267e-08	phosphodiesterase 4D	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. {ECO:0000269|PubMed:15260978, ECO:0000269|PubMed:15576036}.; 	DISEASE: Note=Genetic variations in PDE4D might be associated with susceptibility to stroke. PubMed:17006457 states that association with stroke has to be considered with caution. {ECO:0000269|PubMed:17006457}.; DISEASE: Acrodysostosis 2, with or without hormone resistance (ACRDYS2) [MIM:614613]: A pleiotropic disorder characterized by skeletal, endocrine, and neurological abnormalities. Skeletal features include brachycephaly, midface hypoplasia with a small upturned nose, brachydactyly, and lumbar spinal stenosis. Endocrine abnormalities include hypothyroidism and hypogonadism in males and irregular menses in females. Developmental disability is a common finding but is variable in severity and can be associated with significant behavioral problems. {ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:23033274, ECO:0000269|PubMed:23043190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in colonic epithelial cells (at protein level). Widespread; most abundant in skeletal muscle. Isoform 6 is detected in brain. Isoform 8 is detected in brain, placenta, lung and kidney. Isoform 7 is detected in heart and skeletal muscle. {ECO:0000269|PubMed:12834813, ECO:0000269|PubMed:17244609}.; 	unclassifiable (Anatomical System);ovary;cartilage;heart;colon;blood;skin;skeletal muscle;uterus;prostate;whole body;lung;endometrium;larynx;pituitary gland;liver;testis;spleen;head and neck;kidney;germinal center;brain;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.24539	0.34543	-1.375949569	4.393724935	15.63977	0.55771	5q11.2		0.3621	0.3550	0.3430	0.3988	0.381	0.3566	0.3697	0.3648	0.0107	0.0031	0.0357	0.0189	0.0087	0.0995	0.0075	0.0277	rs776434889						
5	60454402	60454403	AA	-	UTR3	SMIM15	NM_001048249:c.*1372_*1371delTT			0.228320204389897	0.646585588537203	0.1250942070729	small integral membrane protein 15	.	.	.	.	.	.	.	0.523736627	80.45529606	42.17786	1.22739	5q12.1										0.5085	0.3400	0.6059	0.5512	0.9167	0.5320	0.5458	0.5328	rs147178654						
5	60628827	60628827	G	-	intronic	ZSWIM6				0.330184633856795	0.487164435485213	0.182650930657992	zinc finger SWIM-type containing 6	.	DISEASE: Acromelic frontonasal dysostosis (AFND) [MIM:603671]: A rare variant form of frontonasal dysplasia, an array of abnormalities affecting the eyes, forehead and nose and linked to midfacial dysraphia. The clinical picture is highly variable. Major findings include true ocular hypertelorism, broadening of the nasal root, median facial cleft affecting the nose and/or upper lip and palate, unilateral or bilateral clefting of the alae nasi, lack of formation of the nasal tip, anterior cranium bifidum occultum, a V-shaped or widow's peak frontal hairline. AFND is characterized by the association of frontonasal malformations with various combinations of polydactyly, tibial hypoplasia, epibulbar dermoid, encephalocoele, corpus callosum agenesis and Dandy-Walker malformation. {ECO:0000269|PubMed:25105228}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	smooth muscle;ovary;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;blood;lens;pancreas;lung;trabecular meshwork;placenta;macula lutea;hippocampus;liver;alveolus;spleen;head and neck;kidney;	parietal lobe;	0.64957	.	0.194852702	67.03231894	5743.17758	15.71993	5q12.1										0.0125	0.0183	0.0216	0	0.0094	0.0133	0.0094	0.0137	rs369791585						
5	64017403	64017403	A	-	UTR3	SREK1IP1	NM_173829:c.*2808delT			0.656016357375955	0.338309900018231	0.00567374260581435	SREK1 interacting protein 1	FUNCTION: Possible splicing regulator involved in the control of cellular survival.; 	.	.	.	.	0.23092	0.09836	0.235309407	68.71903751	130.49652	2.48867	5q12.3										0.0290	0.0061	0.0306	0.1009	0	0.2273	0.0322	0.0491	rs112025936						
5	64886375	64886375	A	-	UTR3	TRIM23	NM_001656:c.*1221delT			0.0669671844650749	0.932910791888065	0.000122023646860497	tripartite motif containing 23	FUNCTION: Acts as an E3 ubiquitin-protein ligase. In the presence of the human cytomegalovirus (HCMV) protein UL144, participates in 'Lys-63'-linked auto-ubiquitination of TRAF6 resulting in the virally controlled activation of NF-kappa-B at early time of infection. The C-terminus can act as an allosteric activator of the cholera toxin catalytic subunit. {ECO:0000269|PubMed:15684077}.; 	.	.	ovary;sympathetic chain;developmental;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;hippocampus;liver;spleen;mammary gland;stomach;	medulla oblongata;superior cervical ganglion;prefrontal cortex;	0.66059	0.12378	-0.624497208	17.16206653	86.98408	1.99201	5q12.3										0.6306	0.6323	0.5377	0.6029	0.4609	0.6468	0.6509	0.6311	rs3836739						
5	64942853	64942853	T	-	intronic	TRAPPC13				0.765500289091919	0.234124474031234	0.000375236876846653	trafficking protein particle complex 13	.	.	.	.	.	.	0.10825	0.12689526	63.00424628	72.15214	1.76947	5q12.3		0.2409	0.2652	0.2279	0.2322	0.2225	0.2344	0.2176	0.2485	0.0120	0.0025	0.0543	0.0341	0.0007	0.0788	0.0080	0.0306	rs781616933						
5	65081746	65081746	T	-	intronic	NLN				3.59597227684907e-07	0.985541392010036	0.0144582483927363	neurolysin	FUNCTION: Hydrolyzes oligopeptides such as neurotensin, bradykinin and dynorphin A. {ECO:0000250}.; 	.	.	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;vein;skin;retina;uterus;prostate;whole body;frontal lobe;endometrium;bone;thyroid;testis;brain;bladder;pineal gland;unclassifiable (Anatomical System);cartilage;heart;adrenal cortex;pharynx;blood;bile duct;pancreas;lung;adrenal gland;placenta;macula lutea;visual apparatus;liver;cervix;kidney;aorta;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.39163	0.14364	-0.354480518	29.42911064	1132.42209	6.41990	5q12.3		0.2728	0.2197	0.2901	0.2832	0.1838	0.2717	0.2571	0.3268	0.0034	0.0009	0.0216	0.0078	0	0.0255	0.0014	0.0089	rs769634832						
5	65375201	65375201	T	-	UTR3	ERBIN	NM_001253697:c.*843delT;NM_018695:c.*843delT;NM_001253701:c.*843delT;NM_001253699:c.*843delT;NM_001253698:c.*843delT;NM_001006600:c.*843delT			.	.	.	erbb2 interacting protein	FUNCTION: Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated 'Tyr-1248' of receptor ERBB2, it may contribute to stabilize this unphosphorylated state (PubMed:16203728). Inhibits NOD2-dependent NF-kappa-B signaling and proinflammatory cytokine secretion (PubMed:16203728). {ECO:0000269|PubMed:10878805, ECO:0000269|PubMed:16203728}.; 	.	TISSUE SPECIFICITY: Highly expressed in brain, heart, kidney, muscle and stomach, followed by liver, spleen and intestine. {ECO:0000269|PubMed:10878805}.; 	.	.	0.44557	0.10863	1.387050485	94.63906582	.	.	5q12.3										0.0165	0.0301	0.0272	0.0229	0.0036	0.0417	0.0075	0.0138	rs201439322						
5	66391516	66391516	-	T	intronic	MAST4				0.00813023877986137	0.991869761152038	6.81004097743866e-11	microtubule associated serine/threonine kinase family member 4	.	.	TISSUE SPECIFICITY: Highly expressed in most normal human tissues, with an exception of in testis, small intestine, colon and peripheral blood leukocyte. {ECO:0000269|PubMed:17086981}.; 	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;bone;thyroid;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;urinary;adrenal cortex;blood;lens;skeletal muscle;pancreas;lung;epididymis;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;testis - seminiferous tubule;tongue;prefrontal cortex;globus pallidus;appendix;ciliary ganglion;trigeminal ganglion;	0.25200	0.08190	-0.21518231	37.7034678	1048.70314	6.21915	5q12.3		0.1276	0.1743	0.0734	0.1106	0.1356	0.1260	0.1486	0.1149	0.0107	0.0055	0.0180	0.0082	0.0205	0.0450	0.0086	0.0134	rs773361906						
5	67584513	67584513	T	-	UTR5	PIK3R1	NM_181524:c.-51del-			0.998240487886569	0.00175951204310482	7.03263733080152e-11	phosphoinositide-3-kinase regulatory subunit 1	FUNCTION: Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed:20348923). {ECO:0000269|PubMed:17626883, ECO:0000269|PubMed:19805105, ECO:0000269|PubMed:20348923, ECO:0000269|PubMed:7518429}.; 	DISEASE: Agammaglobulinemia 7, autosomal recessive (AGM7) [MIM:615214]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:22351933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: SHORT syndrome (SHORTS) [MIM:269880]: A rare, multisystem disease characterized by short stature, anomalies of the anterior chamber of the eye, characteristic facial features such as triangular facies, lack of facial fat, and hypoplastic nasal alae with overhanging columella, partial lipodystrophy, hernias, hyperextensibility, and delayed dentition. The clinical phenotype can include insulin resistance, nephrocalcinosis, and hearing deficits. Developmental milestones and cognition are normal. {ECO:0000269|PubMed:23810378, ECO:0000269|PubMed:23810379, ECO:0000269|PubMed:23810382}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 36 (IMD36) [MIM:616005]: A primary immunodeficiency characterized by impaired B-cell function, hypogammaglobulinemia and recurrent infections. {ECO:0000269|PubMed:25133428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level). {ECO:0000269|PubMed:8628286}.; 	ovary;sympathetic chain;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;germinal center;brain;gall bladder;cartilage;heart;urinary;adrenal cortex;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;spleen;mammary gland;colon;parathyroid;choroid;fovea centralis;uterus;whole body;cerebral cortex;larynx;bone;pituitary gland;testis;pineal gland;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;lung;adrenal gland;placenta;head and neck;kidney;stomach;thymus;	amygdala;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;pons;atrioventricular node;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.88821	0.86719	-0.756778259	13.44656759	2135.01489	8.50101	5q13.1										0.0174	0.0456	0.0213	0	0.0006	0.0325	0.0011	0.0113	rs796402339						
5	67595055	67595055	A	-	UTR3	PIK3R1	NM_181523:c.*1626delA;NM_181524:c.*1626delA;NM_181504:c.*1626delA;NM_001242466:c.*1626delA			0.998240487886569	0.00175951204310482	7.03263733080152e-11	phosphoinositide-3-kinase regulatory subunit 1	FUNCTION: Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed:20348923). {ECO:0000269|PubMed:17626883, ECO:0000269|PubMed:19805105, ECO:0000269|PubMed:20348923, ECO:0000269|PubMed:7518429}.; 	DISEASE: Agammaglobulinemia 7, autosomal recessive (AGM7) [MIM:615214]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:22351933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: SHORT syndrome (SHORTS) [MIM:269880]: A rare, multisystem disease characterized by short stature, anomalies of the anterior chamber of the eye, characteristic facial features such as triangular facies, lack of facial fat, and hypoplastic nasal alae with overhanging columella, partial lipodystrophy, hernias, hyperextensibility, and delayed dentition. The clinical phenotype can include insulin resistance, nephrocalcinosis, and hearing deficits. Developmental milestones and cognition are normal. {ECO:0000269|PubMed:23810378, ECO:0000269|PubMed:23810379, ECO:0000269|PubMed:23810382}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 36 (IMD36) [MIM:616005]: A primary immunodeficiency characterized by impaired B-cell function, hypogammaglobulinemia and recurrent infections. {ECO:0000269|PubMed:25133428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level). {ECO:0000269|PubMed:8628286}.; 	ovary;sympathetic chain;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;germinal center;brain;gall bladder;cartilage;heart;urinary;adrenal cortex;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;spleen;mammary gland;colon;parathyroid;choroid;fovea centralis;uterus;whole body;cerebral cortex;larynx;bone;pituitary gland;testis;pineal gland;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;lung;adrenal gland;placenta;head and neck;kidney;stomach;thymus;	amygdala;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;pons;atrioventricular node;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.88821	0.86719	-0.756778259	13.44656759	2135.01489	8.50101	5q13.1										0.0001	0.0001	0	0	0	0	7.722e-05	0.0012	rs373752070						
5	68413043	68413043	T	-	intronic	SLC30A5				0.230512231685005	0.76942383353524	6.39347797548508e-05	solute carrier family 30 member 5	FUNCTION: Functions as a zinc transporter. May be a transporter of zinc into beta cells in order to form insulin crystals. Partly regulates cellular zinc homeostasis. Required with ZNT7 for the activation of zinc-requiring enzymes, alkaline phosphatases (ALPs). Transports zinc into the lumens of the Golgi apparatus and vesicular compartments where ALPs locate, thus, converting apoALPs to holoALPs. Required with ZNT6 and ZNT7 for the activation of TNAP. {ECO:0000269|PubMed:11904301, ECO:0000269|PubMed:11937503, ECO:0000269|PubMed:15276077, ECO:0000269|PubMed:15525635, ECO:0000269|PubMed:15994300}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in pancreas, liver and kidney. Expressed abundantly in insulin- containing beta cells, undetectable in other endocrine cell types including glucagon-secreting alpha cells and most acinar cells. {ECO:0000269|PubMed:11904301, ECO:0000269|PubMed:11937503}.; 	.	.	0.61924	0.13187	-0.088107893	47.06298655	141.89318	2.60037	5q13.2		0.4700	0.3034	0.5496	0.5781	0.4020	0.4702	0.4312	0.4871	0.3853	0.2638	0.5222	0.4014	0.5286	0.3774	0.4325	0.4133	rs3840519						
5	68498811	68498811	T	-	intronic	CENPH				7.52859796072614e-05	0.917590267529032	0.0823344464913607	centromere protein H	FUNCTION: Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. Required for chromosome congression and efficiently align the chromosomes on a metaphase plate. {ECO:0000269|PubMed:14536089, ECO:0000269|PubMed:16875666, ECO:0000269|PubMed:18007590}.; 	.	.	ovary;salivary gland;intestine;colon;skin;bone marrow;prostate;cochlea;endometrium;bone;testis;bladder;brain;unclassifiable (Anatomical System);lymph node;tongue;islets of Langerhans;pharynx;blood;pancreas;lung;placenta;visual apparatus;liver;head and neck;cervix;kidney;	testis;tumor;	0.17285	0.09314	0.014844891	54.94810097	21.20796	0.71661	5q13.2		0.0064	0.0045	0.0046	0.0072	0.0009	0.0086	0.0046	0.0019	6.563e-05	0	0	0	0	0.0006	0	0	rs759909125						
5	70837261	70837262	TT	-	intronic	BDP1				4.37097990000324e-11	0.999999989940482	1.00158085371442e-08	B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	FUNCTION: General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site. {ECO:0000269|PubMed:11040218}.; 	.	TISSUE SPECIFICITY: Isoform 2 is highly expressed in cerebellum. {ECO:0000269|PubMed:11161782}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;endometrium;pituitary gland;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;liver;cervix;kidney;mammary gland;stomach;aorta;cerebellum;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;fetal brain;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	0.23466	0.06953	2.388915264	98.48431234	3262.01073	10.89109	5q13.2																								
5	70888666	70888666	T	-	intronic	MCCC2				4.09035244002361e-08	0.940771768682395	0.0592281904140803	methylcrotonoyl-CoA carboxylase 2	FUNCTION: Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3- methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism. {ECO:0000269|PubMed:17360195}.; 	DISEASE: 3-methylcrotonoyl-CoA carboxylase 2 deficiency (MCC2D) [MIM:210210]: An autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3- hydroxyisovaleric acid and 3-methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency. {ECO:0000269|PubMed:11170888, ECO:0000269|PubMed:11181649, ECO:0000269|PubMed:11406611, ECO:0000269|PubMed:16010683, ECO:0000269|PubMed:17968484, ECO:0000269|PubMed:21071250, ECO:0000269|PubMed:22150417, ECO:0000269|PubMed:22264772, ECO:0000269|PubMed:22642865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);islets of Langerhans;colon;skeletal muscle;breast;uterus;prostate;lung;endometrium;bone;thyroid;placenta;visual apparatus;liver;testis;spleen;cervix;kidney;brain;stomach;	superior cervical ganglion;kidney;atrioventricular node;trigeminal ganglion;	0.03572	0.18035	-0.224023033	37.4321774	68.762	1.71805	5q13.2										0.0131	0.0188	0.0513	0.0093	0.0007	0.0509	0.0067	0.0135							
5	72168585	72168585	T	-	intronic	TNPO1				0.999998700726593	1.29927340572571e-06	9.84896444796015e-16	transportin 1	FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Involved in nuclear import of M9- containing proteins. In vitro, binds directly to the M9 region of the heterogeneous nuclear ribonucleoproteins (hnRNP), A1 and A2 and mediates their nuclear import. Appears also to be involved in hnRNP A1/A2 nuclear export. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones, and SRP19. In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. Mediates nuclear import of ADAR/ADAR1 (isoform 5) in a RanGTP-dependent manner. {ECO:0000250, ECO:0000269|PubMed:11682607, ECO:0000269|PubMed:19124606, ECO:0000269|PubMed:8986607, ECO:0000269|PubMed:9687515}.; 	.	.	ovary;salivary gland;colon;parathyroid;vein;skin;retina;uterus;prostate;whole body;frontal lobe;cochlea;larynx;bone;thyroid;pituitary gland;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;tongue;islets of Langerhans;hypothalamus;muscle;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;lung;adrenal gland;epididymis;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	amygdala;superior cervical ganglion;testis - interstitial;olfactory bulb;pons;atrioventricular node;fetal thyroid;skeletal muscle;prostate;fetal brain;testis - seminiferous tubule;prefrontal cortex;testis;ciliary ganglion;trigeminal ganglion;pituitary;	0.97077	0.18297	-0.780646273	12.77423921	36.30496	1.08710	5q13.2		0.0935	0.0711	0.1071	0.0919	0.0332	0.0926	0.0622	0.1368	0.0036	0.0083	0.0081	0	0	0.0119	0.0003	0.0028	rs750763786						
5	72204948	72204948	T	-	UTR3	TNPO1	NM_002270:c.*448delT;NM_153188:c.*448delT			0.999998700726593	1.29927340572571e-06	9.84896444796015e-16	transportin 1	FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Involved in nuclear import of M9- containing proteins. In vitro, binds directly to the M9 region of the heterogeneous nuclear ribonucleoproteins (hnRNP), A1 and A2 and mediates their nuclear import. Appears also to be involved in hnRNP A1/A2 nuclear export. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones, and SRP19. In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. Mediates nuclear import of ADAR/ADAR1 (isoform 5) in a RanGTP-dependent manner. {ECO:0000250, ECO:0000269|PubMed:11682607, ECO:0000269|PubMed:19124606, ECO:0000269|PubMed:8986607, ECO:0000269|PubMed:9687515}.; 	.	.	ovary;salivary gland;colon;parathyroid;vein;skin;retina;uterus;prostate;whole body;frontal lobe;cochlea;larynx;bone;thyroid;pituitary gland;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;tongue;islets of Langerhans;hypothalamus;muscle;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;lung;adrenal gland;epididymis;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	amygdala;superior cervical ganglion;testis - interstitial;olfactory bulb;pons;atrioventricular node;fetal thyroid;skeletal muscle;prostate;fetal brain;testis - seminiferous tubule;prefrontal cortex;testis;ciliary ganglion;trigeminal ganglion;pituitary;	0.97077	0.18297	-0.780646273	12.77423921	36.30496	1.08710	5q13.2										0.7729	0.6722	0.7692	0.7634	0.8442	0.7097	0.8332	0.7888	rs35315909						
5	72795161	72795165	ATCTC	-	intronic	BTF3				0.904371539633102	0.0948302739845624	0.000798186382335167	basic transcription factor 3	FUNCTION: When associated with NACA, prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. BTF3 is also a general transcription factor that can form a stable complex with RNA polymerase II. Required for the initiation of transcription. {ECO:0000269|PubMed:10982809}.; 	.	.	ovary;salivary gland;sympathetic chain;intestine;colon;vein;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;pituitary gland;testis;germinal center;brain;artery;bladder;gall bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;pineal body;muscle;adrenal cortex;pharynx;blood;cerebrum;breast;bile duct;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;duodenum;liver;cervix;spleen;kidney;mammary gland;aorta;stomach;thymus;	uterus;placenta;thyroid;white blood cells;	0.40567	0.10783	-0.141298762	42.87567823	16.96823	0.59753	5q13.2		0.1433	0.4615	0.1291	0.5743	0.1495	0.0732	0.1667	0.1166	0.2032	0.4358	0.1077	0.0662	0.5031	0.1207	0.0702	0.1158	rs3057009						
5	72875092	72875092	T	-	intronic	UTP15				0.985835503072082	0.0141642156681029	2.81259815009216e-07	UTP15, small subunit processome component	FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);islets of Langerhans;colon;skin;retina;uterus;whole body;lung;placenta;liver;testis;cervix;kidney;brain;stomach;	.	0.18584	0.12379	0.088260113	60.56853031	.	.	5q13.2		0.0699	0.0608	0.0810	0.073	0.0448	0.0686	0.0724	0.0859	0.0002	0.0003	0	0	0	0.0007	0	0.0011	rs200416122						
5	72876583	72876583	T	-	UTR3	UTP15	NM_032175:c.*664delT;NM_001284430:c.*664delT;NM_001284431:c.*664delT			0.985835503072082	0.0141642156681029	2.81259815009216e-07	UTP15, small subunit processome component	FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);islets of Langerhans;colon;skin;retina;uterus;whole body;lung;placenta;liver;testis;cervix;kidney;brain;stomach;	.	0.18584	0.12379	0.088260113	60.56853031	.	.	5q13.2										0.0014	0.0008	0.0036	0.0040	0	0.0082	0.0008	0.0013							
5	75624595	75624595	T	-	UTR3	SV2C	NM_014979:c.*3223delT			6.35694393316701e-05	0.994705085807682	0.00523134475298617	synaptic vesicle glycoprotein 2C	FUNCTION: Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);optic nerve;whole body;macula lutea;fovea centralis;choroid;lens;retina;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;ciliary ganglion;atrioventricular node;skeletal muscle;parietal lobe;	0.17231	0.13580	-0.24061166	36.28214201	2282.13442	8.83934	5q13.3										0.0532	0.0919	0.1069	0.0654	0.0241	0.1972	0.0159	0.0683							
5	75625890	75625890	A	-	UTR3	SV2C	NM_014979:c.*4518delA			6.35694393316701e-05	0.994705085807682	0.00523134475298617	synaptic vesicle glycoprotein 2C	FUNCTION: Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);optic nerve;whole body;macula lutea;fovea centralis;choroid;lens;retina;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;ciliary ganglion;atrioventricular node;skeletal muscle;parietal lobe;	0.17231	0.13580	-0.24061166	36.28214201	2282.13442	8.83934	5q13.3										0.5456	0.5027	0.5735	0.5909	0.4594	0.5145	0.5835	0.5612	rs11323774						
5	76264841	76264842	CA	-	UTR3	CRHBP	NM_001882:c.*131_*132delCA			0.989594470418958	0.0104023085279995	3.22105304206757e-06	corticotropin releasing hormone binding protein	FUNCTION: Binds CRF and inactivates it. May prevent inappropriate pituitary-adrenal stimulation in pregnancy.; 	.	.	unclassifiable (Anatomical System);ovary;heart;placenta;hippocampus;liver;parathyroid;spleen;kidney;germinal center;brain;mammary gland;skin;skeletal muscle;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;trigeminal ganglion;	0.68030	0.09992	-0.095386216	46.48502005	33.18155	1.02649	5q13.3										0.0184	0.0627	0.0050	0.0135	0	0.0003	0.0003	0.0010	rs146359925						
5	76722864	76722864	-	A	UTR3	PDE8B	NM_001349752:c.*485_*486insA;NM_001349750:c.*485_*486insA;NM_001349753:c.*485_*486insA;NM_001349751:c.*571_*572insA;NM_001029852:c.*485_*486insA;NM_001029851:c.*485_*486insA;NM_003719:c.*485_*486insA;NM_001029854:c.*485_*486insA;NM_001029853:c.*485_*486insA;NM_001349748:c.*485_*486insA;NM_001349749:c.*485_*486insA			0.986862335777411	0.0131376546495197	9.57306907025439e-09	phosphodiesterase 8B	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in specific signaling in the thyroid gland.; 	DISEASE: Striatal degeneration autosomal dominant (ADSD) [MIM:609161]: A movement disorder affecting the striatal part of the basal ganglia and characterized by bradykinesia, dysarthria and muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but tremor is not present. {ECO:0000269|PubMed:20085714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 3 (PPNAD3) [MIM:614190]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:18431404}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Abundantly expressed in the thyroid. Also very weakly expressed in brain, spinal cord and placenta. In the thyroid isoform 1 predominates, and isoforms 2 and 6 are also highly expressed. In the placenta isoforms 1 and 2 are expressed equally. In the brain isoform 2 predominates. {ECO:0000269|PubMed:12372422, ECO:0000269|PubMed:12681444}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;tongue;islets of Langerhans;parathyroid;skin;uterus;prostate;lung;frontal lobe;bone;thyroid;placenta;hippocampus;liver;testis;head and neck;cervix;germinal center;kidney;mammary gland;brain;	whole brain;occipital lobe;temporal lobe;caudate nucleus;pons;fetal thyroid;skeletal muscle;subthalamic nucleus;thyroid;prefrontal cortex;globus pallidus;ciliary ganglion;parietal lobe;	0.47483	.	-0.688817379	15.20405756	135.71543	2.53301	5q13.3										0.2838	0.4752	0.2896	0.1822	0.5530	0.2227	0.1318	0.2378	rs397778825	304545	Striatal_Degeneration	MedGen:CN239279	criteria_provided,_single_submitter	Benign	
5	76722877	76722877	C	-	UTR3	PDE8B	NM_001349752:c.*498delC;NM_001349750:c.*498delC;NM_001349753:c.*498delC;NM_001349751:c.*584delC;NM_001029852:c.*498delC;NM_001029851:c.*498delC;NM_003719:c.*498delC;NM_001029854:c.*498delC;NM_001029853:c.*498delC;NM_001349748:c.*498delC;NM_001349749:c.*498delC			0.986862335777411	0.0131376546495197	9.57306907025439e-09	phosphodiesterase 8B	FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in specific signaling in the thyroid gland.; 	DISEASE: Striatal degeneration autosomal dominant (ADSD) [MIM:609161]: A movement disorder affecting the striatal part of the basal ganglia and characterized by bradykinesia, dysarthria and muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but tremor is not present. {ECO:0000269|PubMed:20085714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 3 (PPNAD3) [MIM:614190]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:18431404}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Abundantly expressed in the thyroid. Also very weakly expressed in brain, spinal cord and placenta. In the thyroid isoform 1 predominates, and isoforms 2 and 6 are also highly expressed. In the placenta isoforms 1 and 2 are expressed equally. In the brain isoform 2 predominates. {ECO:0000269|PubMed:12372422, ECO:0000269|PubMed:12681444}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;tongue;islets of Langerhans;parathyroid;skin;uterus;prostate;lung;frontal lobe;bone;thyroid;placenta;hippocampus;liver;testis;head and neck;cervix;germinal center;kidney;mammary gland;brain;	whole brain;occipital lobe;temporal lobe;caudate nucleus;pons;fetal thyroid;skeletal muscle;subthalamic nucleus;thyroid;prefrontal cortex;globus pallidus;ciliary ganglion;parietal lobe;	0.47483	.	-0.688817379	15.20405756	135.71543	2.53301	5q13.3										0.0188	0.0075	0.0251	0.0403	0	0.0167	0.0268	0.0226	rs567378113						
5	78982337	78982337	T	-	UTR3	PAPD4	NM_001114393:c.*1241delT;NM_001114394:c.*1241delT;NM_001297744:c.*1241delT;NM_001297745:c.*1241delT;NM_001349548:c.*1241delT;NM_001349549:c.*1241delT;NM_001349550:c.*1241delT;NM_001349551:c.*1241delT;NM_001349552:c.*1241delT;NM_001349553:c.*1241delT;NM_001349554:c.*1241delT;NM_173797:c.*1241delT			0.000956870232763351	0.998511360188335	0.000531769578901851	PAP associated domain containing 4	FUNCTION: Cytoplasmic poly(A) RNA polymerase that adds successive AMP monomers to the 3'-end of specific RNAs, forming a poly(A) tail. In contrast to the canonical nuclear poly(A) RNA polymerase, it only adds poly(A) to selected cytoplasmic mRNAs. Does not play a role in replication-dependent histone mRNA degradation.; 	.	TISSUE SPECIFICITY: Expressed in brain. Within brain, it is expressed in cerebellum, hippocampus and medulla. {ECO:0000269|PubMed:15987818}.; 	ovary;colon;parathyroid;bone marrow;uterus;prostate;whole body;cochlea;bone;thyroid;testis;germinal center;brain;artery;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;blood;skeletal muscle;bile duct;lung;adrenal gland;nasopharynx;placenta;liver;spleen;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.19948	.	-0.22584292	37.32012267	75.54621	1.81881	5q14.1										0.0007	0.0001	0.0031	0	0	0.0056	0.0002	0.0012							
5	79276388	79276388	A	-	UTR3	MTX3	NM_001167741:c.*3119delT;NM_001010891:c.*3222delT			0.10035111705881	0.865704468111771	0.033944414829419	metaxin 3	FUNCTION: Could function in transport of proteins into the mitochondrion. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);heart;islets of Langerhans;skeletal muscle;skin;retina;uterus;whole body;lung;hippocampus;liver;testis;kidney;mammary gland;brain;	.	0.30585	0.10254	0.505321956	80.00707714	861.67074	5.72574	5q14.1										0.0081	0.0181	0.0056	0	0.0096	0.0100	0.0021	0.0049							
5	79276997	79276997	A	-	UTR3	MTX3	NM_001167741:c.*2510delT;NM_001010891:c.*2613delT			0.10035111705881	0.865704468111771	0.033944414829419	metaxin 3	FUNCTION: Could function in transport of proteins into the mitochondrion. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);heart;islets of Langerhans;skeletal muscle;skin;retina;uterus;whole body;lung;hippocampus;liver;testis;kidney;mammary gland;brain;	.	0.30585	0.10254	0.505321956	80.00707714	861.67074	5.72574	5q14.1										0.0099	0.0025	0.0378	0.0138	0	0.1253	0.0065	0.0177							
5	79277953	79277954	AC	-	UTR3	MTX3	NM_001167741:c.*1554_*1553delGT;NM_001010891:c.*1657_*1656delGT			0.10035111705881	0.865704468111771	0.033944414829419	metaxin 3	FUNCTION: Could function in transport of proteins into the mitochondrion. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);heart;islets of Langerhans;skeletal muscle;skin;retina;uterus;whole body;lung;hippocampus;liver;testis;kidney;mammary gland;brain;	.	0.30585	0.10254	0.505321956	80.00707714	861.67074	5.72574	5q14.1										0	0	0	0	0	0	0	0	rs768472327						
5	80404698	80404701	TGTA	-	intronic	RASGRF2				0.998743353862856	0.00125664613709219	5.1892166340433e-14	Ras protein specific guanine nucleotide releasing factor 2	FUNCTION: Functions as a calcium-regulated nucleotide exchange factor activating both Ras and RAC1 through the exchange of bound GDP for GTP. Preferentially activates HRAS in vivo compared to RRAS based on their different types of prenylation. Functions in synaptic plasticity by contributing to the induction of long term potentiation. {ECO:0000269|PubMed:15128856}.; 	.	TISSUE SPECIFICITY: Widely expressed with higher expression in brain, followed by heart, lung, pancreas and kidney. Detected in placenta. Expressed in brain and lung (at protein level). {ECO:0000269|PubMed:10373510, ECO:0000269|PubMed:11856323}.; 	unclassifiable (Anatomical System);spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;prostate;optic nerve;frontal lobe;macula lutea;liver;spleen;brain;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.19695	.	-1.256630467	5.343241331	592.56723	4.93365	5q14.1										0.0009	0.0006	0	0	0	0.0006	0.0013	0							
5	80710644	80710647	AGTC	-	ncRNA_intronic	RNU5D-1;RNU5E-1																			5q14.1										0.0769	0.0245	0.1265	0.0795	0.0824	0.0920	0.0989	0.1	rs71000831						
5	82933833	82933833	-	T	downstream	HAPLN1	dist=184			0.260833364813835	0.733416191266102	0.00575044392006368	hyaluronan and proteoglycan link protein 1	FUNCTION: Stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.; 	.	TISSUE SPECIFICITY: Widely expressed. Weakly expressed in the brain. {ECO:0000269|PubMed:11027579, ECO:0000269|PubMed:12663660}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;parathyroid;bone marrow;bile duct;prostate;whole body;lung;cochlea;bone;placenta;visual apparatus;liver;testis;head and neck;kidney;brain;	superior cervical ganglion;heart;atrioventricular node;trigeminal ganglion;	0.21811	0.18489	-0.53631094	20.53550366	33.08596	1.02480	5q14.3																								
5	82933835	82933835	-	T	downstream	HAPLN1	dist=182			0.260833364813835	0.733416191266102	0.00575044392006368	hyaluronan and proteoglycan link protein 1	FUNCTION: Stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.; 	.	TISSUE SPECIFICITY: Widely expressed. Weakly expressed in the brain. {ECO:0000269|PubMed:11027579, ECO:0000269|PubMed:12663660}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;parathyroid;bone marrow;bile duct;prostate;whole body;lung;cochlea;bone;placenta;visual apparatus;liver;testis;head and neck;kidney;brain;	superior cervical ganglion;heart;atrioventricular node;trigeminal ganglion;	0.21811	0.18489	-0.53631094	20.53550366	33.08596	1.02480	5q14.3										0.3421	0.3940	0.4844	0.3462	0.2954	0.3248	0.3118	0.3573	rs71709944						
5	82937252	82937252	A	-	UTR3	HAPLN1	NM_001884:c.*63delT			0.260833364813835	0.733416191266102	0.00575044392006368	hyaluronan and proteoglycan link protein 1	FUNCTION: Stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.; 	.	TISSUE SPECIFICITY: Widely expressed. Weakly expressed in the brain. {ECO:0000269|PubMed:11027579, ECO:0000269|PubMed:12663660}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;parathyroid;bone marrow;bile duct;prostate;whole body;lung;cochlea;bone;placenta;visual apparatus;liver;testis;head and neck;kidney;brain;	superior cervical ganglion;heart;atrioventricular node;trigeminal ganglion;	0.21811	0.18489	-0.53631094	20.53550366	33.08596	1.02480	5q14.3										0.0008	0.0018	0	0	0.0019	0.0008	0.0001	0							
5	86705006	86705007	TC	-	intronic	CCNH				0.00472976282475442	0.965781501976408	0.0294887351988374	cyclin H	FUNCTION: Regulates CDK7, the catalytic subunit of the CDK- activating kinase (CAK) enzymatic complex. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Involved in cell cycle control and in RNA transcription by RNA polymerase II. Its expression and activity are constant throughout the cell cycle. {ECO:0000269|PubMed:10024882, ECO:0000269|PubMed:7533895}.; 	.	.	ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;endometrium;bone;pituitary gland;testis;dura mater;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);meninges;lacrimal gland;cerebellum cortex;islets of Langerhans;pharynx;blood;skeletal muscle;breast;pancreas;pia mater;lung;adrenal gland;nasopharynx;placenta;visual apparatus;alveolus;duodenum;liver;spleen;cervix;kidney;mammary gland;stomach;	amygdala;superior cervical ganglion;occipital lobe;testis - interstitial;testis - seminiferous tubule;testis;globus pallidus;parietal lobe;skeletal muscle;cingulate cortex;	0.68027	0.13330	0.106667882	61.73036093	1653.808	7.51621	5q14.3										0.0006	0.0005	0.0015	0	0	0.0016	0.0005	0.0024	rs150775288						
5	88016153	88016153	-	T	ncRNA_intronic	MEF2C-AS2																			5q14.3										0.6591	0.5293	0.5448	0.6511	0.9331	0.6321	0.7151	0.6667	rs3841444	305209	Intellectual_Disability,_Stereotypic_Movements,_Epilepsy,_and/or_Cerebral_Malformations	MedGen:CN239216	criteria_provided,_single_submitter	Benign	
5	88018306	88018306	T	-	ncRNA_intronic	MEF2C-AS2																			5q14.3										0.0041	0.0063	0.0036	0.0078	0.0044	0.0035	0.0028	0.0025	rs553216678	298377	Intellectual_Disability,_Stereotypic_Movements,_Epilepsy,_and/or_Cerebral_Malformations	MedGen:CN239216	criteria_provided,_single_submitter	Uncertain_significance	
5	88018389	88018389	A	-	ncRNA_intronic	MEF2C-AS2																			5q14.3		0.3667	0.4546	0.3228	0.3537	0.3963	0.3653	0.3746	0.3345	0.1975	0.3743	0.1239	0.1724	0.0007	0.3119	0.1039	0.1436	rs373455781						
5	89909990	89909990	G	-	intronic	ADGRV1				.	.	.	adhesion G protein-coupled receptor V1	FUNCTION: Receptor that may have an important role in the development of the central nervous system.; 	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed at low levels in adult tissues. {ECO:0000269|PubMed:10976914}.; 	.	.	0.07741	0.17025	8.124040712	99.95281906	.	.	5q14.3																		rs371789514						
5	90002220	90002220	-	T	intronic	ADGRV1				.	.	.	adhesion G protein-coupled receptor V1	FUNCTION: Receptor that may have an important role in the development of the central nervous system.; 	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed at low levels in adult tissues. {ECO:0000269|PubMed:10976914}.; 	.	.	0.07741	0.17025	8.124040712	99.95281906	.	.	5q14.3		0.4806	0.5473	0.4404	0.5156	0.4971	0.4717	0.4829	0.4693	0.6731	0.8027	0.6175	0.6341	0.7841	0.5372	0.6102	0.6201	rs397817530	194208	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Likely_benign	
5	92953846	92953846	T	-	UTR3	FAM172A	NM_001163418:c.*2847delA;NM_032042:c.*2847delA;NM_001163417:c.*2847delA			0.0182871087954041	0.977357868317006	0.00435502288758984	family with sequence similarity 172 member A	.	.	.	.	.	0.37235	0.11009	-0.071520315	48.34866714	202.3911	3.06977	5q15										0.0077	0.0055	0.0258	0.0130	0.0006	0.0666	0.0036	0.0068							
5	92956180	92956180	A	-	UTR3	FAM172A	NM_001163418:c.*513delT;NM_032042:c.*513delT;NM_001163417:c.*513delT			0.0182871087954041	0.977357868317006	0.00435502288758984	family with sequence similarity 172 member A	.	.	.	.	.	0.37235	0.11009	-0.071520315	48.34866714	202.3911	3.06977	5q15										0.0219	0.0252	0.0660	0.0318	0.0013	0.1640	0.0119	0.0385							
5	94206958	94206958	T	-	intronic	MCTP1				0.00988911824115707	0.990107196180482	3.68557836071386e-06	multiple C2 and transmembrane domain containing 1	.	.	.	unclassifiable (Anatomical System);prostate;ovary;heart;nasopharynx;bone;testis;blood;brain;bone marrow;	superior cervical ganglion;appendix;globus pallidus;ciliary ganglion;caudate nucleus;skin;	0.65576	0.08898	-1.506435464	3.544468035	969.67998	6.02016	5q15										0.0051	0.0015	0.0136	0.0083	0.0007	0.0482	0.0037	0.0074	rs201600301						
5	94800112	94800112	T	-	UTR3	TTC37	NM_014639:c.*199delA			7.99341870810084e-20	0.980894720699824	0.0191052793001758	tetratricopeptide repeat domain 37	FUNCTION: Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1 complex (PAF1C).; 	.	TISSUE SPECIFICITY: Widely expressed with the highest levels observed in vascular tissues, lymph node, pituitary, lung and intestine. Not expressed in the liver. {ECO:0000269|PubMed:21120949}.; 	lymphoreticular;smooth muscle;ovary;skin;retina;bone marrow;prostate;frontal lobe;endometrium;thyroid;germinal center;bladder;brain;tonsil;amygdala;heart;cartilage;urinary;pharynx;blood;skeletal muscle;breast;epididymis;trabecular meshwork;visual apparatus;liver;spleen;mammary gland;peripheral nerve;salivary gland;colon;uterus;whole body;larynx;bone;pituitary gland;testis;dura mater;unclassifiable (Anatomical System);meninges;islets of Langerhans;oral cavity;bile duct;pancreas;pia mater;lung;mesenchyma;nasopharynx;placenta;amnion;head and neck;kidney;stomach;aorta;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;prefrontal cortex;atrioventricular node;	0.35178	0.08885	0.058725693	58.00896438	4654.37589	13.73819	5q15										0.2437	0.4543	0.2428	0.3179	0.1172	0.1450	0.1517	0.2041	rs371334485						
5	94940245	94940245	T	-	UTR3	ARSK	NM_198150:c.*1015delT			0.00461420992933416	0.988837487313671	0.00654830275699448	arylsulfatase family member K	.	.	.	.	.	0.04508	.	-0.26629572	34.81953291	87.35964	1.99657	5q15										0.0013	0.0017	0.0044	0.0036	0	0.0055	0.0004	0.0012	rs375530266						
5	98132038	98132038	-	C	UTR3	RGMB	NM_001012761:c.*2581_*2582insC			0.0607554230019872	0.868851843662038	0.0703927333359746	repulsive guidance molecule family member b	FUNCTION: Member of the repulsive guidance molecule (RGM) family that contributes to the patterning of the developing nervous system (By similarity). Acts as a bone morphogenetic protein (BMP) coreceptor that potentiates BMP signaling (By similarity). Promotes neuronal adhesion (By similarity). May inhibit neurite outgrowth. {ECO:0000250, ECO:0000269|PubMed:19324014}.; 	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;ovary;hypothalamus;visual apparatus;iris;testis;colon;lens;brain;skin;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;cerebellum;	0.14432	0.16919	-0.071520315	48.34866714	284.22194	3.60834	5q15										0.0004	0.0015	0.0017	0	0	0.0004	9.471e-05	0							
5	100145662	100145662	-	ACAC	UTR3	ST8SIA4	NM_005668:c.*1888_*1889insGTGT			0.675929296308764	0.323087572810319	0.000983130880917615	ST8 alpha-N-acetylneuraminate alpha-2,8-sialyltransferase 4	FUNCTION: Catalyzes the polycondensation of alpha-2,8-linked sialic acid required for the synthesis of polysialic acid (PSA), which is present on the embryonic neural cell adhesion molecule (N-CAM), necessary for plasticity of neural cells.; 	.	TISSUE SPECIFICITY: Highly expressed in fetal brain, lung and kidney and in adult heart, spleen and thymus. Present to a lesser extent in adult brain, placenta, lung, large and small intestine and peripheral blood leukocytes.; 	unclassifiable (Anatomical System);cartilage;blood;skeletal muscle;bone marrow;breast;uterus;bile duct;pancreas;whole body;lung;endometrium;thyroid;placenta;hypopharynx;testis;head and neck;germinal center;kidney;brain;mammary gland;aorta;peripheral nerve;	superior cervical ganglion;trigeminal ganglion;	0.16759	0.11031	-0.339715008	30.06605331	21.20035	0.71609	5q21.1										0.5456	0.4404	0.5193	0.6986	0.7276	0.5383	0.5847	0.5904	rs35914490						
5	100147023	100147023	-	A	UTR3	ST8SIA4	NM_005668:c.*527_*528insT			0.675929296308764	0.323087572810319	0.000983130880917615	ST8 alpha-N-acetylneuraminate alpha-2,8-sialyltransferase 4	FUNCTION: Catalyzes the polycondensation of alpha-2,8-linked sialic acid required for the synthesis of polysialic acid (PSA), which is present on the embryonic neural cell adhesion molecule (N-CAM), necessary for plasticity of neural cells.; 	.	TISSUE SPECIFICITY: Highly expressed in fetal brain, lung and kidney and in adult heart, spleen and thymus. Present to a lesser extent in adult brain, placenta, lung, large and small intestine and peripheral blood leukocytes.; 	unclassifiable (Anatomical System);cartilage;blood;skeletal muscle;bone marrow;breast;uterus;bile duct;pancreas;whole body;lung;endometrium;thyroid;placenta;hypopharynx;testis;head and neck;germinal center;kidney;brain;mammary gland;aorta;peripheral nerve;	superior cervical ganglion;trigeminal ganglion;	0.16759	0.11031	-0.339715008	30.06605331	21.20035	0.71609	5q21.1										0.5918	0.5185	0.53	0.7269	0.7491	0.5837	0.6178	0.6142	rs3842024						
5	106716351	106716351	A	-	UTR3	EFNA5	NM_001962:c.*605delT			0.889436552296034	0.109405383000763	0.00115806470320301	ephrin-A5	FUNCTION: Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Induces compartmentalized signaling within a caveolae-like membrane microdomain when bound to the extracellular domain of its cognate receptor. This signaling event requires the activity of the Fyn tyrosine kinase. Activates the EPHA3 receptor to regulate cell-cell adhesion and cytoskeletal organization. With the receptor EPHA2 may regulate lens fiber cells shape and interactions and be important for lens transparency maintenance. May function actively to stimulate axon fasciculation. The interaction of EFNA5 with EPHA5 also mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion. Cognate/functional ligand for EPHA7, their interaction regulates brain development modulating cell-cell adhesion and repulsion. {ECO:0000269|PubMed:10601038, ECO:0000269|PubMed:11870224}.; 	.	.	breast;pituitary gland;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - interstitial;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.35594	0.35747	-0.163345027	41.24793583	19.98197	0.68062	5q21.3										0.0251	0.0780	0.0118	0.0152	0	0.0022	0.0007	0.0143	rs368717510						
5	108203452	108203452	T	-	intronic	FER				0.968420467139565	0.031579516007219	1.68532157760407e-08	FER tyrosine kinase	FUNCTION: Tyrosine-protein kinase that acts downstream of cell surface receptors for growth factors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, lamellipodia formation, cell adhesion, cell migration and chemotaxis. Acts downstream of EGFR, KIT, PDGFRA and PDGFRB. Acts downstream of EGFR to promote activation of NF-kappa-B and cell proliferation. May play a role in the regulation of the mitotic cell cycle. Plays a role in the insulin receptor signaling pathway and in activation of phosphatidylinositol 3-kinase. Acts downstream of the activated FCER1 receptor and plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Plays a role in the regulation of mast cell degranulation. Plays a role in leukocyte recruitment and diapedesis in response to bacterial lipopolysaccharide (LPS). Plays a role in synapse organization, trafficking of synaptic vesicles, the generation of excitatory postsynaptic currents and neuron-neuron synaptic transmission. Plays a role in neuronal cell death after brain damage. Phosphorylates CTTN, CTNND1, PTK2/FAK1, GAB1, PECAM1 and PTPN11. May phosphorylate JUP and PTPN1. Can phosphorylate STAT3, but the biological relevance of this depends on cell type and stimulus. {ECO:0000269|PubMed:12972546, ECO:0000269|PubMed:14517306, ECO:0000269|PubMed:19147545, ECO:0000269|PubMed:19339212, ECO:0000269|PubMed:19738202, ECO:0000269|PubMed:20111072, ECO:0000269|PubMed:21518868, ECO:0000269|PubMed:22223638, ECO:0000269|PubMed:7623846, ECO:0000269|PubMed:9722593}.; 	.	TISSUE SPECIFICITY: Isoform 1 is detected in normal colon and in fibroblasts (at protein level). Isoform 3 is detected in normal testis, in colon carcinoma-derived metastases in lung, liver and ovary, and in colon carcinoma and hepato carcinoma cell lines (at protein level). Isoform 3 is not detected in normal colon or in normal fibroblasts (at protein level). Widely expressed. {ECO:0000269|PubMed:18985748, ECO:0000269|PubMed:2156206, ECO:0000269|PubMed:22223638}.; 	unclassifiable (Anatomical System);uterus;prostate;lung;ovary;placenta;testis;cervix;stomach;	testis - interstitial;testis - seminiferous tubule;testis;globus pallidus;atrioventricular node;skeletal muscle;	0.10446	0.14420	-0.440847477	24.59896202	528.33339	4.69026	5q21.3		0.1931	0.3039	0.1347	0.2488	0.2043	0.1873	0.1377	0.1604	0.0999	0.1840	0.0648	0.1412	0.0745	0.0739	0.0563	0.0812	rs67418706						
5	108524089	108524089	A	-	UTR3	FER	NM_005246:c.*813delA;NM_001308028:c.*813delA;NM_001308031:c.*813delA			0.968420467139565	0.031579516007219	1.68532157760407e-08	FER tyrosine kinase	FUNCTION: Tyrosine-protein kinase that acts downstream of cell surface receptors for growth factors and plays a role in the regulation of the actin cytoskeleton, microtubule assembly, lamellipodia formation, cell adhesion, cell migration and chemotaxis. Acts downstream of EGFR, KIT, PDGFRA and PDGFRB. Acts downstream of EGFR to promote activation of NF-kappa-B and cell proliferation. May play a role in the regulation of the mitotic cell cycle. Plays a role in the insulin receptor signaling pathway and in activation of phosphatidylinositol 3-kinase. Acts downstream of the activated FCER1 receptor and plays a role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Plays a role in the regulation of mast cell degranulation. Plays a role in leukocyte recruitment and diapedesis in response to bacterial lipopolysaccharide (LPS). Plays a role in synapse organization, trafficking of synaptic vesicles, the generation of excitatory postsynaptic currents and neuron-neuron synaptic transmission. Plays a role in neuronal cell death after brain damage. Phosphorylates CTTN, CTNND1, PTK2/FAK1, GAB1, PECAM1 and PTPN11. May phosphorylate JUP and PTPN1. Can phosphorylate STAT3, but the biological relevance of this depends on cell type and stimulus. {ECO:0000269|PubMed:12972546, ECO:0000269|PubMed:14517306, ECO:0000269|PubMed:19147545, ECO:0000269|PubMed:19339212, ECO:0000269|PubMed:19738202, ECO:0000269|PubMed:20111072, ECO:0000269|PubMed:21518868, ECO:0000269|PubMed:22223638, ECO:0000269|PubMed:7623846, ECO:0000269|PubMed:9722593}.; 	.	TISSUE SPECIFICITY: Isoform 1 is detected in normal colon and in fibroblasts (at protein level). Isoform 3 is detected in normal testis, in colon carcinoma-derived metastases in lung, liver and ovary, and in colon carcinoma and hepato carcinoma cell lines (at protein level). Isoform 3 is not detected in normal colon or in normal fibroblasts (at protein level). Widely expressed. {ECO:0000269|PubMed:18985748, ECO:0000269|PubMed:2156206, ECO:0000269|PubMed:22223638}.; 	unclassifiable (Anatomical System);uterus;prostate;lung;ovary;placenta;testis;cervix;stomach;	testis - interstitial;testis - seminiferous tubule;testis;globus pallidus;atrioventricular node;skeletal muscle;	0.10446	0.14420	-0.440847477	24.59896202	528.33339	4.69026	5q21.3										0.0012	0.0001	0.0028	0.0096	0	0.0201	0.0014	0							
5	110407274	110407274	T	-	upstream	TSLP	dist=116			0.0447881738846191	0.851408999394046	0.103802826721335	thymic stromal lymphopoietin	FUNCTION: Isoform 1: Cytokine that induces the release of T-cell- attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c+ dendritic cells. Can induce allergic inflammation by directly activating mast cells. {ECO:0000269|PubMed:11418668, ECO:0000269|PubMed:11480573, ECO:0000269|PubMed:17242164}.; 	.	TISSUE SPECIFICITY: Isoform 1 is expressed in a number of tissues including heart, liver and prostate. Isoform 2 is the predominant form in keratinocytes of oral mucosa, skin and in salivary glands. It is secreted into saliva. {ECO:0000269|PubMed:11480573, ECO:0000269|PubMed:24850429}.; 	unclassifiable (Anatomical System);meninges;pia mater;lung;cartilage;testis;dura mater;brain;skin;	superior cervical ganglion;testis;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.14117	0.07053	-0.273576253	33.97027601	3.9088	0.14518	5q22.1										0.0037	0.0044	0.0145	0.0075	0.0006	0.0163	0.0014	0.0025	rs368718795						
5	110840745	110840745	A	-	intronic	STARD4				2.95656598761803e-07	0.173957488365896	0.826042215977505	StAR related lipid transfer domain containing 4	FUNCTION: May be involved in the intracellular transport of sterols or other lipids. May bind cholesterol or other sterols (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);amygdala;hypothalamus;sympathetic chain;blood;skeletal muscle;pancreas;prostate;lung;frontal lobe;liver;testis;germinal center;	superior cervical ganglion;ciliary ganglion;atrioventricular node;	0.12935	0.12152	-0.295622497	32.61972163	25.69887	0.83663	5q22.1		0.0211	0.0060	0	0.0328	.	0.0266	0.0278	0.0194	0.0013	0.0007	0.0070	0.0167	0.0013	0.0036	0.0009	0	rs761601515						
5	111500546	111500546	G	-	UTR3	EPB41L4A	NM_022140:c.*141delC			1.98631994116418e-11	0.951565139984968	0.0484348599951689	erythrocyte membrane protein band 4.1 like 4A	.	.	TISSUE SPECIFICITY: Expressed in many tissues. High levels of expression in brain, liver, thymus and peripheral blood leukocytes and low levels of expression in heart, kidney, testis and colon.; 	unclassifiable (Anatomical System);heart;ovary;colon;parathyroid;blood;skeletal muscle;prostate;lung;placenta;testis;kidney;brain;spinal ganglion;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;placenta;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	0.12696	0.10578	1.605718424	95.91295117	1187.73182	6.53635	5q22.2										6.651e-05	0.0001	0	0	0	0.0003	0	0	rs375733809						
5	112180228	112180228	-	A	UTR3	APC	NM_001127511:c.*405_*406insA;NM_001127510:c.*405_*406insA;NM_000038:c.*405_*406insA			0.999999927739402	7.22605979150577e-08	1.20102861496063e-23	adenomatous polyposis coli	FUNCTION: Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}.; 	DISEASE: Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. {ECO:0000269|PubMed:10470088, ECO:0000269|PubMed:1338691, ECO:0000269|PubMed:1338764, ECO:0000269|PubMed:1338904, ECO:0000269|PubMed:1651563, ECO:0000269|PubMed:7833149, ECO:0000269|PubMed:7833931, ECO:0000269|PubMed:8990002}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. {ECO:0000269|PubMed:10782927, ECO:0000269|PubMed:8940264}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:7661930}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	TISSUE SPECIFICITY: Expressed in a variety of tissues.; 	myocardium;smooth muscle;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;pituitary gland;testis;germinal center;brain;pineal gland;artery;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;small intestine;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;breast;lung;placenta;macula lutea;hippocampus;liver;spleen;head and neck;kidney;mammary gland;aorta;	amygdala;medulla oblongata;superior cervical ganglion;occipital lobe;thalamus;temporal lobe;atrioventricular node;skeletal muscle;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.53216	0.57092	-2.523543479	0.902335456	395.17068	4.17713	5q22.2										0.6032	0.5442	0.6930	0.6224	0.8034	0.5629	0.6173	0.6342	rs11432316	300417	APC-Associated_Polyposis_Disorders	MedGen:CN239210	criteria_provided,_single_submitter	Benign	
5	114605499	114605499	A	-	intronic	CCDC112				0.821147626124143	0.178816765454547	3.56084213102203e-05	coiled-coil domain containing 112	.	.	.	.	.	0.26944	0.09900	-0.203796826	38.81811748	330.76803	3.86663	5q22.3	ID=COSM1619335;OCCURENCE=2(liver)	0.1340	0.1095	0.1716	0.2066	0.1031	0.1458	0.1545	0.0835	0.0122	0.0044	0.0124	0.0039	0.0384	0.0408	0.0108	0.0134	rs200426840						
5	114858640	114858641	GA	-	UTR3	FEM1C	NM_020177:c.*1365_*1364delTC			0.624676084568469	0.373753959920523	0.00156995551100737	fem-1 homolog c (C. elegans)	FUNCTION: Probable component of an E3 ubiquitin-protein ligase complex, in which it may act as a substrate recognition subunit. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Widely expressed. Highly expressed in kidney, cardiac tissue, skeletal muscle and testis. Expressed at lower levels in other tissues, including cartilage. {ECO:0000269|PubMed:11733146, ECO:0000269|PubMed:14527725}.; 	smooth muscle;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;urinary;blood;breast;lung;placenta;hippocampus;liver;cervix;kidney;stomach;thymus;	testis;cerebellum;	0.62830	0.11262	-0.626318434	17.03231894	19.14031	0.65963	5q22.3										0.0019	0.0007	0.0031	0.0038	0	0.0121	0.0011	0.0012	rs373455006						
5	114950622	114950622	-	A	ncRNA_intronic	LOC101927100																			5q22.3										0.0276	0.0203	0.0395	0.0214	0.0020	0.1679	0.0248	0.0465	rs779618501						
5	115779929	115779929	A	-	UTR3	SEMA6A	NM_020796:c.*2380delT;NM_001300780:c.*2380delT			0.999546536591411	0.000453463096922415	3.11666709857472e-10	semaphorin 6A	FUNCTION: Cell surface receptor for PLXNA2 that plays an important role in cell-cell signaling. Required for normal granule cell migration in the developing cerebellum. Promotes reorganization of the actin cytoskeleton and plays an important role in axon guidance in the developing central nervous system. Can act as repulsive axon guidance cue. Has repulsive action towards migrating granular neurons. May play a role in channeling sympathetic axons into the sympathetic chains and controlling the temporal sequence of sympathetic target innervation (By similarity). {ECO:0000250}.; 	.	.	ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;larynx;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;hypothalamus;muscle;adrenal cortex;lens;skeletal muscle;breast;lung;epididymis;adrenal gland;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;mammary gland;stomach;cerebellum;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;adrenal gland;adrenal cortex;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;parietal lobe;	0.56513	0.46987	-0.058785319	48.90894079	464.02903	4.46288	5q23.1										0.0365	0.0060	0.0625	0.0759	0.0034	0.2210	0.0428	0.0782	rs35304104						
5	115781961	115781966	TGTGTG	-	UTR3	SEMA6A	NM_020796:c.*348_*343delCACACA;NM_001300780:c.*348_*343delCACACA			0.999546536591411	0.000453463096922415	3.11666709857472e-10	semaphorin 6A	FUNCTION: Cell surface receptor for PLXNA2 that plays an important role in cell-cell signaling. Required for normal granule cell migration in the developing cerebellum. Promotes reorganization of the actin cytoskeleton and plays an important role in axon guidance in the developing central nervous system. Can act as repulsive axon guidance cue. Has repulsive action towards migrating granular neurons. May play a role in channeling sympathetic axons into the sympathetic chains and controlling the temporal sequence of sympathetic target innervation (By similarity). {ECO:0000250}.; 	.	.	ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;larynx;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;hypothalamus;muscle;adrenal cortex;lens;skeletal muscle;breast;lung;epididymis;adrenal gland;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;mammary gland;stomach;cerebellum;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;adrenal gland;adrenal cortex;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;parietal lobe;	0.56513	0.46987	-0.058785319	48.90894079	464.02903	4.46288	5q23.1										0.7872	0.6628	0.8449	0.8453	0.7539	0.8246	0.8388	0.8205	rs16372						
5	115781961	115781968	TGTGTGTG	-	UTR3	SEMA6A	NM_020796:c.*348_*341delCACACACA;NM_001300780:c.*348_*341delCACACACA			0.999546536591411	0.000453463096922415	3.11666709857472e-10	semaphorin 6A	FUNCTION: Cell surface receptor for PLXNA2 that plays an important role in cell-cell signaling. Required for normal granule cell migration in the developing cerebellum. Promotes reorganization of the actin cytoskeleton and plays an important role in axon guidance in the developing central nervous system. Can act as repulsive axon guidance cue. Has repulsive action towards migrating granular neurons. May play a role in channeling sympathetic axons into the sympathetic chains and controlling the temporal sequence of sympathetic target innervation (By similarity). {ECO:0000250}.; 	.	.	ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;larynx;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;hypothalamus;muscle;adrenal cortex;lens;skeletal muscle;breast;lung;epididymis;adrenal gland;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;mammary gland;stomach;cerebellum;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;adrenal gland;adrenal cortex;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;parietal lobe;	0.56513	0.46987	-0.058785319	48.90894079	464.02903	4.46288	5q23.1										0.0002	0.0003	0.0013	0	0	0.0003	0.0002	0							
5	115805142	115805142	T	-	ncRNA_intronic	SEMA6A-AS1				.	.	.	SEMA6A antisense RNA 1	.	.	.	.	.	.	.	.	.	.	.	5q23.1										0.0797	0.0467	0.0578	0.0621	0.2264	0.0940	0.0819	0.0723	rs33934040						
5	117938635	117938640	ACATAT	-	ncRNA_intronic	LINC02215																			5q23.1										0.0049	0.0017	0.0065	0	0.0008	0.0141	0.0050	0.0078							
5	117938637	117938640	ATAT	-	ncRNA_intronic	LINC02215																			5q23.1										0.1617	0.1313	0.2735	0.1259	0.4030	0.1900	0.1401	0.1575	rs199946167						
5	118576097	118576097	T	-	intronic	DMXL1				0.999998843167901	1.15683209865886e-06	3.49660717260196e-24	Dmx like 1	.	.	TISSUE SPECIFICITY: Expressed in bone, breast, eye, foreskin, heart, parathyroid, small intestine, testis, tonsils, placenta and uterus. {ECO:0000269|PubMed:10708522}.; 	sympathetic chain;colon;parathyroid;skin;retina;uterus;prostate;whole body;endometrium;larynx;bone;thyroid;testis;germinal center;brain;pineal gland;unclassifiable (Anatomical System);lymph node;small intestine;heart;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;placenta;hippocampus;liver;spleen;head and neck;kidney;mammary gland;stomach;	amygdala;medulla oblongata;prostate;hypothalamus;thyroid;spinal cord;prefrontal cortex;caudate nucleus;	0.71329	0.11984	-0.820119436	11.8895966	2325.86474	8.93384	5q23.1		0.4086	0.3953	0.4243	0.4371	0.3839	0.4095	0.3960	0.3973	0.0096	0.0056	0.0844	0.0083	0.0430	0.0309	0.0033	0.0121	rs377456338						
5	118583501	118583502	GT	-	UTR3	DMXL1	NM_001349240:c.*587_*588delGT;NM_005509:c.*587_*588delGT;NM_001290321:c.*587_*588delGT;NM_001290322:c.*587_*588delGT;NM_001349239:c.*587_*588delGT			0.999998843167901	1.15683209865886e-06	3.49660717260196e-24	Dmx like 1	.	.	TISSUE SPECIFICITY: Expressed in bone, breast, eye, foreskin, heart, parathyroid, small intestine, testis, tonsils, placenta and uterus. {ECO:0000269|PubMed:10708522}.; 	sympathetic chain;colon;parathyroid;skin;retina;uterus;prostate;whole body;endometrium;larynx;bone;thyroid;testis;germinal center;brain;pineal gland;unclassifiable (Anatomical System);lymph node;small intestine;heart;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;placenta;hippocampus;liver;spleen;head and neck;kidney;mammary gland;stomach;	amygdala;medulla oblongata;prostate;hypothalamus;thyroid;spinal cord;prefrontal cortex;caudate nucleus;	0.71329	0.11984	-0.820119436	11.8895966	2325.86474	8.93384	5q23.1										0.0147	0.0335	0.0244	0.0079	0	0.0266	0.0036	0.0086	rs141470513						
5	121362853	121362853	A	-	UTR3	SRFBP1	NM_152546:c.*32delA			8.19334299777791e-05	0.925468385495652	0.0744496810743707	serum response factor binding protein 1	FUNCTION: May be involved in regulating transcriptional activation of cardiac genes during the aging process. May play a role in biosynthesis and/or processing of SLC2A4 in adipose cells (By similarity). {ECO:0000250|UniProtKB:Q9CZ91}.; 	.	TISSUE SPECIFICITY: Abundantly expressed in heart and skeletal muscle, and at much lower levels in brain and lung. {ECO:0000269|PubMed:15492011}.; 	unclassifiable (Anatomical System);heart;islets of Langerhans;blood;skeletal muscle;pancreas;prostate;lung;nasopharynx;bone;placenta;liver;testis;spleen;kidney;brain;mammary gland;aorta;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.09344	0.13743	1.021500656	91.01792876	403.85455	4.21623	5q23.1		0.0858	0.0712	0.1045	0.0670	0.0309	0.0875	0.0662	0.1204	0.0010	0.0002	0.0047	0	0	0.0054	0.0007	0.0013	rs770458096						
5	121400141	121400141	A	-	UTR3	LOX	NM_001317073:c.*2297delT;NM_002317:c.*2297delT;NM_001178102:c.*2297delT			0.97935777427103	0.0206387152914771	3.51043749306924e-06	lysyl oxidase	FUNCTION: Responsible for the post-translational oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin. In addition to cross-linking of extracellular matrix proteins, may have a direct role in tumor suppression.; 	.	TISSUE SPECIFICITY: Heart, placenta, skeletal muscle, kidney, lung and pancreas. {ECO:0000269|PubMed:7706256}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;breast;bile duct;uterus;whole body;lung;mesenchyma;bone;placenta;visual apparatus;liver;testis;kidney;brain;mammary gland;	dorsal root ganglion;superior cervical ganglion;smooth muscle;adipose tissue;heart;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.39100	0.98092	0.215080721	67.91696155	868.16804	5.73987	5q23.2										0.0224	0.0297	0.0354	0.0038	0.0573	0.0285	0.0123	0.0311	rs564568778						
5	122950255	122950255	T	-	UTR3	CSNK1G3	NM_001270573:c.*165delT;NM_001270574:c.*165delT;NM_001031812:c.*165delT;NM_001044723:c.*165delT;NM_001270572:c.*165delT;NM_004384:c.*165delT			0.996751666329429	0.00324832600670227	7.66386867006088e-09	casein kinase 1 gamma 3	FUNCTION: Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Regulates fast synaptic transmission mediated by glutamate (By similarity). {ECO:0000250}.; 	.	.	ovary;parathyroid;skin;uterus;prostate;endometrium;thyroid;bone;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;heart;lacrimal gland;islets of Langerhans;hypothalamus;adrenal cortex;skeletal muscle;pancreas;lung;adrenal gland;placenta;visual apparatus;hippocampus;liver;amnion;spleen;head and neck;kidney;mammary gland;stomach;	.	0.42585	0.18081	-0.317668748	31.45789101	9.29304	0.34102	5q23.2										0.0217	0.0610	0.0112	0.0122	0.0006	0.0207	0.0013	0.0154	rs369266560						
5	122951692	122951692	T	-	UTR3	CSNK1G3	NM_001270573:c.*1602delT;NM_001270574:c.*1602delT;NM_001031812:c.*1602delT;NM_001044723:c.*1602delT;NM_001270572:c.*1602delT;NM_004384:c.*1602delT			0.996751666329429	0.00324832600670227	7.66386867006088e-09	casein kinase 1 gamma 3	FUNCTION: Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Regulates fast synaptic transmission mediated by glutamate (By similarity). {ECO:0000250}.; 	.	.	ovary;parathyroid;skin;uterus;prostate;endometrium;thyroid;bone;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;heart;lacrimal gland;islets of Langerhans;hypothalamus;adrenal cortex;skeletal muscle;pancreas;lung;adrenal gland;placenta;visual apparatus;hippocampus;liver;amnion;spleen;head and neck;kidney;mammary gland;stomach;	.	0.42585	0.18081	-0.317668748	31.45789101	9.29304	0.34102	5q23.2										6.585e-05	0.0002	0	0	0	0	0	0							
5	123972785	123972785	-	A	UTR3	ZNF608	NM_020747:c.*807_*808insT			0.999968158467997	3.18415296182291e-05	2.38501180288726e-12	zinc finger protein 608	.	.	.	unclassifiable (Anatomical System);lymph node;cartilage;heart;ovary;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;breast;uterus;prostate;lung;frontal lobe;larynx;bone;thyroid;placenta;testis;head and neck;germinal center;kidney;brain;stomach;	.	0.17709	0.11646	-2.162653931	1.433121019	135.02857	2.52784	5q23.2										0.0690	0.1631	0.0925	0.0382	0.0038	0.1050	0.0169	0.0542	rs57925933						
5	123972785	123972785	-	AA	UTR3	ZNF608	NM_020747:c.*807_*808insTT			0.999968158467997	3.18415296182291e-05	2.38501180288726e-12	zinc finger protein 608	.	.	.	unclassifiable (Anatomical System);lymph node;cartilage;heart;ovary;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;breast;uterus;prostate;lung;frontal lobe;larynx;bone;thyroid;placenta;testis;head and neck;germinal center;kidney;brain;stomach;	.	0.17709	0.11646	-2.162653931	1.433121019	135.02857	2.52784	5q23.2										0.7598	0.6251	0.7544	0.8015	0.9900	0.6920	0.8169	0.8130	rs34398324						
5	125829169	125829169	T	-	UTR3	GRAMD2B	NM_001146319:c.*521delT;NM_001349544:c.*521delT;NM_001349543:c.*521delT;NM_001146321:c.*521delT;NM_023927:c.*521delT;NM_001146320:c.*521delT;NM_001349542:c.*521delT;NM_001349541:c.*521delT;NM_001146322:c.*521delT																		5q23.2										3.363e-05	0.0001	0	0	0	0	0	0	rs530776629						
5	125877659	125877659	-	A	UTR3	ALDH7A1	NM_001201377:c.*2997_*2998insT;NM_001182:c.*2997_*2998insT;NM_001202404:c.*2997_*2998insT			1.95312955165253e-12	0.362501991453821	0.637498008544226	aldehyde dehydrogenase 7 family member A1	FUNCTION: Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism. {ECO:0000269|PubMed:16491085, ECO:0000269|PubMed:20207735}.; 	.	TISSUE SPECIFICITY: Abundant in hepatoma cells and fetal cochlea, ovary, eye, heart, adrenal gland, liver and kidney. Low levels present in adult peripheral blood leukocytes and fetal brain, thymus, spleen, skeletal muscle, lung and tongue. {ECO:0000269|PubMed:8088832, ECO:0000269|PubMed:9417906}.; 	.	.	0.46546	0.37812	-0.468351206	23.42533616	838.40275	5.67131	5q23.2										0.9867	0.9880	0.9642	0.9818	0.9962	0.9393	0.9926	0.9740	rs397760043	300521	Pyridoxine-dependent_epilepsy	MedGen:C1849508,OMIM:266100,Orphanet:ORPHA3006	criteria_provided,_single_submitter	Benign	
5	125950802	125950802	T	-	intronic	PHAX				0.00269319619944417	0.983312838187735	0.0139939656128211	phosphorylated adaptor for RNA export	FUNCTION: A phosphoprotein adapter involved in the XPO1-mediated U snRNA export from the nucleus. Bridge components required for U snRNA export, the cap binding complex (CBC)-bound snRNA on the one hand and the GTPase Ran in its active GTP-bound form together with the export receptor XPO1 on the other. Its phosphorylation in the nucleus is required for U snRNA export complex assembly and export, while its dephosphorylation in the cytoplasm causes export complex disassembly. It is recycled back to the nucleus via the importin alpha/beta heterodimeric import receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Its compartmentalized phosphorylation cycle may also contribute to the directionality of export. Binds strongly to m7G-capped U1 and U5 small nuclear RNAs (snRNAs) in a sequence-unspecific manner and phosphorylation- independent manner (By similarity). Plays also a role in the biogenesis of U3 small nucleolar RNA (snoRNA). Involved in the U3 snoRNA transport from nucleoplasm to Cajal bodies. Binds strongly to m7G-capped U3, U8 and U13 precursor snoRNAs and weakly to trimethylated (TMG)-capped U3, U8 and U13 snoRNAs. Binds also to telomerase RNA. {ECO:0000250, ECO:0000269|PubMed:15574332, ECO:0000269|PubMed:15574333}.; 	.	.	ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;frontal lobe;larynx;bone;thyroid;pituitary gland;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);cartilage;cerebellum cortex;islets of Langerhans;adrenal cortex;pharynx;blood;lens;breast;bile duct;lung;mesenchyma;nasopharynx;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;	.	0.17782	0.12170	-0.268115223	34.70747818	1174.52587	6.51141	5q23.2										0.0681	0.0350	0.0677	0.0349	0.0032	0.1149	0.0859	0.1051	rs34630842						
5	126250505	126250506	GT	-	intronic	MARCH3				0.636727871339738	0.356542253419104	0.00672987524115773	membrane associated ring-CH-type finger 3	FUNCTION: E3 ubiquitin-protein ligase which may be involved in endosomal trafficking. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates (By similarity). {ECO:0000250}.; 	.	.	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;pharynx;blood;lens;breast;pancreas;lung;adrenal gland;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;kidney;stomach;	superior cervical ganglion;testis;	0.73374	0.11466	-0.426079032	25.36565228	76.02084	1.82692	5q23.2										0.0180	0.0102	0.0112	0.0328	0.0164	0.0158	0.0230	0.0227							
5	126866120	126866120	T	-	intronic	PRRC1				2.13078587199281e-05	0.720328173841593	0.279650518299687	proline rich coiled-coil 1	.	.	TISSUE SPECIFICITY: Isoform 4 is specifically expressed in liver. Ubiquitously expressed with higher expression in kidney, liver and placenta. {ECO:0000269|PubMed:15541471}.; 	lymphoreticular;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;amniotic fluid;germinal center;bladder;brain;heart;cartilage;tongue;urinary;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;mammary gland;peripheral nerve;colon;parathyroid;fovea centralis;choroid;uterus;whole body;atrium;oesophagus;larynx;bone;pituitary gland;testis;unclassifiable (Anatomical System);lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	superior cervical ganglion;placenta;liver;pons;trigeminal ganglion;skeletal muscle;	0.11923	0.08564	-0.911109353	9.961075725	104.99985	2.21582	5q23.2		0.0095	0.0059	0.0072	0.0099	0.0010	0.0103	0.0116	0.0144	0.0004	0.0001	0	0	0.0044	0.0004	0.0001	0	rs757721592						
5	126884849	126884849	A	-	intronic	PRRC1				2.13078587199281e-05	0.720328173841593	0.279650518299687	proline rich coiled-coil 1	.	.	TISSUE SPECIFICITY: Isoform 4 is specifically expressed in liver. Ubiquitously expressed with higher expression in kidney, liver and placenta. {ECO:0000269|PubMed:15541471}.; 	lymphoreticular;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;amniotic fluid;germinal center;bladder;brain;heart;cartilage;tongue;urinary;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;mammary gland;peripheral nerve;colon;parathyroid;fovea centralis;choroid;uterus;whole body;atrium;oesophagus;larynx;bone;pituitary gland;testis;unclassifiable (Anatomical System);lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	superior cervical ganglion;placenta;liver;pons;trigeminal ganglion;skeletal muscle;	0.11923	0.08564	-0.911109353	9.961075725	104.99985	2.21582	5q23.2										0.4733	0.6254	0.5076	0.4331	0.6297	0.4513	0.3655	0.4260	rs35793768						
5	127522153	127522153	-	T	intronic	SLC12A2				0.999438621805128	0.000561378193993525	8.78936358367503e-13	solute carrier family 12 member 2	FUNCTION: Electrically silent transporter system. Mediates sodium and chloride reabsorption. Plays a vital role in the regulation of ionic balance and cell volume.; 	.	TISSUE SPECIFICITY: Expressed in many tissues.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;whole body;cochlea;endometrium;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;spinal cord;urinary;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;cornea;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;hypopharynx;liver;head and neck;cervix;kidney;mammary gland;stomach;cerebellum;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;trachea;appendix;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	0.22943	0.31452	-1.30798293	4.877329559	115.75595	2.34001	5q23.3		0.4984	0.5243	0.5100	0.4464	0.5541	0.4959	0.5012	0.4879	0.8109	0.9348	0.7793	0.7201	0.5776	0.7863	0.7730	0.7548	rs11382084						
5	130729510	130729510	G	-	UTR3	CDC42SE2	NM_020240:c.*1917delG;NM_001038702:c.*1917delG			0.753728627374484	0.236652021637092	0.00961935098842438	CDC42 small effector 2	FUNCTION: Probably involved in the organization of the actin cytoskeleton by acting downstream of CDC42, inducing actin filament assembly. Alters CDC42-induced cell shape changes. In activated T-cells, may play a role in CDC42-mediated F-actin accumulation at the immunological synapse. May play a role in early contractile events in phagocytosis in macrophages. {ECO:0000269|PubMed:10816584, ECO:0000269|PubMed:15840583}.; 	.	TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in T-lymphocytes. Highly expressed in CCRF-CEM T-lymphocytes, Jurkat T-lymphocytes, and Raji B-lymphocytes compared (at protein level). {ECO:0000269|PubMed:15840583}.; 	lymphoreticular;smooth muscle;ovary;skin;prostate;frontal lobe;endometrium;gum;thyroid;germinal center;bladder;brain;heart;cartilage;tongue;urinary;adrenal cortex;pharynx;blood;skeletal muscle;breast;trabecular meshwork;visual apparatus;liver;spleen;mammary gland;salivary gland;intestine;colon;parathyroid;uterus;whole body;larynx;bone;testis;spinal ganglion;pineal gland;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;duodenum;head and neck;kidney;stomach;	trigeminal ganglion;	0.27557	0.12378	-0.09720619	46.20193442	1.83486	0.05767	5q31.1																								
5	130978261	130978261	A	-	UTR3	FNIP1	NM_001346114:c.*2117delT;NM_133372:c.*2117delT;NM_001008738:c.*2117delT			0.99981944509088	0.000180554908845711	2.73921817377501e-13	folliculin interacting protein 1	FUNCTION: May be involved in energy and/or nutrient sensing through the AMPK and mTOR signaling pathways. May regulate phosphorylation of RPS6KB1. {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}.; 	.	TISSUE SPECIFICITY: Strong expression is found in the heart, liver placenta, muscle, nasal mucosa, salivary gland and uvula and moderate expression in kidney and lung. Higher levels detected in clear cell renal cell carcinoma (RCC) and chromophobe RCC than in normal kidney tissue. {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18403135}.; 	unclassifiable (Anatomical System);heart;islets of Langerhans;colon;parathyroid;blood;skin;uterus;lung;frontal lobe;placenta;liver;testis;spleen;germinal center;kidney;brain;stomach;	.	0.56317	.	-0.571310997	19.01391838	387.17012	4.14356	5q31.1										0.0309	0.0135	0.1239	0.0539	0.0007	0.3045	0.0174	0.0646							
5	131730920	131730920	-	TA	UTR3	SLC22A5	NM_003060:c.*956_*957insTA;NM_001308122:c.*956_*957insTA			4.90000271154311e-09	0.369125278718753	0.630874716381245	solute carrier family 22 member 5	FUNCTION: Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3. {ECO:0000269|PubMed:10454528}.; 	.	TISSUE SPECIFICITY: Strongly expressed in kidney, skeletal muscle, heart and placenta. Highly expressed in intestinal cell types affected by Crohn disease, including epithelial cells. Expressed in CD68 macrophage and CD43 T-cells but not in CD20 B-cells. {ECO:0000269|PubMed:10454528}.; 	unclassifiable (Anatomical System);heart;ovary;islets of Langerhans;colon;parathyroid;fovea centralis;lens;skin;retina;uterus;pancreas;whole body;lung;endometrium;placenta;macula lutea;visual apparatus;hippocampus;liver;testis;kidney;brain;mammary gland;bladder;stomach;	superior cervical ganglion;kidney;atrioventricular node;skeletal muscle;	0.17596	0.28558	0.801024817	87.65628686	511.75179	4.63180	5q31.1																			300931	Renal_carnitine_transport_defect	MedGen:C0342788,OMIM:212140,Orphanet:ORPHA158,SNOMED_CT:21764004	criteria_provided,_single_submitter	Uncertain_significance	
5	131730923	131730923	-	C	UTR3	SLC22A5	NM_003060:c.*959_*960insC;NM_001308122:c.*959_*960insC			4.90000271154311e-09	0.369125278718753	0.630874716381245	solute carrier family 22 member 5	FUNCTION: Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3. {ECO:0000269|PubMed:10454528}.; 	.	TISSUE SPECIFICITY: Strongly expressed in kidney, skeletal muscle, heart and placenta. Highly expressed in intestinal cell types affected by Crohn disease, including epithelial cells. Expressed in CD68 macrophage and CD43 T-cells but not in CD20 B-cells. {ECO:0000269|PubMed:10454528}.; 	unclassifiable (Anatomical System);heart;ovary;islets of Langerhans;colon;parathyroid;fovea centralis;lens;skin;retina;uterus;pancreas;whole body;lung;endometrium;placenta;macula lutea;visual apparatus;hippocampus;liver;testis;kidney;brain;mammary gland;bladder;stomach;	superior cervical ganglion;kidney;atrioventricular node;skeletal muscle;	0.17596	0.28558	0.801024817	87.65628686	511.75179	4.63180	5q31.1										0.7340	0.5257	0.7492	0.8089	0.9107	0.7656	0.8340	0.7859	rs144261584	300759	Renal_carnitine_transport_defect	MedGen:C0342788,OMIM:212140,Orphanet:ORPHA158,SNOMED_CT:21764004	criteria_provided,_single_submitter	Benign	
5	132028864	132028864	-	A	UTR3	KIF3A	NM_001300792:c.*3461_*3462insT;NM_007054:c.*3461_*3462insT;NM_001300791:c.*3461_*3462insT			0.992416127781631	0.00758385990988457	1.23084841489024e-08	kinesin family member 3A	FUNCTION: Microtubule-based anterograde translocator for membranous organelles. Plus end-directed microtubule sliding activity in vitro. Plays a role in primary cilia formation (By similarity). {ECO:0000250}.; 	.	.	.	.	0.54259	0.24823	-0.626318434	17.03231894	3767.74634	12.00714	5q31.1										0.3049	0.3786	0.3942	0.1714	0.7986	0.3995	0.1844	0.2637	rs111609523						
5	132031957	132031957	-	T	UTR3	KIF3A	NM_001300792:c.*368_*369insA;NM_007054:c.*368_*369insA;NM_001300791:c.*368_*369insA			0.992416127781631	0.00758385990988457	1.23084841489024e-08	kinesin family member 3A	FUNCTION: Microtubule-based anterograde translocator for membranous organelles. Plus end-directed microtubule sliding activity in vitro. Plays a role in primary cilia formation (By similarity). {ECO:0000250}.; 	.	.	.	.	0.54259	0.24823	-0.626318434	17.03231894	3767.74634	12.00714	5q31.1										0.2925	0.3659	0.4067	0.1619	0.7870	0.3874	0.1749	0.2459	rs397760002						
5	133316708	133316708	T	-	intronic	VDAC1				0.975595138410154	0.0243786889131345	2.6172676711743e-05	voltage dependent anion channel 1	FUNCTION: Forms a channel through the mitochondrial outer membrane and also the plasma membrane. The channel at the outer mitochondrial membrane allows diffusion of small hydrophilic molecules; in the plasma membrane it is involved in cell volume regulation and apoptosis. It adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV. The open state has a weak anion selectivity whereas the closed state is cation-selective (PubMed:11845315, PubMed:18755977, PubMed:20230784, PubMed:8420959). May participate in the formation of the permeability transition pore complex (PTPC) responsible for the release of mitochondrial products that triggers apoptosis (PubMed:15033708, PubMed:25296756). {ECO:0000269|PubMed:11845315, ECO:0000269|PubMed:15033708, ECO:0000269|PubMed:18755977, ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:25296756, ECO:0000269|PubMed:8420959}.; 	.	TISSUE SPECIFICITY: Heart, liver and skeletal muscle.; 	myocardium;lymphoreticular;smooth muscle;ovary;sympathetic chain;skin;retina;bone marrow;prostate;frontal lobe;endometrium;gum;thyroid;germinal center;bladder;brain;heart;cartilage;pharynx;blood;skeletal muscle;breast;visual apparatus;liver;spleen;cervix;mammary gland;peripheral nerve;salivary gland;intestine;colon;parathyroid;uterus;whole body;bone;pituitary gland;testis;spinal ganglion;artery;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;placenta;duodenum;hypopharynx;head and neck;kidney;stomach;aorta;thymus;cerebellum;	amygdala;occipital lobe;thalamus;cingulate cortex;skeletal muscle;	.	.	-0.295622497	32.61972163	24.73819	0.81167	5q31.1										0.0795	0.0776	0.1996	0.1189	0.1257	0.2720	0.0505	0.0891							
5	133655030	133655030	A	-	intronic	CDKL3				4.32898502493702e-07	0.600309181846894	0.399690385254604	cyclin dependent kinase like 3	.	.	.	unclassifiable (Anatomical System);heart;fovea centralis;choroid;lens;skin;retina;uterus;optic nerve;whole body;lung;macula lutea;testis;kidney;brain;	testis;	0.18586	0.10438	0.328949044	73.41354093	99.29071	2.15668	5q31.1		0.3311	0.3613	0.2959	0.3716	0.3565	0.3738	0.3696	0.2416	0.0051	0.0022	0.0318	0.0324	0.0083	0.0268	0.0033	0.0089	rs764852664						
5	133944044	133944044	T	-	intronic	SAR1B				0.00630041605283772	0.910141255140546	0.0835583288066165	secretion associated Ras related GTPase 1B	FUNCTION: Involved in transport from the endoplasmic reticulum to the Golgi apparatus. Activated by the guanine nucleotide exchange factor PREB. Involved in the selection of the protein cargo and the assembly of the COPII coat complex.; 	.	TISSUE SPECIFICITY: Expressed in many tissues including small intestine, liver, muscle and brain.; 	.	.	0.45660	0.14201	-0.229483771	36.86010852	11.40907	0.41222	5q31.1		0.4873	0.4841	0.4778	0.4942	0.5115	0.4852	0.4802	0.4905	0.1739	0.1691	0.3441	0.1260	0.2965	0.3373	0.1339	0.2064	rs201249311						
5	133944044	133944045	TT	-	intronic	SAR1B				0.00630041605283772	0.910141255140546	0.0835583288066165	secretion associated Ras related GTPase 1B	FUNCTION: Involved in transport from the endoplasmic reticulum to the Golgi apparatus. Activated by the guanine nucleotide exchange factor PREB. Involved in the selection of the protein cargo and the assembly of the COPII coat complex.; 	.	TISSUE SPECIFICITY: Expressed in many tissues including small intestine, liver, muscle and brain.; 	.	.	0.45660	0.14201	-0.229483771	36.86010852	11.40907	0.41222	5q31.1		0.0292	0.0273	0.0778	0.0950	0.0517	0.0229	0.0396	0.0280	0.0019	0.0006	0.0085	0.0039	0	0.0181	0.0005	0.0025	rs199526981						
5	134572190	134572191	TC	-	ncRNA_exonic	C5orf66-AS2				.	.	.	C5orf66 antisense RNA 2	.	.	.	.	.	.	.	.	.	.	.	5q31.1										0.3924	0.2176	0.3501	0.3704	0.6707	0.4632	0.4453	0.4600	rs397842990						
5	134680064	134680064	T	-	UTR3	C5orf66	NM_001277348:c.*908delT			.	.	.	chromosome 5 open reading frame 66	.	.	.	.	.	.	.	.	.	37.27076	1.11113	5q31.1										0.0126	0.0322	0.0156	0.008	0	0.0190	0.0019	0.0078	rs60483029						
5	136313114	136313114	A	-	UTR3	SPOCK1	NM_004598:c.*1229delT			0.320886444579516	0.678398903152666	0.000714652267818124	sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1	FUNCTION: May play a role in cell-cell and cell-matrix interactions. May contribute to various neuronal mechanisms in the central nervous system.; 	.	.	smooth muscle;ovary;sympathetic chain;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;brain;amygdala;heart;cartilage;tongue;pineal body;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;colon;parathyroid;choroid;fovea centralis;vein;uterus;whole body;atrium;larynx;synovium;bone;pituitary gland;testis;pineal gland;unclassifiable (Anatomical System);hypothalamus;pancreas;lung;mesenchyma;adrenal gland;placenta;hippocampus;head and neck;kidney;aorta;cerebellum;	thalamus;medulla oblongata;occipital lobe;adipose tissue;cerebellum peduncles;hypothalamus;caudate nucleus;pons;subthalamic nucleus;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;cerebellum;	0.28758	0.20627	-0.490397599	22.50530786	83.60687	1.94449	5q31.2										0.0014	0.0006	0.0090	0.0038	0	0.0082	0.0005	0.0013							
5	136954582	136954582	-	A	UTR3	KLHL3	NM_001257195:c.*3204_*3205insT;NM_017415:c.*3204_*3205insT;NM_001257194:c.*3204_*3205insT			0.924154761446343	0.0758415188204071	3.71973325002462e-06	kelch like family member 3	FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a regulator of ion transport in the distal nephron. The BCR(KLHL3) complex acts by mediating ubiquitination of WNK4, an inhibitor of potassium channel KCNJ1, leading to WNK4 degradation. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:22406640, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:23665031}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:22406640}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;colon;parathyroid;skin;skeletal muscle;retina;uterus;whole body;lung;frontal lobe;endometrium;bone;thyroid;placenta;hippocampus;liver;testis;spleen;germinal center;kidney;brain;cerebellum;	cerebellum peduncles;cerebellum;	0.28841	0.11001	-0.868835007	10.65109696	39.76309	1.17177	5q31.2										0.0253	0.0161	0.0163	0.05	0.0655	0.0126	0.0272	0.0286	rs774186035	301145	Pseudohypoaldosteronism_type_1_autosomal_dominant	MedGen:C1449842,OMIM:177735,Orphanet:ORPHA171871	criteria_provided,_single_submitter	Uncertain_significance	
5	136957467	136957468	AC	-	UTR3	KLHL3	NM_001257195:c.*320_*319delGT;NM_017415:c.*320_*319delGT;NM_001257194:c.*320_*319delGT			0.924154761446343	0.0758415188204071	3.71973325002462e-06	kelch like family member 3	FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that acts as a regulator of ion transport in the distal nephron. The BCR(KLHL3) complex acts by mediating ubiquitination of WNK4, an inhibitor of potassium channel KCNJ1, leading to WNK4 degradation. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:22406640, ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:23665031}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:22406640}.; 	unclassifiable (Anatomical System);cartilage;heart;ovary;colon;parathyroid;skin;skeletal muscle;retina;uterus;whole body;lung;frontal lobe;endometrium;bone;thyroid;placenta;hippocampus;liver;testis;spleen;germinal center;kidney;brain;cerebellum;	cerebellum peduncles;cerebellum;	0.28841	0.11001	-0.868835007	10.65109696	39.76309	1.17177	5q31.2										0.8296	0.7984	0.7657	0.7971	0.5669	0.8490	0.8775	0.8279	rs3044778	295447	Pseudohypoaldosteronism_type_1_autosomal_dominant	MedGen:C1449842,OMIM:177735,Orphanet:ORPHA171871	criteria_provided,_single_submitter	Uncertain_significance	
5	137274916	137274916	A	-	UTR3	FAM13B	NM_016603:c.*998delT;NM_001101801:c.*998delT;NM_001101800:c.*998delT			0.900071909481818	0.0999280278545732	6.26636081968545e-08	family with sequence similarity 13 member B	.	.	.	ovary;sympathetic chain;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;bone;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;islets of Langerhans;adrenal cortex;blood;breast;lung;adrenal gland;placenta;liver;spleen;cervix;kidney;stomach;	amygdala;dorsal root ganglion;medulla oblongata;occipital lobe;hypothalamus;pons;caudate nucleus;atrioventricular node;subthalamic nucleus;fetal brain;testis - seminiferous tubule;prefrontal cortex;testis;globus pallidus;trigeminal ganglion;parietal lobe;cingulate cortex;	0.36494	0.12763	-0.995664936	8.539749941	288.15523	3.63441	5q31.2										0.0043	0.0011	0.0067	0	0.0013	0.0298	0.0035	0.0087							
5	137513369	137513369	-	A	intronic	BRD8				0.000590819287003113	0.999408819477291	3.61235706442662e-07	bromodomain containing 8	FUNCTION: May act as a coactivator during transcriptional activation by hormone-activated nuclear receptors (NR). Isoform 2 stimulates transcriptional activation by AR/DHTR, ESR1/NR3A1, RXRA/NR2B1 and THRB/ERBA2. At least isoform 1 and isoform 2 are components of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Component of a SWR1- like complex that specifically mediates the removal of histone H2A.Z/H2AFZ from the nucleosome. {ECO:0000269|PubMed:10517671, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:24463511}.; 	.	TISSUE SPECIFICITY: Expressed in adipose tissue, brain, heart, kidney, liver, lung, pancreas, placenta and skeletal muscle. {ECO:0000269|PubMed:8611617}.; 	myocardium;ovary;skin;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;tonsil;heart;cartilage;urinary;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;cervix;spleen;mammary gland;salivary gland;colon;parathyroid;fovea centralis;choroid;uterus;whole body;oesophagus;bone;pituitary gland;testis;unclassifiable (Anatomical System);islets of Langerhans;muscle;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;cerebellum;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;prefrontal cortex;testis;globus pallidus;atrioventricular node;trigeminal ganglion;skeletal muscle;parietal lobe;cingulate cortex;	0.17308	0.11543	0.159856957	64.91507431	1921.62369	8.07167	5q31.2		0.1629	0.2836	0.1383	0.1381	0.1501	0.1603	0.1689	0.1355	0.0527	0.1487	0.0294	0.0234	0	0.0183	0.0087	0.0251	rs10671440						
5	137513369	137513369	-	AA	intronic	BRD8				0.000590819287003113	0.999408819477291	3.61235706442662e-07	bromodomain containing 8	FUNCTION: May act as a coactivator during transcriptional activation by hormone-activated nuclear receptors (NR). Isoform 2 stimulates transcriptional activation by AR/DHTR, ESR1/NR3A1, RXRA/NR2B1 and THRB/ERBA2. At least isoform 1 and isoform 2 are components of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Component of a SWR1- like complex that specifically mediates the removal of histone H2A.Z/H2AFZ from the nucleosome. {ECO:0000269|PubMed:10517671, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:24463511}.; 	.	TISSUE SPECIFICITY: Expressed in adipose tissue, brain, heart, kidney, liver, lung, pancreas, placenta and skeletal muscle. {ECO:0000269|PubMed:8611617}.; 	myocardium;ovary;skin;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;tonsil;heart;cartilage;urinary;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;cervix;spleen;mammary gland;salivary gland;colon;parathyroid;fovea centralis;choroid;uterus;whole body;oesophagus;bone;pituitary gland;testis;unclassifiable (Anatomical System);islets of Langerhans;muscle;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;cerebellum;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;prefrontal cortex;testis;globus pallidus;atrioventricular node;trigeminal ganglion;skeletal muscle;parietal lobe;cingulate cortex;	0.17308	0.11543	0.159856957	64.91507431	1921.62369	8.07167	5q31.2		0.4320	0.4652	0.3989	0.4176	0.4638	0.4400	0.4441	0.3981	0.6643	0.7115	0.5779	0.6719	0.6376	0.6188	0.6484	0.6616	rs10671440						
5	137524389	137524389	A	-	UTR3	CDC23	NM_004661:c.*278delT			0.999307693129197	0.00069230599695052	8.73852150967702e-10	cell division cycle 23	FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:18485873}.; 	.	.	.	.	0.80825	0.14086	-0.005381972	53.50908233	136.88847	2.54297	5q31.2										0.0157	0.0032	0.0436	0.0417	0	0.1751	0.0117	0.0385							
5	137804275	137804275	A	-	UTR3	EGR1	NM_001964:c.*505delA			0.674344947164404	0.320861373024958	0.00479367981063715	early growth response 1	FUNCTION: Transcriptional regulator. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'(EGR-site). Activates the transcription of target genes whose products are required for mitogenesis and differentiation.; 	.	.	myocardium;ovary;sympathetic chain;colon;parathyroid;choroid;skin;bone marrow;uterus;prostate;optic nerve;frontal lobe;cochlea;oesophagus;endometrium;larynx;bone;thyroid;pituitary gland;testis;amniotic fluid;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;muscle;urinary;blood;skeletal muscle;breast;bile duct;pancreas;lung;adrenal gland;epididymis;placenta;visual apparatus;liver;head and neck;kidney;mammary gland;stomach;aorta;thymus;	superior cervical ganglion;adrenal cortex;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.98853	0.88685	-0.846787714	11.05803255	55.14984	1.48872	5q31.2										0.0128	0.0048	0.0303	0.0256	0.0155	0.0748	0.0117	0.0141	rs761470879						
5	137896597	137896597	-	T	intronic	HSPA9				0.981119322463888	0.0188806541837	2.33524119712582e-08	heat shock protein family A (Hsp70) member 9	FUNCTION: Implicated in the control of cell proliferation and cellular aging. May also act as a chaperone. {ECO:0000269|PubMed:23501103}.; 	.	.	ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;tongue;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;spleen;cervix;mammary gland;peripheral nerve;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;bone;pituitary gland;testis;unclassifiable (Anatomical System);lymph node;cerebellum cortex;islets of Langerhans;muscle;pancreas;lung;cornea;placenta;duodenum;head and neck;kidney;stomach;	thalamus;occipital lobe;superior cervical ganglion;hypothalamus;pons;parietal lobe;cingulate cortex;skeletal muscle;	0.62414	0.73410	-0.846787714	11.05803255	21.59412	0.72579	5q31.2		0.3635	0.3272	0.3913	0.4490	0.5	0.3191	0.4306	0.3838	0.4084	0.4418	0.3938	0.3648	0.7853	0.2943	0.3496	0.3709	rs10652442						
5	138216626	138216626	A	-	intronic	CTNNA1				0.970554290062812	0.0294456957694366	1.41677517993259e-08	catenin alpha 1	FUNCTION: Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation.; 	DISEASE: Hereditary diffuse gastric cancer (HDGC) [MIM:137215]: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. {ECO:0000269|PubMed:23208944}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	TISSUE SPECIFICITY: Expressed ubiquitously in normal tissues.; 	lymphoreticular;ovary;salivary gland;colon;skin;retina;bone marrow;uterus;prostate;cerebral cortex;endometrium;bone;thyroid;iris;pituitary gland;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;heart;tongue;muscle;blood;skeletal muscle;breast;bile duct;pancreas;lung;mesenchyma;nasopharynx;placenta;visual apparatus;hypopharynx;liver;spleen;head and neck;kidney;mammary gland;stomach;	.	0.45557	0.22076	-0.841329384	11.36470866	60.25736	1.57722	5q31.2										0.0382	0.0237	0.0267	0.0075	0.0013	0.0584	0.0491	0.0362	rs777347287						
5	139907751	139907751	T	-	intronic	ANKHD1;ANKHD1-EIF4EBP3																			5q31.3		0.2697	0.2657	0.2588	0.2987	0.2325	0.2749	0.2439	0.2599	0.0003	0.0003	0	0	0	0.0012	0.0002	0.0017	rs774999774						
5	139931628	139931628	-	GTC	exonic	SRA1		nonframeshift insertion	SRA1:NM_001035235:exon3:c.328_329insGAC:p.V110GL	5.00127987809857e-06	0.239831209767016	0.760163788953106	steroid receptor RNA activator 1	FUNCTION: Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand- dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis. {ECO:0000269|PubMed:10199399, ECO:0000269|PubMed:12943696, ECO:0000269|PubMed:14517287, ECO:0000269|PubMed:15147866, ECO:0000269|PubMed:15351741}.; 	.	TISSUE SPECIFICITY: Highly expressed in liver and skeletal muscle and to a lesser extent in brain. Also expressed in both normal and tumorigenic breast epithelial cell lines. Significantly up- regulated in human tumors of the breast, ovary, and uterus. {ECO:0000269|PubMed:10199399, ECO:0000269|PubMed:12565891, ECO:0000269|PubMed:14517287}.; 	lymphoreticular;medulla oblongata;ovary;salivary gland;sympathetic chain;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;muscle;urinary;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;cornea;nasopharynx;placenta;macula lutea;visual apparatus;duodenum;liver;cervix;spleen;kidney;mammary gland;aorta;stomach;peripheral nerve;	.	0.35845	0.08818	0.595326758	82.66100495	6876.60504	17.67578	5q31.3	ID=COSM1192026;OCCURENCE=1(central_nervous_system)	1.989e-05	0	0	0.0001	0	0	0	7.804e-05									rs3085220						
5	140085391	140085392	GT	-	UTR3	ZMAT2	NM_144723:c.*50_*51delGT			0.971433760073875	0.0285276235273582	3.8616398766377e-05	zinc finger matrin-type 2	.	.	.	ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;bone;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;lacrimal gland;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;alveolus;liver;spleen;cervix;kidney;mammary gland;stomach;aorta;	medulla oblongata;superior cervical ganglion;pons;caudate nucleus;	0.64216	0.11262	-0.031067188	51.03798066	2.53643	0.09383	5q31.3		0.0060	0.0045	0.0071	0.0050	0.0023	0.0055	0.0036	0.0115	0	0	0	0	0	0	0	0	rs780532305						
5	140532478	140532478	-	CC	UTR3	PCDHB6	NM_001303145:c.*255_*256insCC;NM_018939:c.*255_*256insCC			0.00172664093496475	0.894344715098226	0.103928643966809	protocadherin beta 6	FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain.; 	.	.	unclassifiable (Anatomical System);myocardium;cartilage;ovary;salivary gland;intestine;pharynx;colon;parathyroid;blood;uterus;prostate;lung;trabecular meshwork;placenta;visual apparatus;duodenum;liver;kidney;brain;bladder;	medulla oblongata;superior cervical ganglion;uterus corpus;	0.07333	.	2.629367354	98.80278368	5415.09796	15.17538	5q31.3										0.0484	0.0149	0.0814	0.0148	0.0143	0.0644	0.0659	0.0649	rs33915713						
5	140755049	140755049	A	-	exonic	PCDHGA6		frameshift deletion	PCDHGA6:NM_018919:exon1:c.1399delA:p.R467Gfs*8,PCDHGA6:NM_032086:exon1:c.1399delA:p.R467Gfs*8	8.20064599747487e-07	0.736871867015814	0.263127312919587	protocadherin gamma subfamily A, 6	FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain.; 	.	.	.	.	0.20048	.	-0.079012906	47.25760793	336.38673	3.89594	5q31.3		0.0020	0	8.654e-05	0.0264	0	0.0001	0	0.0002	0.0015	0	0	0	0.0271	0	0.0001	0	rs140643836						
5	141321537	141321538	CA	-	UTR3	KIAA0141	NM_014773:c.*3213_*3214delCA;NM_001142603:c.*2420_*2421delCA			3.06120841888116e-10	0.281915894729241	0.718084104964638	KIAA0141	FUNCTION: Essential for the induction of death receptor-mediated apoptosis through the regulation of caspase activation. {ECO:0000269|PubMed:20563667}.; 	.	TISSUE SPECIFICITY: Detected in liver, skeletal muscle, kidney, pancreas, spleen, thyroid, testis, ovary, small intestine and colon. {ECO:0000269|PubMed:8590280}.; 	lymphoreticular;myocardium;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;synovium;larynx;bone;thyroid;iris;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;muscle;urinary;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;alveolus;liver;head and neck;spleen;kidney;mammary gland;stomach;cerebellum;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;parietal lobe;	0.04807	.	0.69078985	85.23826374	2730.37291	9.84899	5q31.3										6.649e-05	0	0	0	0	0	0.0001	0	rs137927996						
5	141324955	141324955	-	CTGCTG	exonic	PCDH12		nonframeshift insertion	PCDH12:NM_016580:exon4:c.3545_3546insCAGCAG:p.S1181_R1182insSS	1.29394215809467e-10	0.319804620938402	0.680195378932204	protocadherin 12	FUNCTION: Cellular adhesion molecule that may play an important role in cell-cell interactions at interendothelial junctions. Promotes homotypic calcium-dependent aggregation and adhesion and clusters at intercellular junctions. Unable to bind to catenins, weakly associates with the cytoskeleton (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in highly vascularized tissues including the heart and placenta, but most tissues contain a low level of expression. Prominent expression in the spleen.; 	unclassifiable (Anatomical System);cartilage;heart;colon;vein;skin;skeletal muscle;uterus;pancreas;lung;bone;placenta;visual apparatus;testis;head and neck;spleen;kidney;brain;mammary gland;aorta;	uterus corpus;superior cervical ganglion;heart;placenta;fetal lung;fetal thyroid;trigeminal ganglion;skeletal muscle;	0.60079	0.11198	0.747656234	86.41778721	545.62472	4.75149	5q31.3		0.0433	0.0371	0.0855	0.1170	0.0172	0.0281	0.0409	0.0470	0.0076	0.0261	0	0	0	0	0.0003	0	rs5871792						
5	141324955	141324955	-	CTGCTGCTG	exonic	PCDH12		nonframeshift insertion	PCDH12:NM_016580:exon4:c.3545_3546insCAGCAGCAG:p.S1181_R1182insSSS	1.29394215809467e-10	0.319804620938402	0.680195378932204	protocadherin 12	FUNCTION: Cellular adhesion molecule that may play an important role in cell-cell interactions at interendothelial junctions. Promotes homotypic calcium-dependent aggregation and adhesion and clusters at intercellular junctions. Unable to bind to catenins, weakly associates with the cytoskeleton (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in highly vascularized tissues including the heart and placenta, but most tissues contain a low level of expression. Prominent expression in the spleen.; 	unclassifiable (Anatomical System);cartilage;heart;colon;vein;skin;skeletal muscle;uterus;pancreas;lung;bone;placenta;visual apparatus;testis;head and neck;spleen;kidney;brain;mammary gland;aorta;	uterus corpus;superior cervical ganglion;heart;placenta;fetal lung;fetal thyroid;trigeminal ganglion;skeletal muscle;	0.60079	0.11198	0.747656234	86.41778721	545.62472	4.75149	5q31.3	ID=COSM1063580;OCCURENCE=2(breast),8(large_intestine),1(liver),3(urinary_tract),1(ovary),1(endometrium)	0.4348	0.2613	0.5894	0.6870	0.3472	0.3723	0.4425	0.5674	0.3937	0.2779	0.6090	0.4392	0.7875	0.4012	0.4030	0.4221	rs5871792						
5	141693390	141693392	GGG	-	UTR3	SPRY4	NM_030964:c.*384_*382delCCC;NM_001293289:c.*384_*382delCCC;NM_001293290:c.*384_*382delCCC;NM_001127496:c.*384_*382delCCC			0.109919685601811	0.776973194700711	0.113107119697478	sprouty RTK signaling antagonist 4	FUNCTION: Suppresses the insulin receptor and EGFR-transduced MAPK signaling pathway, but does not inhibit MAPK activation by a constitutively active mutant Ras. Probably impairs the formation of GTP-Ras. Inhibits Ras-independent, but not Ras-dependent, activation of RAF1. {ECO:0000269|PubMed:12717443}.; 	DISEASE: Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in SPRY4 also have a heterozygous mutation in another HH-associated gene including DUSP6 and FGFR1 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	.	ovary;colon;parathyroid;skin;uterus;prostate;whole body;endometrium;larynx;thyroid;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;muscle;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;thymus;	superior cervical ganglion;pons;skeletal muscle;	0.93024	0.14190	-0.045835247	50.34206181	112.70425	2.30891	5q31.3										0.8639	0.8287	0.9020	0.8609	0.9695	0.8446	0.8729	0.8691	rs398065271						
5	142606070	142606072	AAG	-	UTR3	ARHGAP26	NM_015071:c.*4059_*4061delAAG;NM_001135608:c.*4059_*4061delAAG;NM_001349547:c.*4059_*4061delAAG			0.998859800147404	0.00114019982817286	2.44227102159874e-11	Rho GTPase activating protein 26	FUNCTION: GTPase-activating protein for RHOA and CDC42.; 	DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal translocation t(5;11)(q31;q23) with KMT2A/MLL1 has been found in leukemic cells from JMML patients, also carrying inactivating mutations on the second allele (PubMed:10908648). {ECO:0000269|PubMed:10908648}.; 	.	ovary;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;oesophagus;endometrium;thyroid;bone;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;heart;blood;skeletal muscle;breast;lung;placenta;visual apparatus;liver;spleen;stomach;cerebellum;	superior cervical ganglion;heart;placenta;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.36857	0.36135	-0.867014353	10.72776598	31.37458	0.98924	5q31.3										3.537e-05	0	0	0	0	0.0003	0	0							
5	142607424	142607424	A	-	UTR3	ARHGAP26	NM_015071:c.*5413delA;NM_001135608:c.*5413delA;NM_001349547:c.*5413delA			0.998859800147404	0.00114019982817286	2.44227102159874e-11	Rho GTPase activating protein 26	FUNCTION: GTPase-activating protein for RHOA and CDC42.; 	DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal translocation t(5;11)(q31;q23) with KMT2A/MLL1 has been found in leukemic cells from JMML patients, also carrying inactivating mutations on the second allele (PubMed:10908648). {ECO:0000269|PubMed:10908648}.; 	.	ovary;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;oesophagus;endometrium;thyroid;bone;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;heart;blood;skeletal muscle;breast;lung;placenta;visual apparatus;liver;spleen;stomach;cerebellum;	superior cervical ganglion;heart;placenta;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.36857	0.36135	-0.867014353	10.72776598	31.37458	0.98924	5q31.3										0.0182	0.0043	0.0137	0.0073	0	0.0607	0.0223	0.0220	rs573709990						
5	143538479	143538479	A	-	UTR3	YIPF5	NM_030799:c.*1482delT;NM_001271732:c.*1482delT;NM_001024947:c.*1482delT			0.931585721197837	0.0680731428764855	0.000341135925677117	Yip1 domain family member 5	FUNCTION: Plays a role in transport between endoplasmic reticulum and Golgi. {ECO:0000269|PubMed:11489904, ECO:0000269|PubMed:15611160}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in coronary smooth muscles. {ECO:0000269|PubMed:15922870}.; 	ovary;salivary gland;sympathetic chain;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;cerebral cortex;endometrium;bone;thyroid;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;spinal cord;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;trabecular meshwork;placenta;visual apparatus;hippocampus;liver;spleen;cervix;kidney;mammary gland;stomach;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;smooth muscle;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.10995	0.10013	0.393270925	76.04977589	54.68309	1.48029	5q31.3										0.0359	0.0106	0.0453	0.044	0	0.0643	0.0530	0.0506							
5	145890610	145890610	T	-	UTR3	TCERG1	NM_006706:c.*405delT;NM_001040006:c.*405delT			0.999962712136281	3.72878637177864e-05	1.18845843310733e-15	transcription elongation regulator 1	FUNCTION: Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner. Necessary for TAT-dependent activation of the human immunodeficiency virus type 1 (HIV-1) promoter. {ECO:0000269|PubMed:11604498, ECO:0000269|PubMed:9315662}.; 	.	TISSUE SPECIFICITY: Detected in brain neurons. {ECO:0000269|PubMed:11172033}.; 	smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;adrenal cortex;blood;lens;skeletal muscle;trabecular meshwork;macula lutea;liver;spleen;mammary gland;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;bone;pituitary gland;testis;pineal gland;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;aorta;	amygdala;superior cervical ganglion;tumor;	0.94723	0.23802	-0.865195027	10.79853739	89.92295	2.04005	5q32										0.0030	0.0017	0.0126	0	0.0012	0.0242	0.0008	0.0038							
5	146833547	146833547	T	-	intronic	DPYSL3				0.996483173643699	0.00351659917110604	2.27185195380906e-07	dihydropyrimidinase like 3	FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Mainly expressed in heart and skeletal muscle. Also strongly expressed in fetal brain and spinal cord.; 	lymphoreticular;myocardium;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;bone;thyroid;iris;testis;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;trophoblast;cartilage;heart;tongue;islets of Langerhans;urinary;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;stomach;aorta;peripheral nerve;	dorsal root ganglion;amygdala;superior cervical ganglion;fetal brain;hypothalamus;spinal cord;ciliary ganglion;caudate nucleus;trigeminal ganglion;	0.89066	0.14682	-0.358119787	29.16371786	99.15207	2.15522	5q32										0.0034	0.0013	0.0102	0.0127	0.0006	0.0158	0.0034	0.0058							
5	147280951	147280951	A	-	intronic	C5orf46				0.29942489197858	0.623116997054355	0.077458110967066	chromosome 5 open reading frame 46	.	.	.	uterus;ovary;heart;skin;	testis - interstitial;salivary gland;testis;skin;	.	.	0.3032669	72.009908	5706.20734	15.63783	5q32										0.1814	0.4051	0.0759	0.0524	0.1431	0.1061	0.0428	0.0872	rs71969066						
5	147554993	147554993	T	-	UTR3	SPINK14	NM_001001325:c.*32delT			0.0163521578795306	0.705051857165835	0.278595984954635	serine peptidase inhibitor, Kazal type 14 (putative)	FUNCTION: May be a serine protease inhibitor. {ECO:0000250}.; 	.	.	.	.	.	.	0.035072054	56.2514744	5.4089	0.19994	5q32		0.0297	0.0200	0.0372	0.0342	0.0188	0.0352	0.0116	0.0157									rs753127604						
5	147785803	147785803	T	-	intronic	FBXO38				0.999962180270506	3.78197294881352e-05	6.07960822415577e-15	F-box protein 38	FUNCTION: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation. May coactivate KLF7, but does not seem to promote KLF7 ubiquitination (By similarity). {ECO:0000250}.; 	DISEASE: Neuronopathy, distal hereditary motor, 2D (HMN2D) [MIM:615575]: A disorder characterized by onset of slowly progressive distal lower limb weakness and atrophy between the second and fourth decades of life. Weakness usually begins in the calf muscles and later involves more proximal muscles. The severity is variable, and some patients have difficulty walking or running. Most also have upper limb involvement, particularly of the triceps and intrinsic hand muscles. Some patients may lose independent ambulation later in the disease course. Sensory impairment is typically not present, and cognition and bulbar function are normal. {ECO:0000269|PubMed:24207122}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;bone;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;tongue;hypothalamus;spinal cord;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;amygdala;superior cervical ganglion;appendix;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.28234	0.10767	-0.883608246	10.50365652	2999.5379	10.39443	5q32		0.3438	0.3599	0.3742	0.3917	0.2565	0.3382	0.3107	0.3455	0.0062	0.0023	0.0274	0.0725	0.0112	0.0244	0.0030	0.0140	rs201558003						
5	148731881	148731881	T	-	ncRNA_intronic	GRPEL2-AS1				.	.	.	GRPEL2 antisense RNA 1	.	.	.	.	.	.	.	.	.	.	.	5q32										0.0174	0.0434	0.0211	0.008	0	0.0350	0.0031	0.0046							
5	148873187	148873187	A	-	intergenic	CARMN;CSNK1A1	dist=60788;dist=2270																		5q32										0.0137	0.0068	0.0509	0.0259	0.0014	0.1598	0.0074	0.0377	rs112272856						
5	148884875	148884875	T	-	intronic	CSNK1A1				0.993657229734498	0.00634181098991656	9.59275585676678e-07	casein kinase 1 alpha 1	FUNCTION: Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates CTNNB1 at 'Ser-45'. May phosphorylate PER1 and PER2. May play a role in segregating chromosomes during mitosis (PubMed:11955436, PubMed:1409656, PubMed:18305108). May play a role in keratin cytoskeleton disassembly and thereby, it may regulate epithelial cell migration (PubMed:23902688). {ECO:0000269|PubMed:11955436, ECO:0000269|PubMed:1409656, ECO:0000269|PubMed:18305108, ECO:0000269|PubMed:23902688}.; 	.	.	lymphoreticular;smooth muscle;ovary;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;brain;tonsil;heart;cartilage;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;cerebral cortex;larynx;bone;pituitary gland;testis;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;muscle;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;head and neck;kidney;stomach;aorta;thymus;	testis;	0.62323	0.12971	-0.053113545	49.38664779	.	.	5q32										0.0074	0.0018	0.0413	0.0195	0	0.0690	0.0027	0.0128	rs573347539						
5	149226648	149226648	A	-	intronic	PPARGC1B				0.934054614318936	0.065945278987448	1.06693615849487e-07	PPARG coactivator 1 beta	FUNCTION: Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcritional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:15546003, ECO:0000269|PubMed:23836911}.; 	.	TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.; 	unclassifiable (Anatomical System);pancreas;optic nerve;heart;placenta;macula lutea;cervix;fovea centralis;choroid;lens;brain;retina;bone marrow;	superior cervical ganglion;trigeminal ganglion;	0.23449	0.21407	1.061821821	91.47204529	2264.36762	8.79368	5q32										0.0034	0.0005	0.0133	0.0182	0	0.0312	0.0026	0.0080							
5	149227268	149227268	A	-	UTR3	PPARGC1B	NM_133263:c.*147delA;NM_001172698:c.*147delA;NM_001172699:c.*147delA			0.934054614318936	0.065945278987448	1.06693615849487e-07	PPARG coactivator 1 beta	FUNCTION: Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcritional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:15546003, ECO:0000269|PubMed:23836911}.; 	.	TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.; 	unclassifiable (Anatomical System);pancreas;optic nerve;heart;placenta;macula lutea;cervix;fovea centralis;choroid;lens;brain;retina;bone marrow;	superior cervical ganglion;trigeminal ganglion;	0.23449	0.21407	1.061821821	91.47204529	2264.36762	8.79368	5q32										0.0220	0.0328	0.0182	0.0086	0	0.0870	0.0118	0.0173							
5	149233894	149233895	GT	-	UTR3	PPARGC1B	NM_133263:c.*6773_*6774delGT;NM_001172698:c.*6773_*6774delGT;NM_001172699:c.*6773_*6774delGT			0.934054614318936	0.065945278987448	1.06693615849487e-07	PPARG coactivator 1 beta	FUNCTION: Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcritional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:15546003, ECO:0000269|PubMed:23836911}.; 	.	TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.; 	unclassifiable (Anatomical System);pancreas;optic nerve;heart;placenta;macula lutea;cervix;fovea centralis;choroid;lens;brain;retina;bone marrow;	superior cervical ganglion;trigeminal ganglion;	0.23449	0.21407	1.061821821	91.47204529	2264.36762	8.79368	5q32										0	0	0	0	0	0	0	0							
5	149233937	149233938	TG	-	UTR3	PPARGC1B	NM_133263:c.*6816_*6817delTG;NM_001172698:c.*6816_*6817delTG;NM_001172699:c.*6816_*6817delTG			0.934054614318936	0.065945278987448	1.06693615849487e-07	PPARG coactivator 1 beta	FUNCTION: Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcritional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:15546003, ECO:0000269|PubMed:23836911}.; 	.	TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.; 	unclassifiable (Anatomical System);pancreas;optic nerve;heart;placenta;macula lutea;cervix;fovea centralis;choroid;lens;brain;retina;bone marrow;	superior cervical ganglion;trigeminal ganglion;	0.23449	0.21407	1.061821821	91.47204529	2264.36762	8.79368	5q32										0.0031	0.0007	0.0012	0	0	0.0035	0.0047	0.0052	rs561491869						
5	149233951	149233952	TG	-	UTR3	PPARGC1B	NM_133263:c.*6830_*6831delTG;NM_001172698:c.*6830_*6831delTG;NM_001172699:c.*6830_*6831delTG			0.934054614318936	0.065945278987448	1.06693615849487e-07	PPARG coactivator 1 beta	FUNCTION: Plays a role of stimulator of transcription factors and nuclear receptors activities. Activates transcritional activity of estrogen receptor alpha, nuclear respiratory factor 1 (NRF1) and glucocorticoid receptor in the presence of glucocorticoids. May play a role in constitutive non-adrenergic-mediated mitochondrial biogenesis as suggested by increased basal oxygen consumption and mitochondrial number when overexpressed. May be involved in fat oxidation and non-oxidative glucose metabolism and in the regulation of energy expenditure. Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921, ECO:0000269|PubMed:15546003, ECO:0000269|PubMed:23836911}.; 	.	TISSUE SPECIFICITY: Ubiquitous with higher expression in heart, brain and skeletal muscle. {ECO:0000269|PubMed:11854298, ECO:0000269|PubMed:12678921}.; 	unclassifiable (Anatomical System);pancreas;optic nerve;heart;placenta;macula lutea;cervix;fovea centralis;choroid;lens;brain;retina;bone marrow;	superior cervical ganglion;trigeminal ganglion;	0.23449	0.21407	1.061821821	91.47204529	2264.36762	8.79368	5q32										0.0209	0.0055	0.0245	0.0396	0.0006	0.0355	0.0277	0.0347	rs796931878						
5	149589366	149589367	AC	-	UTR3	SLC6A7	NM_014228:c.*188_*189delAC			7.14638706508392e-06	0.976649657622941	0.0233431959899939	solute carrier family 6 member 7	FUNCTION: Terminates the action of proline by its high affinity sodium-dependent reuptake into presynaptic terminals.; 	.	TISSUE SPECIFICITY: Brain.; 	unclassifiable (Anatomical System);optic nerve;macula lutea;colon;fovea centralis;choroid;lens;brain;tonsil;retina;cerebellum;	superior cervical ganglion;temporal lobe;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;skeletal muscle;	0.21530	0.51251	-1.285933373	5.083746167	154.49049	2.71751	5q32										0.0032	0.0002	0	0	0.0409	0.0058	0.0005	0.0031	rs140293447						
5	149759066	149759070	CTCTC	-	intronic	TCOF1				0.765232862711561	0.234767111348379	2.59400602069905e-08	treacle ribosome biogenesis factor 1	FUNCTION: May be involved in nucleolar-cytoplasmic transport. May play a fundamental role in early embryonic development, particularly in development of the craniofacial complex (By similarity). May participate in certain stages of ribosome biogenesis. {ECO:0000250, ECO:0000269|PubMed:12777385}.; 	DISEASE: Treacher Collins syndrome 1 (TCS1) [MIM:154500]: A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss. {ECO:0000269|PubMed:9042910}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;larynx;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;adrenal cortex;blood;lens;skeletal muscle;breast;lung;epididymis;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	subthalamic nucleus;superior cervical ganglion;pons;parietal lobe;cerebellum;	0.11725	0.19531	0.466523353	78.69780609	3192.10978	10.76481	5q32		0.0688	0.0119	0.0337	0.1199	0.0750	0.0703	0.0586	0.0947	0.0637	0.0147	0.0430	0.0364	0.1267	0.0688	0.0851	0.0764	rs151182547	251824	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
5	149919109	149919109	T	-	intronic	NDST1				0.998138371728285	0.0018616278729017	3.98813674923818e-10	N-deacetylase/N-sulfotransferase 1	FUNCTION: Essential bifunctional enzyme that catalyzes both the N- deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis. Plays a role in determining the extent and pattern of sulfation of heparan sulfate. Compared to other NDST enzymes, its presence is absolutely required. Participates in biosynthesis of heparan sulfate that can ultimately serve as L- selectin ligands, thereby playing a role in inflammatory response. {ECO:0000269|PubMed:10758005, ECO:0000269|PubMed:12634318}.; 	.	TISSUE SPECIFICITY: Widely expressed. Expression is most abundant in heart, liver and pancreas.; 	ovary;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;thyroid;bone;testis;bladder;brain;unclassifiable (Anatomical System);lymph node;heart;blood;lens;skeletal muscle;breast;lung;placenta;macula lutea;hypopharynx;head and neck;cervix;kidney;	superior cervical ganglion;testis - interstitial;tongue;pons;fetal thyroid;trigeminal ganglion;skeletal muscle;	0.75606	0.18509	-1.747196778	2.359046945	49.57817	1.37784	5q33.1																		rs368486461						
5	150647377	150647377	T	-	UTR3	GM2A	NM_000405:c.*365delT;NM_001167607:c.*176delT			0.111186454530615	0.777402352408525	0.11141119306086	GM2 ganglioside activator	FUNCTION: The large binding pocket can accommodate several single chain phospholipids and fatty acids, GM2A also exhibits some calcium-independent phospholipase activity (By similarity). Binds gangliosides and stimulates ganglioside GM2 degradation. It stimulates only the breakdown of ganglioside GM2 and glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 molecules from membranes and presents them in soluble form to beta- hexosaminidase A for cleavage of N-acetyl-D-galactosamine and conversion to GM3. {ECO:0000250}.; 	DISEASE: GM2-gangliosidosis AB (GM2GAB) [MIM:272750]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the presence of both normal hexosaminidase A and B. {ECO:0000269|PubMed:1915858, ECO:0000269|PubMed:8244332, ECO:0000269|PubMed:8900233}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;larynx;bone;thyroid;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;pharynx;blood;skeletal muscle;pancreas;lung;cornea;nasopharynx;placenta;visual apparatus;hypopharynx;duodenum;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;lung;placenta;trigeminal ganglion;	0.26723	0.19354	0.681699246	84.93158764	326.06898	3.83913	5q33.1										0.4018	0.469	0.3660	0.4296	0.3795	0.4528	0.3558	0.4007	rs35295884	298358	Tay-Sachs_disease,_variant_AB	MedGen:C0268275,OMIM:272750,Orphanet:ORPHA309246,SNOMED_CT:71253000	criteria_provided,_single_submitter	Benign	
5	150846707	150846711	GCATT	-	intronic	SLC36A1				0.0234724316059047	0.973513461950046	0.00301410644404907	solute carrier family 36 member 1	FUNCTION: Neutral amino acid/proton symporter. Has a pH-dependent electrogenic transport activity for small amino acids such as glycine, alanine and proline. Besides small apolar L-amino acids, it also recognize their D-enantiomers and selected amino acid derivatives such as gamma-aminobutyric acid (By similarity). {ECO:0000250, ECO:0000269|PubMed:12809675}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;frontal lobe;larynx;bone;thyroid;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);heart;blood;lens;skeletal muscle;pancreas;lung;placenta;liver;spleen;head and neck;cervix;kidney;stomach;peripheral nerve;thymus;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;cerebellum;	0.13898	0.14921	-0.620857637	17.3566879	66.87625	1.68879	5q33.1										0.1085	0.0278	0.1014	0.23	0.3177	0.0913	0.1328	0.1442	rs76799041						
5	150883681	150883681	A	-	UTR3	FAT2	NM_001447:c.*1445delT			7.35015824204342e-11	0.999999998965583	9.60915250083777e-10	FAT atypical cadherin 2	FUNCTION: Plays a role in the migration of epidermal cells. May modulate the extracellular space surronding parallel fibers of cerebellar during development (By similarity). {ECO:0000250, ECO:0000269|PubMed:18534823}.; 	.	TISSUE SPECIFICITY: Expressed in epidermal keratinocytes, infant brain, cerebellum, and also in a variety of tumors, such as pancreatic cancer, diffuse type gastric cancer, ovarian cancer, esophageal cancer, skin squamous cell carcinoma, head and neck cancer. Not expressed in melanoma cell line A375 cells, normal epidermal melanocytes or normal dermal fibroblasts. Expressed in epidermal keratinocytes and squamous cell carcinoma (at protein level). {ECO:0000269|PubMed:16865240, ECO:0000269|PubMed:17900869}.; 	ovary;tongue;parathyroid;lens;skin;skeletal muscle;uterus;breast;lung;bone;thyroid;liver;pituitary gland;testis;head and neck;spleen;kidney;brain;stomach;	cerebellum peduncles;cerebellum;	0.15430	0.09701	1.951664999	97.53479594	17917.39848	28.44166	5q33.1										0.0005	0.0001	0	0	0.0006	0.0007	0.0006	0.0011							
5	151771614	151771614	A	-	UTR3	NMUR2	NM_020167:c.*138delT			0.421657260997351	0.570605939899117	0.00773679910353184	neuromedin U receptor 2	FUNCTION: Receptor for the neuromedin-U and neuromedin-S neuropeptides. {ECO:0000250, ECO:0000269|PubMed:10899166}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in the CNS, particularly in the medulla oblongata, pontine reticular formation, spinal cord, and thalamus. High level in testis whereas lower levels are present in a variety of peripheral tissues including the gastrointestinal tract, genitourinary tract, liver, pancreas, adrenal gland, thyroid gland, lung, trachea, spleen and thymus. {ECO:0000269|PubMed:10887190, ECO:0000269|PubMed:10894543, ECO:0000269|PubMed:10899166, ECO:0000269|PubMed:11010960}.; 	unclassifiable (Anatomical System);uterus;heart;testis;brain;skin;stomach;	.	0.11625	0.10378	1.376101648	94.5329087	2423.32741	9.14747	5q33.1										0.1628	0.0513	0.3486	0.1617	0.0346	0.3198	0.2119	0.2178	rs200216792						
5	156190731	156190731	A	-	UTR3	SGCD	NM_001128209:c.*4330delA;NM_000337:c.*4330delA			0.00233910042363156	0.92474998969308	0.0729109098832882	sarcoglycan delta	FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.; 	DISEASE: Limb-girdle muscular dystrophy 2F (LGMD2F) [MIM:601287]: An autosomal recessive degenerative myopathy initially affecting the proximal limb girdle musculature. Muscle from patients shows a complete loss of delta-sarcoglycan as well as of the others components of the sarcoglycan complex. {ECO:0000269|PubMed:9832045}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1L (CMD1L) [MIM:606685]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10974018}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Most strongly expressed in skeletal and cardiac muscle. Also detected in smooth muscle. Weak expression in brain and lung.; 	myocardium;ovary;colon;parathyroid;choroid;skin;uterus;atrium;whole body;thyroid;bone;pituitary gland;testis;spinal ganglion;brain;pineal gland;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;adrenal cortex;skeletal muscle;lung;adrenal gland;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;	occipital lobe;medulla oblongata;superior cervical ganglion;olfactory bulb;ciliary ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;cingulate cortex;	0.14985	0.36776	-0.271755481	34.31823543	233.51927	3.30188	5q33.3										0.0071	0.0051	0.0189	0.0042	0.0006	0.0558	0.0035	0.0072							
5	158588634	158588634	A	-	intronic	RNF145				0.663621979090798	0.336332443022211	4.55778869912241e-05	ring finger protein 145	.	.	.	ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cerebral cortex;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);heart;tongue;islets of Langerhans;lens;bile duct;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;alveolus;head and neck;kidney;stomach;peripheral nerve;	amygdala;placenta;fetal lung;	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	5q33.3		0.0251	0.0210	0.0198	0.0731	0.0248	0.0238	0.0187	0.0115	0.0085	0.0197	0.0026	0	0.0232	0.0038	0.0016	0.0068	rs769174313						
5	159519021	159519022	AT	-	UTR3	PWWP2A	NM_001130864:c.*368_*367delAT;NM_001349732:c.*368_*367delAT			0.920215651464739	0.0796812531599757	0.000103095375284973	PWWP domain containing 2A	.	.	.	unclassifiable (Anatomical System);meninges;heart;colon;skin;uterus;breast;prostate;pia mater;lung;visual apparatus;hippocampus;liver;testis;spleen;dura mater;germinal center;brain;	superior cervical ganglion;temporal lobe;ciliary ganglion;atrioventricular node;skeletal muscle;	0.15294	.	-0.003562597	53.72729417	395.64117	4.17888	5q33.3																								
5	159519033	159519036	ACAC	-	UTR3	PWWP2A	NM_001130864:c.*356_*353delGTGT;NM_001349732:c.*356_*353delGTGT			0.920215651464739	0.0796812531599757	0.000103095375284973	PWWP domain containing 2A	.	.	.	unclassifiable (Anatomical System);meninges;heart;colon;skin;uterus;breast;prostate;pia mater;lung;visual apparatus;hippocampus;liver;testis;spleen;dura mater;germinal center;brain;	superior cervical ganglion;temporal lobe;ciliary ganglion;atrioventricular node;skeletal muscle;	0.15294	.	-0.003562597	53.72729417	395.64117	4.17888	5q33.3										0.0002	0.0007	0	0	0	0	0	0	rs779456449						
5	160717255	160717255	T	-	UTR3	GABRB2	NM_021911:c.*3833delA;NM_000813:c.*3833delA			0.940299230468594	0.059690762733396	1.0006798009612e-05	gamma-aminobutyric acid type A receptor beta2 subunit	FUNCTION: Component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the vertebrate brain. Functions also as histamine receptor and mediates cellular responses to histamine. Functions as receptor for diazepines and various anesthetics, such as pentobarbital; these are bound at a separate allosteric effector binding site. Functions as ligand- gated chloride channel. {ECO:0000269|PubMed:19763268, ECO:0000269|PubMed:8264558}.; 	.	TISSUE SPECIFICITY: Isoform 1 and isoform 2 show reduced expression in schizophrenic brain. Isoform 3 shows increased expression in schizophrenic and bipolar disorder brains while isoform 4 shows reduced expression. {ECO:0000269|PubMed:16983389, ECO:0000269|PubMed:19763268}.; 	unclassifiable (Anatomical System);amygdala;colon;	superior cervical ganglion;pons;	0.31714	0.15588	-0.692458599	14.96815287	15.77729	0.56225	5q34										0.0087	0.0258	0.0078	0	0.0006	0.0006	0.0008	0.0027							
5	161322653	161322653	T	-	intronic	GABRA1				0.963866034985763	0.0361199250282176	1.40399860194151e-05	gamma-aminobutyric acid type A receptor alpha1 subunit	FUNCTION: Component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the vertebrate brain. Functions also as histamine receptor and mediates cellular responses to histamine. Functions as receptor for diazepines and various anesthetics, such as pentobarbital; these are bound at a separate allosteric effector binding site. Functions as ligand- gated chloride channel (By similarity). {ECO:0000250}.; 	DISEASE: Epilepsy, childhood absence 4 (ECA4) [MIM:611136]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:16718694}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. {ECO:0000269|PubMed:21714819}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. {ECO:0000269|PubMed:11992121}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 19 (EIEE19) [MIM:615744]: A severe neurologic disorder characterized by onset of seizures in the first months of life and usually associated with EEG abnormalities. Affected infants have convulsive seizures (hemiclonic or generalized) that are often prolonged and triggered by fever. Other seizure types include focal, myoclonic, absence seizures, and drop attacks. Development is normal in the first year of life with later slowing and intellectual disability. {ECO:0000269|PubMed:24623842}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	amygdala;frontal lobe;cerebellum cortex;adrenal gland;hypothalamus;macula lutea;fovea centralis;brain;cerebellum;	amygdala;whole brain;occipital lobe;medulla oblongata;cerebellum peduncles;hypothalamus;temporal lobe;pons;subthalamic nucleus;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;cerebellum;	0.56574	0.26790	-0.449946534	24.00330267	14.94107	0.53856	5q34		0.0635	0.0805	0.0692	0.0695	0.0403	0.0745	0.0482	0.0274	0.0068	0.0160	0.0044	0	0.0025	0.0004	0.0031	0.0061	rs3214859	190769	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
5	161324996	161324996	A	-	UTR3	GABRA1	NM_000806:c.*568delA;NM_001127643:c.*568delA;NM_001127644:c.*568delA;NM_001127645:c.*568delA;NM_001127648:c.*568delA			0.963866034985763	0.0361199250282176	1.40399860194151e-05	gamma-aminobutyric acid type A receptor alpha1 subunit	FUNCTION: Component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the vertebrate brain. Functions also as histamine receptor and mediates cellular responses to histamine. Functions as receptor for diazepines and various anesthetics, such as pentobarbital; these are bound at a separate allosteric effector binding site. Functions as ligand- gated chloride channel (By similarity). {ECO:0000250}.; 	DISEASE: Epilepsy, childhood absence 4 (ECA4) [MIM:611136]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:16718694}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. {ECO:0000269|PubMed:21714819}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. {ECO:0000269|PubMed:11992121}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 19 (EIEE19) [MIM:615744]: A severe neurologic disorder characterized by onset of seizures in the first months of life and usually associated with EEG abnormalities. Affected infants have convulsive seizures (hemiclonic or generalized) that are often prolonged and triggered by fever. Other seizure types include focal, myoclonic, absence seizures, and drop attacks. Development is normal in the first year of life with later slowing and intellectual disability. {ECO:0000269|PubMed:24623842}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	amygdala;frontal lobe;cerebellum cortex;adrenal gland;hypothalamus;macula lutea;fovea centralis;brain;cerebellum;	amygdala;whole brain;occipital lobe;medulla oblongata;cerebellum peduncles;hypothalamus;temporal lobe;pons;subthalamic nucleus;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;cerebellum;	0.56574	0.26790	-0.449946534	24.00330267	14.94107	0.53856	5q34										0.0079	0.0029	0.0212	0.0466	0	0.0274	0.0087	0.0177	rs748975579						
5	162945388	162945388	T	-	UTR3	MAT2B	NM_182796:c.*19delT;NM_013283:c.*19delT			0.252497397412429	0.741318276446667	0.00618432614090406	methionine adenosyltransferase 2B	FUNCTION: Non-catalytic regulatory subunit of S-adenosylmethionine synthetase 2 (MAT2A), an enzyme that catalyzes the formation of S- adenosylmethionine from methionine and ATP. Regulates the activity of S-adenosylmethionine synthetase 2 by changing its kinetic properties, rendering the enzyme more susceptible to S- adenosylmethionine inhibition. {ECO:0000269|PubMed:10644686}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10644686, ECO:0000269|PubMed:11337507}.; 	medulla oblongata;smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;germinal center;bladder;brain;heart;pharynx;blood;lens;breast;macula lutea;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;choroid;fovea centralis;vein;uterus;whole body;cerebral cortex;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;hypothalamus;pancreas;lung;nasopharynx;placenta;hippocampus;amnion;head and neck;kidney;stomach;	superior cervical ganglion;occipital lobe;globus pallidus;kidney;whole blood;parietal lobe;	0.76157	0.29199	-0.337894035	30.37272942	31.67303	0.99678	5q34		0.3752	0.3087	0.4188	0.3647	0.3194	0.3694	0.3621	0.4436	0.1281	0.1118	0.1966	0.1301	0.0642	0.2726	0.1214	0.1574	rs200442777						
5	169507131	169507132	TG	-	intronic	DOCK2				0.999999892553994	1.07446005463636e-07	6.38720031627346e-24	dedicator of cytokinesis 2	FUNCTION: Involved in cytoskeletal rearrangements required for lymphocyte migration in response of chemokines. Activates RAC1 and RAC2, but not CDC42, by functioning as a guanine nucleotide exchange factor (GEF), which exchanges bound GDP for free GTP. May also participate in IL2 transcriptional activation via the activation of RAC2. {ECO:0000269|PubMed:21613211}.; 	DISEASE: Immunodeficiency 40 (IMD40) [MIM:616433]: A form of combined immunodeficiency characterized by lymphopenia, and defective T-cell, B-cell, and NK-cell responses. Patients suffer from severe invasive bacterial and viral infections in early childhood and may die without bone marrow transplantation. {ECO:0000269|PubMed:26083206}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Specifically expressed in hematopoietic cells. Highly expressed in peripheral blood leukocytes, and expressed at intermediate level in thymus and spleen. Expressed at very low level in the small intestine and colon. {ECO:0000269|PubMed:10559471}.; 	lymphoreticular;smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;bone;thyroid;testis;germinal center;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;adrenal cortex;pharynx;blood;skeletal muscle;breast;pancreas;lung;adrenal gland;placenta;visual apparatus;alveolus;liver;spleen;kidney;mammary gland;stomach;thymus;	lymph node;tumor;white blood cells;whole blood;tonsil;bone marrow;thymus;	0.50359	0.10971	-1.155796362	6.10403397	368.53431	4.05624	5q35.1		0.2185	0.1910	0.2430	0.2494	0.1825	0.2136	0.2175	0.2431	6.608e-05	0	0	0	0	0	6.799e-05	0.0011	rs138478687						
5	170884163	170884163	A	-	UTR3	FGF18	NM_003862:c.*354delA			0.175827312241956	0.768136897525061	0.0560357902329829	fibroblast growth factor 18	FUNCTION: Plays an important role in the regulation of cell proliferation, cell differentiation and cell migration. Required for normal ossification and bone development. Stimulates hepatic and intestinal proliferation. {ECO:0000269|PubMed:16597617}.; 	.	.	unclassifiable (Anatomical System);uterus;lung;ovary;heart;placenta;colon;parathyroid;skin;	dorsal root ganglion;superior cervical ganglion;uterus corpus;ciliary ganglion;atrioventricular node;skeletal muscle;	0.55384	0.26913	-0.317668748	31.45789101	7.53265	0.27949	5q35.1										0.0063	0.0105	0.008	0.0195	0	0.0192	0.0035	0.0057	rs530164788						
5	171760545	171760545	A	-	UTR3	SH3PXD2B	NM_001017995:c.*4828delT			0.0185367927997724	0.981286619463668	0.000176587736559825	SH3 and PX domains 2B	FUNCTION: Adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. Plays a role in mitotic clonal expansion during the immediate early stage of adipocyte differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497}.; 	DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in fibroblasts. {ECO:0000269|PubMed:20137777}.; 	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;oesophagus;endometrium;larynx;thyroid;bone;testis;amniotic fluid;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lens;skeletal muscle;breast;lung;placenta;macula lutea;visual apparatus;cervix;head and neck;mammary gland;stomach;cerebellum;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;cerebellum;	0.26216	0.10532	-0.279250919	33.56923803	389.35486	4.15627	5q35.1										0.6235	0.5452	0.6194	0.6714	0.6376	0.6386	0.6617	0.6742	rs35951290	303168	Frank_Ter_Haar_syndrome	MedGen:C1855305,OMIM:249420,Orphanet:ORPHA137834	criteria_provided,_single_submitter	Benign	
5	172114302	172114303	GA	-	UTR3	NEURL1B	NM_001308177:c.*374_*375delGA;NM_001308178:c.*374_*375delGA;NM_001142651:c.*374_*375delGA			0.370536573297444	0.480094712575494	0.149368714127062	neuralized E3 ubiquitin protein ligase 1B	FUNCTION: E3 ubiquitin-protein ligase involved in regulation of the Notch pathway through influencing the stability and activity of several Notch ligands. {ECO:0000269|PubMed:19723503}.; 	.	TISSUE SPECIFICITY: Highest expression in brain, prostate and small intestine. In the brain the levels are higher in fetal than in adult stage. In the adult brain the highest levels are detected in the olfactory system, cerebellar cortex, optic nerve and the frontal lobe. {ECO:0000269|PubMed:19723503}.; 	.	.	.	.	.	.	214.68822	3.16031	5q35.1										0.0005	0.0009	0	0	0	0.0011	0.0003	0.0011	rs147474603						
5	172566001	172566001	T	-	UTR3	CREBRF	NM_153607:c.*5253delT			0.998406138401379	0.00159382863543768	3.29631834680336e-08	CREB3 regulatory factor	FUNCTION: Acts as a negative regulator of the endoplasmic reticulum stress response or unfolded protein response (UPR). Represses the transcriptional activity of CREB3 during the UPR. Recruits CREB3 into nuclear foci. {ECO:0000269|PubMed:18391022}.; 	.	.	.	.	0.40707	0.07442	-0.824740496	11.67728238	20.36051	0.69441	5q35.1										0.0017	0.0002	0	0.0039	0.0031	0.0179	0.0003	0.0013							
5	173383607	173383607	T	-	UTR3	CPEB4	NM_001308189:c.*467delT;NM_001308191:c.*467delT;NM_030627:c.*467delT;NM_001308192:c.*467delT;NM_001308193:c.*467delT			0.996854727820052	0.00314526509598533	7.08396234479541e-09	cytoplasmic polyadenylation element binding protein 4	.	.	.	lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;optic nerve;frontal lobe;endometrium;thyroid;iris;germinal center;brain;tonsil;heart;cartilage;spinal cord;adrenal cortex;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;visual apparatus;liver;alveolus;cervix;spleen;mammary gland;colon;parathyroid;fovea centralis;choroid;uterus;whole body;bone;pituitary gland;testis;dura mater;unclassifiable (Anatomical System);meninges;islets of Langerhans;hypothalamus;pancreas;lung;pia mater;adrenal gland;nasopharynx;placenta;kidney;stomach;aorta;	globus pallidus;atrioventricular node;	0.67807	0.11104	-0.22584292	37.32012267	29.93649	0.95618	5q35.2																								
5	173388721	173388721	T	-	downstream	CPEB4	dist=727			0.996854727820052	0.00314526509598533	7.08396234479541e-09	cytoplasmic polyadenylation element binding protein 4	.	.	.	lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;optic nerve;frontal lobe;endometrium;thyroid;iris;germinal center;brain;tonsil;heart;cartilage;spinal cord;adrenal cortex;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;visual apparatus;liver;alveolus;cervix;spleen;mammary gland;colon;parathyroid;fovea centralis;choroid;uterus;whole body;bone;pituitary gland;testis;dura mater;unclassifiable (Anatomical System);meninges;islets of Langerhans;hypothalamus;pancreas;lung;pia mater;adrenal gland;nasopharynx;placenta;kidney;stomach;aorta;	globus pallidus;atrioventricular node;	0.67807	0.11104	-0.22584292	37.32012267	29.93649	0.95618	5q35.2										0.4189	0.5311	0.3652	0.3556	0.1743	0.3604	0.3954	0.3845	rs34255035						
5	174954580	174954580	T	-	UTR3	SFXN1	NM_001322977:c.*843delT;NM_001322982:c.*843delT;NM_001322981:c.*898delT;NM_001322980:c.*898delT;NM_001322978:c.*843delT;NM_022754:c.*843delT			0.58517754975236	0.41437385959553	0.000448590652110729	sideroflexin 1	FUNCTION: Might be involved in the transport of a component required for iron utilization into or out of the mitochondria.; 	.	.	ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cerebral cortex;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;tongue;islets of Langerhans;spinal cord;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;mesenchyma;epididymis;nasopharynx;placenta;visual apparatus;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;	ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.23911	0.15578	0.174625237	65.9648502	64.03438	1.64025	5q35.2										7.011e-05	0	0.0029	0	0	0	0	0							
5	175805999	175805999	A	-	intergenic	ARL10;NOP16	dist=5496;dist=4941																		5q35.2										0	0	0	0	0	0	0	0							
5	176026120	176026143	CTCAAAGACCCAGGATCCTCCTTC	-	exonic	GPRIN1		nonframeshift deletion	GPRIN1:NM_052899:exon2:c.693_716del:p.E233Vfs*769	0.787287341879441	0.21242825806323	0.000284400057328623	G protein regulated inducer of neurite outgrowth 1	FUNCTION: May be involved in neurite outgrowth. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Widely expressed in the central nervous system, with highest levels in spinal cord. {ECO:0000269|PubMed:10480904}.; 	colon;fovea centralis;choroid;skin;retina;uterus;optic nerve;whole body;frontal lobe;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;blood;lens;pancreas;lung;placenta;hippocampus;visual apparatus;macula lutea;duodenum;kidney;mammary gland;	.	0.09709	0.08002	0.159856957	64.91507431	2314.51425	8.90786	5q35.2	ID=COSM1436171;OCCURENCE=1(urinary_tract),4(large_intestine)	1.272e-05	0	0	0.0002	0	0	0	0									rs142779818						
5	176492859	176492859	-	TG	UTR3	ZNF346	NM_001308218:c.*1259_*1260insTG;NM_001308216:c.*1101_*1102insTG;NM_001308215:c.*1259_*1260insTG;NM_001308214:c.*1259_*1260insTG;NM_012279:c.*1259_*1260insTG;NM_001308221:c.*1259_*1260insTG			0.782525684649077	0.215997761463374	0.00147655388754921	zinc finger protein 346	FUNCTION: Binds with low affinity to dsDNA and ssRNA, and with high affinity to dsRNA, with no detectable sequence specificity. {ECO:0000269|PubMed:24521053}.; 	.	.	lymphoreticular;ovary;fovea centralis;skin;retina;uterus;prostate;whole body;frontal lobe;thyroid;bone;testis;brain;artery;unclassifiable (Anatomical System);cartilage;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;kidney;mammary gland;aorta;cerebellum;	.	0.09848	0.09546	-0.207437529	38.2814343	16.90108	0.59524	5q35.2										0.0060	0.0112	0.0169	0	0.0060	0.0009	0.0014	0.0044	rs11377166						
5	176516969	176516970	GT	-	intronic	FGFR4				1.30017490282e-06	0.997645977567797	0.00235272225730068	fibroblast growth factor receptor 4	FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.; 	.	TISSUE SPECIFICITY: Expressed in gastrointestinal epithelial cells, pancreas, and gastric and pancreatic cancer cell lines. {ECO:0000269|PubMed:10631118}.; 	unclassifiable (Anatomical System);lymph node;cartilage;ovary;heart;tongue;muscle;adrenal cortex;colon;skin;retina;uterus;pancreas;whole body;lung;placenta;iris;liver;testis;spleen;kidney;brain;stomach;peripheral nerve;	liver;pons;trigeminal ganglion;skeletal muscle;	0.93925	0.31636	-1.16661987	6.074545883	3921.42674	12.37862	5q35.2		0.1453	0.0969	0.1714	0.1186	0	0.1368	0.1923	0.1506	6.608e-05	0	0	0	0	0.0003	6.789e-05	0	rs376782192						
5	176517136	176517136	-	GT	intronic	FGFR4				1.30017490282e-06	0.997645977567797	0.00235272225730068	fibroblast growth factor receptor 4	FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.; 	.	TISSUE SPECIFICITY: Expressed in gastrointestinal epithelial cells, pancreas, and gastric and pancreatic cancer cell lines. {ECO:0000269|PubMed:10631118}.; 	unclassifiable (Anatomical System);lymph node;cartilage;ovary;heart;tongue;muscle;adrenal cortex;colon;skin;retina;uterus;pancreas;whole body;lung;placenta;iris;liver;testis;spleen;kidney;brain;stomach;peripheral nerve;	liver;pons;trigeminal ganglion;skeletal muscle;	0.93925	0.31636	-1.16661987	6.074545883	3921.42674	12.37862	5q35.2		0.2906	0.1817	0.2582	0.4175	0.125	0.2381	0.2984	0.3223	0.0039	0.0051	0.0044	0.0035	0.0044	0.0034	0.0032	0.0056	rs59390048						
5	176517136	176517136	-	GTGT	intronic	FGFR4				1.30017490282e-06	0.997645977567797	0.00235272225730068	fibroblast growth factor receptor 4	FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.; 	.	TISSUE SPECIFICITY: Expressed in gastrointestinal epithelial cells, pancreas, and gastric and pancreatic cancer cell lines. {ECO:0000269|PubMed:10631118}.; 	unclassifiable (Anatomical System);lymph node;cartilage;ovary;heart;tongue;muscle;adrenal cortex;colon;skin;retina;uterus;pancreas;whole body;lung;placenta;iris;liver;testis;spleen;kidney;brain;stomach;peripheral nerve;	liver;pons;trigeminal ganglion;skeletal muscle;	0.93925	0.31636	-1.16661987	6.074545883	3921.42674	12.37862	5q35.2		0.4931	0.4353	0.4890	0.5340	0.5	0.4830	0.5	0.5013	0.6950	0.5858	0.7639	0.7199	0.9686	0.7053	0.7207	0.7350	rs397943303						
5	176729734	176729734	A	-	intronic	RAB24				0.725032093168432	0.274370897289113	0.000597009542455695	RAB24, member RAS oncogene family	FUNCTION: May be involved in autophagy-related processes. {ECO:0000250}.; 	.	.	medulla oblongata;ovary;colon;fovea centralis;skin;bone marrow;prostate;optic nerve;whole body;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;islets of Langerhans;adrenal cortex;blood;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;head and neck;spleen;cervix;kidney;stomach;aorta;	.	0.10222	.	-0.207437529	38.2814343	3.30707	0.12045	5q35.3		3.32e-05	9.878e-05	0	0.0002	0	0	0	6.101e-05	0.0003	0.0003	0	0	0.0008	0	0.0003	0.0015	rs777241439						
5	176942372	176942373	AG	-	intronic	DDX41				0.000984379620636701	0.998505065554851	0.000510554824512249	DEAD-box helicase 41	FUNCTION: Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing.; 	.	.	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;pharynx;blood;lens;breast;bile duct;pancreas;lung;nasopharynx;placenta;macula lutea;visual apparatus;hippocampus;alveolus;liver;spleen;head and neck;kidney;mammary gland;stomach;thymus;	whole brain;temporal lobe;prefrontal cortex;pons;	0.22452	0.25806	-1.089312628	7.047652748	219.21549	3.20188	5q35.3		0.1517	0.1015	0.0810	0.0723	0.0538	0.1061	0.2	0.3489	0.0126	0.0305	0.0132	0.0038	0	0.0264	0.0016	0.0099	rs372373486						
5	177023098	177023098	A	-	UTR3	TMED9	NM_017510:c.*681delA			0.159567867411613	0.824925537035199	0.0155065955531875	transmembrane p24 trafficking protein 9	FUNCTION: Appears to be involved in vesicular protein trafficking, mainly in the early secretory pathway. In COPI vesicle-mediated retrograde transport involved in the coatomer recruitment to membranes of the early secretory pathway. Increases coatomer- dependent activity of ARFGAP2. Thought to play a crucial role in the specific retention of p24 complexes in cis-Golgi membranes; specifically contributes to the coupled localization of TMED2 and TMED10 in the cis-Golgi network. May be involved in organization of intracellular membranes, such as of the ER-Golgi intermediate compartment and the Golgi apparatus. Involved in ER localization of PTPN2 isoform PTPB. {ECO:0000269|PubMed:10852829, ECO:0000269|PubMed:14600267, ECO:0000269|PubMed:16595549, ECO:0000269|PubMed:18287528, ECO:0000269|PubMed:19296914}.; 	.	.	ovary;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;endometrium;bone;thyroid;iris;pituitary gland;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;muscle;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;amnion;duodenum;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	prostate;lung;heart;placenta;liver;	0.26927	0.10752	-0.029247611	51.40363293	98.95034	2.15230	5q35.3										0.0003	0.0004	0	0	0	0.0004	0.0003	0.0013							
5	177577386	177577386	T	-	intronic	NHP2				0.0342616850367737	0.824649538855987	0.14108877610724	NHP2 ribonucleoprotein	FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ("psi") residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme. {ECO:0000269|PubMed:15044956}.; 	DISEASE: Dyskeratosis congenita, autosomal recessive, 2 (DKCB2) [MIM:613987]: A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. {ECO:0000269|PubMed:18523010}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in brain, colon, heart, kidney, ovary, pancreas, placenta, prostate, skeletal muscle, small intestine, spleen, testis and thymus. Also expressed at lower levels in the liver. {ECO:0000269|PubMed:12020816}.; 	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;iris;pituitary gland;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);trophoblast;heart;islets of Langerhans;hypothalamus;muscle;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;aorta;cerebellum;thymus;	whole brain;cerebellum peduncles;globus pallidus;pons;parietal lobe;	0.60362	0.15588	0.415317661	76.81056853	26.41417	0.85525	5q35.3										0.2715	0.3998	0.2168	0.2741	0.4119	0.2603	0.1821	0.2222	rs58292208						
5	177676986	177676986	-	CA	intronic	COL23A1				9.57449236414112e-10	0.90264393009584	0.0973560689467103	collagen type XXIII alpha 1	.	.	.	.	.	0.07258	0.08141	0.75875178	86.82472281	1444.11081	7.08807	5q35.3										0.0633	0.1829	0.0327	0.0221	0.0441	0.0013	0.0062	0.0164	rs201108478						
5	178411291	178411299	GCACGCCTC	-	intronic	GRM6				2.41818920529745e-09	0.445039690245563	0.554960307336247	glutamate receptor, metabotropic 6	FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity (By similarity). Signaling stimulates TRPM1 channel activity and Ca(2+) uptake. Required for normal vision. {ECO:0000250, ECO:0000269|PubMed:23452348}.; 	.	TISSUE SPECIFICITY: Detected in melanocytes. {ECO:0000269|PubMed:23452348}.; 	breast;optic nerve;whole body;macula lutea;fovea centralis;choroid;lens;brain;stomach;retina;	dorsal root ganglion;superior cervical ganglion;globus pallidus;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;skeletal muscle;	0.28520	.	-1.31556435	4.794762916	962.94902	6.00597	5q35.3										0.5054	0.2487	0.6238	0.64	0.4301	0.6057	0.6255	0.5947	rs11279361						
5	179032861	179032861	T	-	intronic	RUFY1				0.0646702146609533	0.935303663176112	2.61221629343127e-05	RUN and FYVE domain containing 1	FUNCTION: Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate and participates in early endosomal trafficking. {ECO:0000269|PubMed:14617813}.; 	.	TISSUE SPECIFICITY: Broadly expressed, with highest levels in lung, testis, kidney and brain. {ECO:0000269|PubMed:11877430}.; 	ovary;colon;parathyroid;skin;uterus;prostate;optic nerve;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;cerebellum cortex;islets of Langerhans;muscle;adrenal cortex;blood;skeletal muscle;breast;lung;placenta;visual apparatus;hippocampus;liver;hypopharynx;head and neck;cervix;kidney;mammary gland;stomach;thymus;	superior cervical ganglion;trigeminal ganglion;	0.24529	.	-0.488577883	22.64685067	95.63276	2.11203	5q35.3		0.0146	0.0124	0.0073	0.0181	0.0080	0.0176	0.0105	0.0103									rs751564755						
5	179287208	179287209	GT	-	ncRNA_exonic	LOC100996419																			5q35.3										0.0011	0.0006	0.0029	0	0	0.0042	0.0009	0	rs796282862						
5	179287622	179287622	-	TA	ncRNA_exonic	LOC100996419																			5q35.3		0.5135	0.2446	0.5699	0.7264	0.25	0.4233	0.5077	0.5696	0.3753	0.2507	0.6859	0.4205	0.7534	0.4258	0.3733	0.4353	rs1611076						
5	179994816	179994817	TG	-	intronic	CNOT6				0.478458001419819	0.521329968440911	0.000212030139269293	CCR4-NOT transcription complex subunit 6	FUNCTION: Poly(A) nuclease with 3'-5' RNase activity. Catalytic component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Involved in mRNA decay mediated by the major-protein- coding determinant of instability (mCRD) of the FOS gene in the cytoplasm. In the presence of ZNF335, enhances ligand-dependent transcriptional activity of nuclear hormone receptors, including RARA. The increase of ligand-dependent ESR1-mediated transcription is much smaller, if any. Mediates cell proliferation and cell survival and prevents cellular senescence. {ECO:0000269|PubMed:11889047, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:20065043, ECO:0000269|PubMed:21233283}.; 	.	.	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;pharynx;blood;skeletal muscle;breast;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;liver;cervix;spleen;kidney;stomach;	superior cervical ganglion;atrioventricular node;	0.46135	0.12733	-0.291981272	33.20358575	52.51247	1.43432	5q35.3		0.2321	0.1896	0.2485	0.2389	0.1558	0.2203	0.2212	0.3263	0.0016	0.0001	0.0013	0	0.0006	0.0103	0.0007	0.0032	rs146190811						
5	180047740	180047741	GT	-	intronic	FLT4				0.999936678740361	6.33212596345212e-05	4.31714994113817e-15	fms related tyrosine kinase 4	FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3- kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr- 185', and of AKT1 at 'Ser-473'. {ECO:0000269|PubMed:11532940, ECO:0000269|PubMed:15102829, ECO:0000269|PubMed:15474514, ECO:0000269|PubMed:16076871, ECO:0000269|PubMed:16452200, ECO:0000269|PubMed:17210781, ECO:0000269|PubMed:19610651, ECO:0000269|PubMed:19779139, ECO:0000269|PubMed:20224550, ECO:0000269|PubMed:20431062, ECO:0000269|PubMed:20445537, ECO:0000269|PubMed:21273538, ECO:0000269|PubMed:7675451, ECO:0000269|PubMed:8700872, ECO:0000269|PubMed:9435229}.; 	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	TISSUE SPECIFICITY: Detected in endothelial cells (at protein level). Widely expressed. Detected in fetal spleen, lung and brain. Detected in adult liver, muscle, thymus, placenta, lung, testis, ovary, prostate, heart, and kidney. {ECO:0000269|PubMed:1327515, ECO:0000269|PubMed:20224550, ECO:0000269|PubMed:7675451}.; 	unclassifiable (Anatomical System);lymph node;placenta;visual apparatus;testis;colon;brain;skeletal muscle;	placenta;	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	5q35.3		0.0641	0.0465	0.0749	0.0696	0.0200	0.0489	0.0623	0.1365	0.0003	0.0002	0	0	0	0.0003	0.0003	0	rs796540739						
5	180481217	180481217	T	-	intronic	BTNL9				6.53404156111455e-10	0.128525451815584	0.871474547531012	butyrophilin like 9	.	.	.	unclassifiable (Anatomical System);cartilage;ovary;islets of Langerhans;colon;parathyroid;fovea centralis;choroid;lens;skeletal muscle;retina;pancreas;optic nerve;lung;endometrium;larynx;placenta;macula lutea;testis;head and neck;germinal center;kidney;spinal ganglion;brain;stomach;	globus pallidus;ciliary ganglion;atrioventricular node;	0.12916	.	-0.134019284	43.90776126	185.79362	2.95953	5q35.3		0.2542	0.1977	0.2264	0.2453	0.3032	0.2742	0.2436	0.2106	0.0410	0.0264	0.0453	0.0543	0.0058	0.0926	0.0475	0.0512	rs548701756						
6	311798	311798	T	-	intronic	DUSP22				0.00430707145380812	0.867381637996829	0.128311290549363	dual specificity phosphatase 22	FUNCTION: Activates the Jnk signaling pathway. Dephosphorylates and deactivates p38 and stress-activated protein kinase/c-Jun N- terminal kinase (SAPK/JNK) (By similarity). {ECO:0000250, ECO:0000269|PubMed:11717427}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Highest expression seen in heart, placenta, lung, liver, kidney and pancreas. {ECO:0000269|PubMed:11717427}.; 	myocardium;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;cerebral cortex;endometrium;bone;pituitary gland;testis;germinal center;brain;gall bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;pancreas;lung;nasopharynx;placenta;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;	testis - seminiferous tubule;testis;	0.19715	0.15782	0.284856336	71.40835103	805.07854	5.59092	6p25.3										0.0068	0.0196	0.0058	0.0038	0.0019	0.0036	0.0005	0	rs74274493						
6	350940	350940	-	A	UTR3	DUSP22	NM_020185:c.*72_*73insA;NM_001286555:c.*1989_*1990insA			0.00430707145380812	0.867381637996829	0.128311290549363	dual specificity phosphatase 22	FUNCTION: Activates the Jnk signaling pathway. Dephosphorylates and deactivates p38 and stress-activated protein kinase/c-Jun N- terminal kinase (SAPK/JNK) (By similarity). {ECO:0000250, ECO:0000269|PubMed:11717427}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Highest expression seen in heart, placenta, lung, liver, kidney and pancreas. {ECO:0000269|PubMed:11717427}.; 	myocardium;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;cerebral cortex;endometrium;bone;pituitary gland;testis;germinal center;brain;gall bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;pancreas;lung;nasopharynx;placenta;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;	testis - seminiferous tubule;testis;	0.19715	0.15782	0.284856336	71.40835103	805.07854	5.59092	6p25.3										0.4767	0.4929	0.4783	0.4533	0.4781	0.4642	0.4710	0.4672	rs11408655						
6	1060450	1060451	AC	-	ncRNA_intronic	LINC01622				.	.	.	long intergenic non-protein coding RNA 1622	.	.	.	.	.	.	.	.	.	.	.	6p25.3										0.0969	0.1425	0.0550	0.0759	0.0199	0.1093	0.0787	0.0962	rs368748926						
6	1395438	1395439	TG	-	UTR3	FOXF2	NM_001452:c.*344_*345delTG			.	.	.	forkhead box F2	FUNCTION: Probable transcription activator for a number of lung- specific genes.; 	.	TISSUE SPECIFICITY: Lung and placenta.; 	cartilage;developmental;skin;retina;pancreas;prostate;lung;trabecular meshwork;liver;testis;cervix;kidney;spinal ganglion;brain;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	0.12698	.	.	.	4302.7333	13.06347	6p25.3										0.0002	0.0002	0.0012	0	0.0006	0	6.742e-05	0							
6	1612420	1612420	A	-	UTR3	FOXC1	NM_001453:c.*78delA			.	.	.	forkhead box C1	FUNCTION: Binding of FREAC-3 and FREAC-4 to their cognate sites results in bending of the DNA at an angle of 80-90 degrees. Regulates FOXO1 through binding to a conserved element, 5'- GTAAACAAA-3' in its promoter region, implicating FOXC1 as an important regulator of cell viability and resistance to oxidative stress in the eye. {ECO:0000269|PubMed:17993506}.; 	DISEASE: Iridogoniodysgenesis anomaly (IGDA) [MIM:601631]: Autosomal dominant phenotype characterized by iris hypoplasia, goniodysgenesis, and juvenile glaucoma. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peters anomaly (PETAN) [MIM:604229]: Consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea. {ECO:0000269|PubMed:12614756}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in all tissues and cell lines examined. {ECO:0000269|PubMed:8499623}.; 	.	.	0.71308	0.29904	.	.	1711.71278	7.62793	6p25.3										0.0042	0.0018	0.0060	0.0043	0	0.0363	0.0031	0.0029							
6	2961550	2961550	T	-	intronic	SERPINB6				0.0356687992106553	0.928371580180581	0.0359596206087639	serpin peptidase inhibitor, clade B (ovalbumin), member 6	FUNCTION: May be involved in the regulation of serine proteinases present in the brain or extravasated from the blood (By similarity). Inhibitor of cathepsin G, kallikrein-8 and thrombin. May play an important role in the inner ear in the protection against leakage of lysosomal content during stress and loss of this protection results in cell death and sensorineural hearing loss. {ECO:0000250, ECO:0000269|PubMed:10068683, ECO:0000269|PubMed:17761692, ECO:0000269|PubMed:20451170, ECO:0000269|PubMed:8136380, ECO:0000269|PubMed:8415716}.; 	.	TISSUE SPECIFICITY: Expressed in keratinocytes (at protein level). Highest levels in skeletal muscle. Also found in placenta, cardiac muscle, lung, liver, kidney and pancreas. Expressed in the inner ear hair cells. Expressed abundantly by normal mast cells in different tissues and by mast cells in mastocytoma lesions. {ECO:0000269|PubMed:14670919, ECO:0000269|PubMed:17761692, ECO:0000269|PubMed:20451170}.; 	medulla oblongata;ovary;sympathetic chain;colon;parathyroid;choroid;vein;skin;uterus;prostate;whole body;frontal lobe;oesophagus;endometrium;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;adrenal cortex;lens;skeletal muscle;pancreas;lung;placenta;visual apparatus;alveolus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;aorta;	testis - interstitial;testis - seminiferous tubule;testis;	0.58499	.	-0.135838822	43.77211607	187.82392	2.97536	6p25.2										0.2418	0.1372	0.2177	0.3113	0.2670	0.2434	0.2970	0.2816	rs35864581						
6	3266965	3266965	-	CGCA	intronic	PSMG4				.	.	.	proteasome (prosome, macropain) assembly chaperone 4	FUNCTION: Chaperone protein which promotes assembly of the 20S proteasome.; 	.	.	unclassifiable (Anatomical System);prostate;lung;heart;placenta;liver;spleen;brain;stomach;	.	.	.	0.72397987	85.91648974	21.5692	0.72553	6p25.2										0.0006	0.0005	0	0	0.0025	0	0.0005	0.0021	rs111315023						
6	3266965	3266965	-	CGCACA	intronic	PSMG4				.	.	.	proteasome (prosome, macropain) assembly chaperone 4	FUNCTION: Chaperone protein which promotes assembly of the 20S proteasome.; 	.	.	unclassifiable (Anatomical System);prostate;lung;heart;placenta;liver;spleen;brain;stomach;	.	.	.	0.72397987	85.91648974	21.5692	0.72553	6p25.2										0.8585	0.8533	0.7733	0.8716	0.6783	0.9187	0.8705	0.8763	rs111315023						
6	3271070	3271070	A	-	UTR3	SLC22A23	NM_015482:c.*2219delT;NM_001286455:c.*2219delT;NM_021945:c.*2219delT			0.366550902975159	0.632950473909413	0.000498623115427995	solute carrier family 22 member 23	.	.	.	.	.	0.49745	0.11030	-0.865195027	10.79853739	46.94609	1.32450	6p25.2										0.0135	0.0043	0.0353	0.0174	0	0.1085	0.0115	0.0194							
6	6318921	6318921	-	A	intronic	F13A1				0.00102736089825156	0.998492486294057	0.000480152807691957	coagulation factor XIII A chain	FUNCTION: Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl- epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.; 	DISEASE: Factor XIII subunit A deficiency (FA13AD) [MIM:613225]: An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. {ECO:0000269|PubMed:1353995, ECO:0000269|PubMed:24286209, ECO:0000269|PubMed:24329762, ECO:0000269|PubMed:24889649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;thyroid;bone;iris;testis;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;islets of Langerhans;urinary;breast;pancreas;lung;adrenal gland;placenta;macula lutea;liver;alveolus;spleen;head and neck;kidney;mammary gland;	superior cervical ganglion;placenta;	0.33587	0.59246	0.249861693	69.66265629	4254.75217	12.96128	6p25.1		0.4170	0.4395	0.3889	0.4251	0.3821	0.4218	0.4240	0.4142	0.7808	0.8550	0.7016	0.7835	0.8310	0.5882	0.7482	0.7281	rs11414870						
6	7284949	7284949	T	-	UTR3	SSR1	NM_001292008:c.*5148delA;NM_003144:c.*5148delA			0.0322896005433474	0.958634179804506	0.00907621965214629	signal sequence receptor, alpha	FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. May be involved in the recycling of the translocation apparatus after completion of the translocation process or may function as a membrane-bound chaperone facilitating folding of translocated proteins.; 	.	.	lymphoreticular;ovary;skin;retina;bone marrow;prostate;optic nerve;cochlea;endometrium;gum;thyroid;germinal center;bladder;brain;gall bladder;heart;cartilage;tongue;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;fovea centralis;choroid;vein;uterus;whole body;oesophagus;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;nasopharynx;placenta;duodenum;head and neck;kidney;stomach;	superior cervical ganglion;thyroid;ciliary ganglion;skeletal muscle;	0.19355	0.18675	0.170987912	65.5579146	1522.7479	7.25123	6p24.3										0.0693	0.0754	0.2173	0.0703	0.1108	0.0897	0.0514	0.0637	rs202175032						
6	7288158	7288158	A	-	UTR3	SSR1	NM_001292008:c.*1939delT;NM_003144:c.*1939delT			0.0322896005433474	0.958634179804506	0.00907621965214629	signal sequence receptor, alpha	FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins. May be involved in the recycling of the translocation apparatus after completion of the translocation process or may function as a membrane-bound chaperone facilitating folding of translocated proteins.; 	.	.	lymphoreticular;ovary;skin;retina;bone marrow;prostate;optic nerve;cochlea;endometrium;gum;thyroid;germinal center;bladder;brain;gall bladder;heart;cartilage;tongue;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;fovea centralis;choroid;vein;uterus;whole body;oesophagus;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;nasopharynx;placenta;duodenum;head and neck;kidney;stomach;	superior cervical ganglion;thyroid;ciliary ganglion;skeletal muscle;	0.19355	0.18675	0.170987912	65.5579146	1522.7479	7.25123	6p24.3										0.0176	0.0143	0.0743	0.0169	0.0051	0.1574	0.0080	0.0206							
6	7410736	7410736	T	-	intronic	RIOK1				8.13737884500142e-07	0.9099849009477	0.0900142853144157	RIO kinase 1	.	.	.	colon;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;islets of Langerhans;muscle;lens;skeletal muscle;breast;pancreas;lung;adrenal gland;nasopharynx;placenta;macula lutea;visual apparatus;liver;amnion;spleen;cervix;kidney;mammary gland;stomach;	.	0.07427	0.09451	0.778977686	87.21396556	153.59995	2.71046	6p24.3		0.1625	0.2143	0.1873	0.1612	0.1132	0.1581	0.1619	0.1473	0.0244	0.0756	0.0066	0.0041	0	0.0101	0.0004	0.0025	rs375991906						
6	9616231	9616231	-	GAAGAAGAG	intergenic	LOC100506207;TFAP2A	dist=830553;dist=780685																		6p24.3										0.0062	0.0141	0.0055	0	0.0019	0.0085	0.0018	0.0044							
6	9616231	9616231	-	GAAGAAGAAGAG	intergenic	LOC100506207;TFAP2A	dist=830553;dist=780685																		6p24.3										0.5569	0.5111	0.6134	0.5321	0.8788	0.5495	0.5460	0.5773	rs143324041						
6	9900599	9900599	-	GAG	intergenic	LOC100506207;TFAP2A	dist=1114921;dist=496317																		6p24.3	ID=COSM112123;OCCURENCE=1(ovary)	0.1918	0.3476	0.0949	0.3139	0.1423	0.1772	0.1960	0.1763	0.2124	0.3377	0.1172	0.2013	0.2974	0.1472	0.1557	0.1462	rs397956158						
6	10397460	10397461	GA	-	UTR3	TFAP2A	NM_003220:c.*1190_*1189delTC;NM_001032280:c.*1190_*1189delTC;NM_001042425:c.*1190_*1189delTC			0.987223276135779	0.0127713960725496	5.32779167126609e-06	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)	FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region. {ECO:0000269|PubMed:11694877, ECO:0000269|PubMed:12586840}.; 	DISEASE: Branchiooculofacial syndrome (BOFS) [MIM:113620]: A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies. {ECO:0000269|PubMed:18423521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;salivary gland;parathyroid;choroid;fovea centralis;skin;retina;optic nerve;iris;unclassifiable (Anatomical System);tongue;lens;breast;pancreas;lung;placenta;visual apparatus;macula lutea;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;aorta;	dorsal root ganglion;superior cervical ganglion;placenta;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.96726	0.95367	-0.427900189	25.14744043	13.97787	0.50725	6p24.3										0.0003	0.0006	0.0013	0	0	0.0003	6.77e-05	0	rs150236619						
6	10398148	10398148	T	-	UTR3	TFAP2A	NM_003220:c.*502delA;NM_001032280:c.*502delA;NM_001042425:c.*502delA			0.987223276135779	0.0127713960725496	5.32779167126609e-06	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)	FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region. {ECO:0000269|PubMed:11694877, ECO:0000269|PubMed:12586840}.; 	DISEASE: Branchiooculofacial syndrome (BOFS) [MIM:113620]: A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies. {ECO:0000269|PubMed:18423521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;salivary gland;parathyroid;choroid;fovea centralis;skin;retina;optic nerve;iris;unclassifiable (Anatomical System);tongue;lens;breast;pancreas;lung;placenta;visual apparatus;macula lutea;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;aorta;	dorsal root ganglion;superior cervical ganglion;placenta;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.96726	0.95367	-0.427900189	25.14744043	13.97787	0.50725	6p24.3										0.0502	0.1061	0.0617	0.0714	0.0016	0.0926	0.0202	0.0405							
6	10989873	10989873	-	A	intronic	ELOVL2				0.000198697181598092	0.902737542792624	0.0970637600257779	ELOVL fatty acid elongase 2	FUNCTION: Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C20:4(n- 6) acyl-CoA. Condensing enzyme that catalyzes the synthesis of polyunsaturated very long chain fatty acid (C20- and C22-PUFA). May participate to the production of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. {ECO:0000255|HAMAP-Rule:MF_03202, ECO:0000269|PubMed:12371743, ECO:0000269|PubMed:20937905}.; 	.	TISSUE SPECIFICITY: Liver and testis. {ECO:0000269|PubMed:20937905}.; 	unclassifiable (Anatomical System);heart;ovary;hypothalamus;parathyroid;skin;skeletal muscle;uterus;prostate;whole body;lung;frontal lobe;cochlea;placenta;visual apparatus;liver;testis;spleen;kidney;spinal ganglion;brain;mammary gland;peripheral nerve;	fetal liver;occipital lobe;superior cervical ganglion;fetal brain;spinal cord;testis;parietal lobe;	0.87008	0.17956	-0.181750739	40.15687662	60.95094	1.58745	6p24.2										0.2180	0.0725	0.4003	0.2418	0.4405	0.4132	0.2320	0.3210	rs397935311						
6	11185072	11185072	T	-	UTR3	NEDD9	NM_006403:c.*323delA;NM_001142393:c.*323delA;NM_001271033:c.*323delA			0.534981125014028	0.464991213449718	2.7661536253666e-05	neural precursor cell expressed, developmentally down-regulated 9	FUNCTION: Docking protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion. May function in transmitting growth control signals between focal adhesions at the cell periphery and the mitotic spindle in response to adhesion or growth factor signals initiating cell proliferation. May play an important role in integrin beta-1 or B cell antigen receptor (BCR) mediated signaling in B- and T-cells. Integrin beta-1 stimulation leads to recruitment of various proteins including CRK, NCK and SHPTP2 to the tyrosine phosphorylated form.; 	.	TISSUE SPECIFICITY: Widely expressed. Higher levels detected in kidney, lung, and placenta. Also detected in T-cells, B-cells and diverse cell lines. The protein has been detected in lymphocytes, in diverse cell lines, and in lung tissues.; 	.	.	0.38853	0.23740	-0.371072278	28.22009908	279.64751	3.58344	6p24.2										0.0001	0.0001	0	0	0	0.0004	7.014e-05	0	rs532988994						
6	11714214	11714214	A	-	UTR3	ADTRP	NM_001143948:c.*497delT;NM_032744:c.*497delT			0.000702618266442128	0.751748460956727	0.247548920776831	androgen dependent TFPI regulating protein	FUNCTION: Regulates the expression and the cell-associated anticoagulant activity of the inhibitor TFPI in endothelial cells (in vitro). {ECO:0000269|PubMed:21868574}.; 	.	TISSUE SPECIFICITY: Expressed in cultured endothelial cells and in placenta. {ECO:0000269|PubMed:21868574}.; 	.	.	0.03391	0.09745	0.439181676	77.69521113	1559.12031	7.31298	6p24.1										0.1384	0.1198	0.0907	0.2038	0.4733	0.1819	0.1035	0.1313	rs3069335						
6	13316781	13316781	A	-	intronic	TBC1D7;TBC1D7-LOC100130357																			6p24.1		0.4377	0.2154	0.4600	0.4848	0.4447	0.4549	0.4314	0.4621	0.0506	0.0232	0.0650	0.0882	0	0.2447	0.0598	0.0690	rs72202814						
6	13597296	13597296	A	-	intronic	SIRT5				1.87753474665446e-05	0.887241146625048	0.112740078027486	sirtuin 5	FUNCTION: NAD-dependent lysine demalonylase, desuccinylase and deglutarylase that specifically removes malonyl, succinyl and glutaryl groups on target proteins (PubMed:21908771, PubMed:22076378, PubMed:24703693). Activates CPS1 and contributes to the regulation of blood ammonia levels during prolonged fasting: acts by mediating desuccinylation and deglutarylation of CPS1, thereby increasing CPS1 activity in response to elevated NAD levels during fasting (PubMed:22076378, PubMed:24703693). Activates SOD1 by mediating its desuccinylation, leading to reduced reactive oxygen species (PubMed:24140062). Modulates ketogenesis through the desuccinylation and activation of HMGCS2 (By similarity). Has weak NAD-dependent protein deacetylase activity; however this activity may not be physiologically relevant in vivo. Can deacetylate cytochrome c (CYCS) and a number of other proteins in vitro such as UOX. {ECO:0000250|UniProtKB:Q8K2C6, ECO:0000269|PubMed:18680753, ECO:0000269|PubMed:21908771, ECO:0000269|PubMed:22076378, ECO:0000269|PubMed:24140062, ECO:0000269|PubMed:24703693}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10381378}.; 	unclassifiable (Anatomical System);cartilage;ovary;heart;lacrimal gland;colon;parathyroid;blood;uterus;prostate;lung;frontal lobe;endometrium;larynx;bone;thyroid;placenta;liver;testis;head and neck;spleen;germinal center;kidney;brain;stomach;thymus;	superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;	0.13111	0.16246	0.332586472	73.61405992	466.72179	4.47531	6p23		0.1240	0.0846	0.1471	0.1258	0.0627	0.1211	0.1114	0.1880	0.0009	0.0005	0.0039	0	0	0.0107	0.0003	0	rs764282853						
6	15651643	15651643	A	-	intronic	DTNBP1				1.33929654176623e-06	0.603943095007221	0.396055565696237	dystrobrevin binding protein 1	FUNCTION: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway. {ECO:0000269|PubMed:15345706, ECO:0000269|PubMed:16837549, ECO:0000269|PubMed:17182842, ECO:0000269|PubMed:17989303, ECO:0000269|PubMed:19094965, ECO:0000269|PubMed:20180862, ECO:0000269|PubMed:20921223}.; 	DISEASE: Hermansky-Pudlak syndrome 7 (HPS7) [MIM:614076]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. {ECO:0000269|PubMed:12923531}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in DTNBP1 are associated with susceptibility to schizophrenia, a mental disorder characterized by a breakdown of thought processes and by poor emotional responsiveness. Genetic mutations lead to alterations in the glutamatergic transmisssion in the brain and modified Akt signaling (PubMed:15345706). Protein levels and expression are reduced in nerve terminals of the hippocampus and there is an increased release of glutamate in schizophrenic patients (PubMed:15124027). Levels of isoform 1 are reduced in the pSTG, but not in HF, by about 48% in 92% of schizophrenic patients. In the HF, there is an average of 33% reduction in synaptic expression of isoform 2 in 67% of cases, and of isoform 3, an average reduction of 35% in 80% of cases. In the dorsolateral prefrontal cortex (DLPFC), significant reductions in levels of isoform 3 are observed about 71% of schizophrenic patients showed an average reduction of this isoform of about 60% (PubMed:19617633). {ECO:0000269|PubMed:15124027, ECO:0000269|PubMed:15345706, ECO:0000269|PubMed:19617633}.; 	TISSUE SPECIFICITY: Detected in brain, in neurons and in neuropil. Isoform 1 is expressed in the cerebral cortex, and hippocampal frontal (HF). Specific expression in the posterior half of the superior temporal gyrus (pSTG). Higher expression of isoform 2 and 3 in the HF than in the pSTG while isoform 1 shows no difference in expression in these areas. In the HF, detected in dentate gyrus (DG) and in pyramidal cells of hippocampus CA2 and CA3 (at protein level). Expressed in all principal neuronal populations of the HF, namely pyramidal neurons in the subiculum and CA1-3, granule cells in the dense cell layer of the DG (DGg), and polymorph cells in the hilus of the DG (DGh). Maximal levels in CA2, CA3, and DGh. Isoform 2 not expressed in the cerebral cortex. {ECO:0000269|PubMed:16980328}.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;bone marrow;uterus;prostate;whole body;cerebral cortex;endometrium;bone;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;cartilage;tongue;islets of Langerhans;muscle;pharynx;blood;lung;cornea;nasopharynx;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;thymus;	.	0.10981	0.28878	0.665103516	84.6131163	517.45762	4.65055	6p22.3		0.4257	0.4303	0.4302	0.4437	0.4346	0.4294	0.4265	0.3939	0.0098	0.0038	0.0653	0.0255	0.0144	0.0936	0.0063	0.0179	rs201022468						
6	16247055	16247055	T	-	intronic	GMPR				0.00252568644042527	0.931077240580624	0.0663970729789504	guanosine monophosphate reductase	FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides. {ECO:0000255|HAMAP-Rule:MF_03195}.; 	.	.	ovary;colon;parathyroid;skin;uterus;prostate;frontal lobe;endometrium;larynx;thyroid;bone;iris;testis;brain;unclassifiable (Anatomical System);heart;cartilage;lens;skeletal muscle;breast;lung;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;testis - seminiferous tubule;testis;skeletal muscle;	0.17422	0.21865	-0.314027422	31.9297004	85.22384	1.96783	6p22.3		0.0021	0.0015	0.0003	0.0010	0.0005	0.0026	0.0048	0.0028									rs778946935						
6	16305506	16305506	A	-	UTR3	ATXN1	NM_000332:c.*1054delT;NM_001128164:c.*1054delT			0.398661149433984	0.599425706431175	0.00191314413484115	ataxin 1	FUNCTION: Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism. {ECO:0000269|PubMed:21475249}.; 	DISEASE: Spinocerebellar ataxia 1 (SCA1) [MIM:164400]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease. {ECO:0000269|PubMed:7647801, ECO:0000269|PubMed:7951322, ECO:0000269|PubMed:8634720}. Note=The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by expansion of the polyglutamine tract to about 40-83 repeats, causing accumulation in neurons and exerting toxicity. {ECO:0000269|PubMed:7647801, ECO:0000269|PubMed:8634720}.; 	TISSUE SPECIFICITY: Widely expressed throughout the body. {ECO:0000269|PubMed:12062018}.; 	lymphoreticular;ovary;salivary gland;parathyroid;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;cartilage;heart;blood;cerebrum;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;liver;spleen;kidney;mammary gland;stomach;	occipital lobe;subthalamic nucleus;temporal lobe;prefrontal cortex;globus pallidus;caudate nucleus;skeletal muscle;	0.97273	0.42931	-0.523584927	20.93654164	313.64901	3.76558	6p22.3										0.0053	0.0129	0.0073	0	0	0.0072	0.0013	0.0017							
6	16753375	16753376	AC	-	intronic	ATXN1				0.398661149433984	0.599425706431175	0.00191314413484115	ataxin 1	FUNCTION: Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism. {ECO:0000269|PubMed:21475249}.; 	DISEASE: Spinocerebellar ataxia 1 (SCA1) [MIM:164400]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to cerebellum degeneration with variable involvement of the brainstem and spinal cord. SCA1 belongs to the autosomal dominant cerebellar ataxias type I (ADCA I) which are characterized by cerebellar ataxia in combination with additional clinical features like optic atrophy, ophthalmoplegia, bulbar and extrapyramidal signs, peripheral neuropathy and dementia. SCA1 is caused by expansion of a CAG repeat in the coding region of ATXN1. Longer expansions result in earlier onset and more severe clinical manifestations of the disease. {ECO:0000269|PubMed:7647801, ECO:0000269|PubMed:7951322, ECO:0000269|PubMed:8634720}. Note=The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by expansion of the polyglutamine tract to about 40-83 repeats, causing accumulation in neurons and exerting toxicity. {ECO:0000269|PubMed:7647801, ECO:0000269|PubMed:8634720}.; 	TISSUE SPECIFICITY: Widely expressed throughout the body. {ECO:0000269|PubMed:12062018}.; 	lymphoreticular;ovary;salivary gland;parathyroid;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;cartilage;heart;blood;cerebrum;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;liver;spleen;kidney;mammary gland;stomach;	occipital lobe;subthalamic nucleus;temporal lobe;prefrontal cortex;globus pallidus;caudate nucleus;skeletal muscle;	0.97273	0.42931	-0.523584927	20.93654164	313.64901	3.76558	6p22.3																		rs71706080						
6	17292449	17292449	A	-	UTR3	RBM24	NM_001143942:c.*99delA;NM_001143941:c.*99delA;NM_153020:c.*99delA			0.196222354193918	0.757508513812541	0.0462691319935416	RNA binding motif protein 24	FUNCTION: Plays a role in myogenic differentiation by regulating MYOG levels. Binds to the 3'-UTR of MYOG mRNA and regulates its stability. {ECO:0000269|PubMed:20977548}.; 	.	.	unclassifiable (Anatomical System);heart;cartilage;skeletal muscle;skin;bile duct;uterus;prostate;lung;larynx;trabecular meshwork;liver;testis;head and neck;brain;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.25596	0.07720	0.058937498	58.26256192	202.43727	3.07067	6p22.3										0.0004	0.0005	0.0017	0	0.0013	0.0013	0.0001	0							
6	17556927	17556927	A	-	UTR3	CAP2	NM_006366:c.*254delA			0.410487087790501	0.58915700966929	0.000355902540209639	CAP, adenylate cyclase-associated protein, 2 (yeast)	FUNCTION: May have a regulatory bifunctional role.; 	.	.	myocardium;smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;optic nerve;whole body;frontal lobe;endometrium;thyroid;bone;iris;testis;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;hypothalamus;muscle;lens;skeletal muscle;bile duct;breast;lung;epididymis;nasopharynx;placenta;macula lutea;visual apparatus;hippocampus;liver;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;medulla oblongata;occipital lobe;superior cervical ganglion;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;trigeminal ganglion;parietal lobe;cingulate cortex;	0.32334	0.10525	-0.047654689	50.22410946	486.9546	4.54178	6p22.3										0.0045	0.0012	0.0071	0.0042	0	0.0220	0.0054	0.0050	rs527725408						
6	18148156	18148156	A	-	intronic	TPMT				7.57391771227039e-05	0.751715695980259	0.248208564842618	thiopurine S-methyltransferase	FUNCTION: Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine. {ECO:0000269|PubMed:18484748}.; 	DISEASE: Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460]: Enzyme involved in the normal metabolic inactivation of thiopurine drugs. These drugs are generally used as immunosuppressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation. Patients with intermediate or no TPMT activity are at risk of toxicity after receiving standard doses of thiopurine drugs and it is shown that inter-individual differences in response to these drugs are largely determined by genetic variation at the TPMT locus. {ECO:0000269|PubMed:10208641, ECO:0000269|PubMed:10751626, ECO:0000269|PubMed:15819814, ECO:0000269|PubMed:16220112, ECO:0000269|PubMed:16476125, ECO:0000269|PubMed:16789994, ECO:0000269|PubMed:7862671, ECO:0000269|PubMed:8561894, ECO:0000269|PubMed:8644731, ECO:0000269|PubMed:9246020, ECO:0000269|PubMed:9336428, ECO:0000269|PubMed:9711875, ECO:0000269|PubMed:9931345, ECO:0000269|PubMed:9931346}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;fovea centralis;skin;bone marrow;uterus;prostate;whole body;endometrium;thyroid;bone;testis;germinal center;bladder;brain;unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;skeletal muscle;bile duct;breast;pancreas;lung;macula lutea;hippocampus;liver;spleen;kidney;mammary gland;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;	0.09520	0.16643	0.793752871	87.40268931	598.55884	4.95305	6p22.3	ID=COSM1621243;OCCURENCE=1(liver)	0.4060	0.3990	0.4135	0.4221	0.3648	0.4054	0.3986	0.4154	0.0048	0.0080	0.0163	0	0	0.0213	0.0018	0	rs368770445						
6	18467630	18467631	TG	-	UTR3	RNF144B	NM_182757:c.*2332_*2333delTG			0.0276377158382251	0.960947695296661	0.0114145888651133	ring finger protein 144B	FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates such as LCMT2, thereby promoting their degradation. Induces apoptosis via a p53/TP53-dependent but caspase-independent mechanism. However, its overexpression also produces a decrease of the ubiquitin-dependent stability of BAX, a pro-apoptotic protein, ultimately leading to protection of cell death; But, it is not an anti-apoptotic protein per se. {ECO:0000269|PubMed:12853982, ECO:0000269|PubMed:20300062}.; 	.	TISSUE SPECIFICITY: Broadly expressed, with lowest levels in brain and thymus, and highest levels detectable in heart, ovary and testis. {ECO:0000269|PubMed:16427630, ECO:0000269|PubMed:20300062}.; 	colon;skin;bone marrow;uterus;atrium;frontal lobe;cochlea;endometrium;larynx;thyroid;bone;testis;germinal center;brain;gall bladder;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;blood;skeletal muscle;breast;lung;placenta;liver;spleen;head and neck;mammary gland;stomach;aorta;	.	0.24190	0.11712	0.060756528	58.52795471	48.42165	1.35715	6p22.3																								
6	20758809	20758809	T	-	intronic	CDKAL1				0.577650480843115	0.422329920579637	1.95985772472756e-05	CDK5 regulatory subunit associated protein 1 like 1	FUNCTION: Catalyzes the methylthiolation of N6- threonylcarbamoyladenosine (t(6)A), leading to the formation of 2- methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine. {ECO:0000269|PubMed:20584901}.; 	.	TISSUE SPECIFICITY: Expressed in pancreatic islets. {ECO:0000269|PubMed:23048041}.; 	unclassifiable (Anatomical System);prostate;lung;frontal lobe;ovary;heart;nasopharynx;bone;visual apparatus;colon;germinal center;brain;mammary gland;skeletal muscle;	superior cervical ganglion;trigeminal ganglion;	0.23384	0.24681	-0.578583623	18.71903751	656.55651	5.13753	6p22.3		0.3885	0.3886	0.3999	0.4721	0.4139	0.3875	0.3743	0.3314	0.1227	0.1376	0.1798	0.0573	0.3397	0.1295	0.0869	0.1276	rs34291318						
6	21232220	21232220	G	-	UTR3	CDKAL1	NM_017774:c.*950delG			0.577650480843115	0.422329920579637	1.95985772472756e-05	CDK5 regulatory subunit associated protein 1 like 1	FUNCTION: Catalyzes the methylthiolation of N6- threonylcarbamoyladenosine (t(6)A), leading to the formation of 2- methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine. {ECO:0000269|PubMed:20584901}.; 	.	TISSUE SPECIFICITY: Expressed in pancreatic islets. {ECO:0000269|PubMed:23048041}.; 	unclassifiable (Anatomical System);prostate;lung;frontal lobe;ovary;heart;nasopharynx;bone;visual apparatus;colon;germinal center;brain;mammary gland;skeletal muscle;	superior cervical ganglion;trigeminal ganglion;	0.23384	0.24681	-0.578583623	18.71903751	656.55651	5.13753	6p22.3										0.5707	0.2977	0.5854	0.6832	0.7264	0.7329	0.7019	0.6780	rs35206923						
6	21596501	21596501	A	-	UTR3	SOX4	NM_003107:c.*311delA			0.384005969080463	0.572001426754163	0.0439926041653743	SRY-box 4	FUNCTION: Transcriptional activator that binds with high affinity to the T-cell enhancer motif 5'-AACAAAG-3' motif.; 	.	TISSUE SPECIFICITY: Testis, brain, and heart.; 	smooth muscle;umbilical cord;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);trophoblast;heart;islets of Langerhans;pharynx;blood;lens;breast;pancreas;lung;cornea;placenta;macula lutea;visual apparatus;alveolus;liver;kidney;mammary gland;stomach;aorta;peripheral nerve;thymus;	prostate;uterus corpus;fetal brain;atrioventricular node;thymus;	0.96100	0.25991	.	.	95.1054	2.10373	6p22.3										0.0130	0.0131	0.0312	0.0144	0	0.0871	0.0078	0.0138	rs796555280						
6	24358357	24358358	CA	-	UTR3	KAAG1	NM_181337:c.*235_*236delCA			0.0191912389509573	0.502144576795006	0.478664184254037	kidney associated antigen 1	.	.	TISSUE SPECIFICITY: Expressed in testis and kidney, and, at lower levels, in urinary bladder and liver. Expressed by a high proportion of tumors of various histologic origin, including melanomas, sarcomas and colorectal carcinomas. {ECO:0000269|PubMed:10601354}.; 	unclassifiable (Anatomical System);bile duct;lung;frontal lobe;visual apparatus;pituitary gland;liver;kidney;	.	0.03783	0.06677	-0.053113545	49.38664779	5.84948	0.22022	6p22.3										0.0002	0.0001	0	0	0	0.0006	0.0001	0	rs151251105						
6	24839587	24839587	T	-	intronic	RIPOR2																			6p22.3										0.0003	0	0	0	0	0.0021	0.0002	0							
6	25452454	25452454	T	-	intronic	CARMIL1																			6p22.2		0.0645	0.0598	0.0652	0.0512	0.0252	0.0657	0.0659	0.0863	0.0008	0.0005	0.0018	0	0	0.0047	0.0006	0	rs747471059						
6	25689379	25689379	T	-	intronic	SCGN				0.0359460022848758	0.956319094418519	0.00773490329660551	secretagogin, EF-hand calcium binding protein	.	.	TISSUE SPECIFICITY: Expressed at high levels in the pancreatic islets of Langerhans and to a much lesser extent in the gastrointestinal tract (stomach, small intestine and colon), the adrenal medulla and cortex and the thyroid C-cells. In the brain, the expression is restricted to distinct subtypes of neurons with highest expression in the molecular layer of the cerebellum (stellate and basket cells), in the anterior part of the pituitary gland, in the thalamus, in the hypothalamus and in a subgroup of neocortical neurons. {ECO:0000269|PubMed:11709487}.; 	unclassifiable (Anatomical System);prostate;pancreas;lung;islets of Langerhans;placenta;colon;substantia nigra;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;pancreas;cerebellum peduncles;hypothalamus;beta cell islets;atrioventricular node;pituitary;cerebellum;	0.06713	0.11112	0.373041938	75.29488087	235.09801	3.31377	6p22.2		0.5954	0.6387	0.6174	0.6518	0.6672	0.5824	0.5940	0.5496	0.7137	0.7798	0.7224	0.5970	0.8204	0.6489	0.6770	0.6989	rs11327870						
6	26096376	26096376	T	-	downstream	HFE	dist=907			8.4969700310781e-07	0.505802901039445	0.494196249263552	hemochromatosis	FUNCTION: Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin. {ECO:0000269|PubMed:9465039}.; 	DISEASE: Hemochromatosis 1 (HFE1) [MIM:235200]: A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading. {ECO:0000269|PubMed:10094552, ECO:0000269|PubMed:10194428, ECO:0000269|PubMed:10401000, ECO:0000269|PubMed:10575540, ECO:0000269|PubMed:11423500, ECO:0000269|PubMed:11446670, ECO:0000269|PubMed:12542741, ECO:0000269|PubMed:12584229, ECO:0000269|PubMed:12737937, ECO:0000269|PubMed:14633868, ECO:0000269|PubMed:15046077, ECO:0000269|PubMed:18157833, ECO:0000269|PubMed:8696333, ECO:0000269|PubMed:9024376, ECO:0000269|PubMed:9106528, ECO:0000269|PubMed:9620340, ECO:0000269|Ref.25}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Variegate porphyria (VP) [MIM:176200]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Variegate porphyria is the most common form of porphyria in South Africa. It is characterized by skin hyperpigmentation and hypertrichosis, abdominal pain, tachycardia, hypertension and neuromuscular disturbances. High fecal levels of protoporphyrin and coproporphyrin, increased urine uroporphyrins and iron overload are typical markers of the disease. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Iron overload due to HFE variants is a precipitating or exacerbating factor in variegate porphyria.; DISEASE: Microvascular complications of diabetes 7 (MVCD7) [MIM:612635]: Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end- stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in all tissues tested except brain.; 	unclassifiable (Anatomical System);cartilage;ovary;colon;parathyroid;skin;uterus;prostate;lung;frontal lobe;adrenal gland;placenta;visual apparatus;alveolus;liver;spleen;kidney;bladder;stomach;	dorsal root ganglion;superior cervical ganglion;thyroid;appendix;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;	0.10665	0.73042	0.084621747	60.31493277	796.87118	5.56445	6p22.2										0.0067	0.0021	0.0308	0.0117	0	0.0489	0.0033	0.0184							
6	26205347	26205347	T	-	downstream	HIST1H4E	dist=98			0.000642250549090646	0.294964991128732	0.704392758322177	histone cluster 1, H4e	FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; 	DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.; 	.	unclassifiable (Anatomical System);pancreas;endometrium;placenta;testis;spleen;blood;brain;skin;thymus;bone marrow;	atrioventricular node;trigeminal ganglion;	0.10242	.	-0.383807564	27.41802312	6.74798	0.24905	6p22.2										0.0137	0.0431	0.0018	0	0	0.0021	0.0006	0							
6	26414919	26414919	T	-	UTR3	BTN3A1	NM_001145009:c.*2161delT;NM_194441:c.*1946delT;NM_007048:c.*999delT;NM_001145008:c.*999delT			8.65113669435817e-07	0.747593221414351	0.252405913471979	butyrophilin subfamily 3 member A1	FUNCTION: Plays a role in T-cell activation and in the adaptive immune response. Regulates the proliferation of activated T-cells. Regulates the release of cytokines and IFNG by activated T-cells. Mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate. {ECO:0000269|PubMed:21113407, ECO:0000269|PubMed:21918970, ECO:0000269|PubMed:22767497, ECO:0000269|PubMed:22846996}.; 	.	TISSUE SPECIFICITY: Detected on T-cells, natural killer cells, dendritic cells and macrophages (at protein level). Ubiquitous. Highly expressed in heart, pancreas and lung, Moderately expressed in placenta, liver and muscle. {ECO:0000269|PubMed:20610803, ECO:0000269|PubMed:21113407, ECO:0000269|PubMed:21918970, ECO:0000269|PubMed:9149941}.; 	colon;skin;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;bone;dura mater;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);meninges;lymph node;cartilage;blood;breast;pia mater;lung;placenta;hippocampus;liver;spleen;kidney;mammary gland;stomach;	superior cervical ganglion;skeletal muscle;	0.06787	0.07707	0.531004228	80.87992451	647.15095	5.10575	6p22.2										0.0212	0.0129	0.0658	0.0433	0.0058	0.1255	0.0128	0.0315	rs759647583						
6	27327608	27327608	T	-	ncRNA_exonic	ZNF204P				.	.	.	zinc finger protein 204, pseudogene	.	.	.	.	.	0.06129	.	.	.	.	.	6p22.1		0.4731	0.4731	0.4722	0.6226	.	0.4791	0.5	0.4632	0.4621	0.4062	0.4455	0.3607	0.5529	0.6278	0.4500	0.4890	rs34125661						
6	27370925	27370925	-	A	UTR3	ZNF391	NM_001322288:c.*1699_*1700insA;NM_001322293:c.*1699_*1700insA;NM_001322289:c.*1699_*1700insA;NM_001076781:c.*1699_*1700insA			9.25869403182407e-07	0.315600702605261	0.684398371525336	zinc finger protein 391	FUNCTION: May be involved in transcriptional regulation. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);breast;lung;testis;colon;	testis - interstitial;superior cervical ganglion;testis;	0.05228	.	-0.314027422	31.9297004	82.90274	1.93373	6p22.1										0.6166	0.6273	0.6696	0.7770	0.5537	0.4789	0.6431	0.6019	rs34885201						
6	28123953	28123954	AC	-	UTR3	ZKSCAN8	NM_001278122:c.*2158_*2159delAC;NM_006298:c.*2158_*2159delAC;NM_001278119:c.*2158_*2159delAC;NM_001278121:c.*2158_*2159delAC			0.000231594506551783	0.980492380073096	0.0192760254203525	zinc finger with KRAB and SCAN domains 8	FUNCTION: May be involved in transcriptional regulation.; 	.	.	.	.	0.15170	0.10440	0.485092724	79.37603208	412.96116	4.25451	6p22.1										0.0035	0.0117	0	0	0.0006	0	0.0002	0	rs146825871						
6	29765077	29765077	-	AAG	ncRNA_exonic	LOC554223																			6p22.1										0.0125	0.0341	0.0348	0.0034	0.0062	0.0029	0.0044	0.0032	rs201094801						
6	29913276	29913276	C	-	UTR3	HLA-A	NM_002116:c.*44delC;NM_001242758:c.*44delC			0.132779664827761	0.862664913079238	0.00455542209300079	major histocompatibility complex, class I, A	FUNCTION: Involved in the presentation of foreign antigens to the immune system.; 	.	.	unclassifiable (Anatomical System);lymph node;endometrium;islets of Langerhans;bone;testis;colon;cervix;	.	0.19139	.	8.928758265	99.95871668	31164.80389	34.46226	6p22.1		0.0007	0.0033	0.0003	0.0021	0	0.0004	0.0011	0.0003	0.0848	0.1793	0.1523	0.0655	0.1306	0.0244	0.0399	0.0458	rs149604815						
6	29977389	29977393	CTTCT	-	ncRNA_exonic	HLA-J				.	.	.	major histocompatibility complex, class I, J (pseudogene)	.	.	.	.	.	.	.	.	.	.	.	6p22.1		0.1168	0.1216	0.1394	0.0989	0.0946	0.1357	0.0903	0.0509	0	0	0	0	0	0	0	0	rs762309517						
6	30545854	30545854	A	-	exonic	ABCF1		frameshift deletion	ABCF1:NM_001025091:exon4:c.218delA:p.K76Sfs*60,ABCF1:NM_001090:exon4:c.218delA:p.K76Sfs*60	2.7302422835602e-06	0.999963882170263	3.33875874534099e-05	ATP binding cassette subfamily F member 1	FUNCTION: Isoform 2 is required for efficient Cap- and IRES- mediated mRNA translation initiation. Isoform 2 is not involved in the ribosome biogenesis. {ECO:0000269|PubMed:19570978}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9790762}.; 	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;atrium;frontal lobe;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;cerebellum cortex;islets of Langerhans;adrenal cortex;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;testis;atrioventricular node;trigeminal ganglion;cerebellum;	0.15350	.	-0.222203495	37.54423213	246.17443	3.38532	6p21.33	ID=COSM1443031;OCCURENCE=1(liver),9(large_intestine)	0.0838	0.0749	0.0774	0.0767	0.0339	0.0856	0.08	0.1106	0.0007	0.0001	0.0015	0	0	0.0062	0.0003	0.0028	rs751873821						
6	30653494	30653496	TGC	-	exonic	PPP1R18		stoploss	PPP1R18:NM_133471:exon1:c.300_302del:p.Q103Rfs*511,PPP1R18:NM_001134870:exon2:c.300_302del:p.M78_79insATIPDWKLQLLARRRQEEASVRREKAERERLSQMPAWKRGLLERRRAKLGLSPGEPSPVLGTVEAGPPDPDESAVLLEAIGPVHQNRFIRQERQQQQQQQQRSEELLAERKPGPLEARERRPSPGEMRDQSPKGRESREERLSPRETRERRLGIGGAQELSLRPLEARDWRQSPGEVGDRSSRLSEAWKWRLSPGETPERSLRLAESREQSPRRKEVESRLSPGESAYQKLGLTEAHKWRPDSRESQEQSLVQLEATEWRLRSGEERQDYSEECGRKEEWPVPGVAPKETAELSETLTREAQGNSSAGVEAAEQRPVEDGERGMKPTEGWKWTLNSGKAREWTPRDIEAQTQKPEPPESAEKLLESPGVEAGEGEAEKEEAGAQGRPLRALQNCCSVPSPLPPEDAGTGGLRQQEEEAVELQPPPPAPLSPPPPAPTAPQPPGDPLMSRLFYGVKAGPGVGAPRRSGHTFTVNPRRSVPPATPATPTSPATVDAAVPGAGKKRYPTAEEILVLGGYLRLSRSCLAKGSPERHHKQLKISFSETALETTYQYPSESSVLEELGPEPEVPSAPNPPAAQPDDEEDEEELLLLQPELQGGLRTKALIVDESCRR*	0.12120153280798	0.877702509386013	0.00109595780600717	protein phosphatase 1 regulatory subunit 18	FUNCTION: Isoform 1: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:24434620}.; 	.	TISSUE SPECIFICITY: Isoform 4 is predominantly expressed in leukocytes and spleen. {ECO:0000269|PubMed:17374523}.; 	smooth muscle;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;bone;thyroid;testis;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;blood;lens;skeletal muscle;pancreas;lung;nasopharynx;placenta;macula lutea;visual apparatus;duodenum;liver;spleen;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;trigeminal ganglion;whole blood;bone marrow;	0.15524	.	0.795569043	87.49115357	377.13358	4.09540	6p21.33	ID=COSM1443086;OCCURENCE=1(large_intestine)	0.0022	0.0024	0.0035	0.0019	0.0020	0.0021	0.0035	0.0021	0	0	0	0	0	0	0	0	rs780558217						
6	30957120	30957120	T	-	UTR3	MUC21	NM_001010909:c.*1149delT;NM_001322370:c.*1149delT;NM_001322371:c.*1149delT			0.331419151101163	0.606016804582376	0.0625640443164608	mucin 21, cell surface associated	.	.	TISSUE SPECIFICITY: Expressed in lung, large intestine, thymus, and testis. Expressed in normal and malignant bronchial epithelial cells. {ECO:0000269|PubMed:17977904}.; 	.	.	0.06345	.	2.443759208	98.56098136	1799.23935	7.82391	6p21.33										3.414e-05	0	0	0	0	0	6.951e-05	0							
6	31236716	31236716	C	-	UTR3	HLA-C	NM_002117:c.*230delG;NM_001243042:c.*230delG			9.94564281082044e-10	0.0870851514429539	0.912914847562482	major histocompatibility complex, class I, C	FUNCTION: Involved in the presentation of foreign antigens to the immune system.; 	.	.	.	.	.	0.79928	7.653485912	99.91743336	21803.44637	30.60876	6p21.33										0.6878	0.7296	0.7185	0.8130	0.7919	0.6869	0.6487	0.6777	rs796222210						
6	31237932	31237934	AGA	-	intronic	HLA-C				9.94564281082044e-10	0.0870851514429539	0.912914847562482	major histocompatibility complex, class I, C	FUNCTION: Involved in the presentation of foreign antigens to the immune system.; 	.	.	.	.	.	0.79928	7.653485912	99.91743336	21803.44637	30.60876	6p21.33										0.6834	0.7095	0.7119	0.8121	0.7946	0.6848	0.6517	0.6805	rs35424484						
6	31323039	31323039	-	GAAGGGCTCCA	ncRNA_exonic	MIR6891				.	.	.	microRNA 6891	.	.	.	.	.	.	.	.	.	.	.	6p21.33		0.4844	0.6456	0.4890	0.6107	0.4943	0.4202	0.5162	0.5831	0.4826	0.6276	0.5049	0.4433	0.6247	0.4597	0.3892	0.4833	rs6149511						
6	31540481	31540481	-	TC	intronic	LTA				0.743246562194033	0.245970562564895	0.0107828752410728	lymphotoxin alpha	FUNCTION: Cytokine that in its homotrimeric form binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM. In its heterotrimeric form with LTB binds to TNFRSF3/LTBR. Lymphotoxin is produced by lymphocytes and cytotoxic for a wide range of tumor cells in vitro and in vivo.; 	DISEASE: Psoriatic arthritis (PSORAS) [MIM:607507]: An inflammatory, seronegative arthritis associated with psoriasis. It is a heterogeneous disorder ranging from a mild, non-destructive disease to a severe, progressive, erosive arthropathy. Five types of psoriatic arthritis have been defined: asymmetrical oligoarthritis characterized by primary involvement of the small joints of the fingers or toes; asymmetrical arthritis which involves the joints of the extremities; symmetrical polyarthritis characterized by a rheumatoid like pattern that can involve hands, wrists, ankles, and feet; arthritis mutilans, which is a rare but deforming and destructive condition; arthritis of the sacroiliac joints and spine (psoriatic spondylitis). {ECO:0000269|PubMed:12746914}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	.	.	0.31616	.	0.525552348	80.57914603	4898.85973	14.25628	6p21.33		0.2449	0.2190	0.1815	0.1857	0.3064	0.2497	0.2561	0.2929	0.2557	0.2280	0.2326	0.2385	0.1902	0.3601	0.2562	0.3298	rs146166975						
6	31692676	31692676	A	-	UTR3	MPIG6B	NM_138277:c.*26delA																		6p21.33		0.3402	0.3221	0.3536	0.3928	0.2132	0.3304	0.2964	0.4082	0.0055	0.0018	0.0228	0.0043	0	0.0384	0.0036	0.0060	rs775494031						
6	31797918	31797919	TG	-	UTR3	HSPA1B	NM_005346:c.*265_*266delTG			.	.	.	heat shock protein family A (Hsp70) member 1B	FUNCTION: In cooperation with other chaperones, Hsp70s stabilize preexistent proteins against aggregation and mediate the folding of newly translated polypeptides in the cytosol as well as within organelles. These chaperones participate in all these processes through their ability to recognize nonnative conformations of other proteins. They bind extended peptide segments with a net hydrophobic character exposed by polypeptides during translation and membrane translocation, or following stress-induced damage. In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:16537599, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223}.; 	.	TISSUE SPECIFICITY: HSPA1B is testis-specific.; 	.	.	0.61105	.	.	.	619.532	5.02167	6p21.33																								
6	32166161	32166161	T	-	intronic	NOTCH4				1.19532150508521e-10	0.999993035219917	6.9646605505226e-06	notch 4	FUNCTION: Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. May regulate branching morphogenesis in the developing vascular system (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Highly expressed in the heart, moderately in the lung and placenta and at low levels in the liver, skeletal muscle, kidney, pancreas, spleen, lymph node, thymus, bone marrow and fetal liver. No expression was seen in adult brain or peripheral blood leukocytes.; 	.	.	0.37424	.	0.1505561	64.32531257	4975.85094	14.38235	6p21.32		0.2509	0.2665	0.2593	0.2452	0.1940	0.2505	0.2395	0.2653	0.0263	0.0665	0.0264	0.008	0.0239	0.0173	0.0044	0.0153	rs368091638						
6	32627712	32627712	-	A	ncRNA_exonic	HLA-DQB1-AS1				.	.	.	HLA-DQB1 antisense RNA 1	.	.	.	.	.	.	.	.	.	.	.	6p21.32																								
6	32634403	32634405	AGC	-	UTR5	HLA-DQB1	NM_001243961:c.-19_-21delGCT;NM_002123:c.-19_-21delGCT			0.353015151654053	0.634074738576959	0.0129101097689875	major histocompatibility complex, class II, DQ beta 1	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.; 	.	.	.	.	0.12207	.	7.699638782	99.92333097	28568.90925	33.37082	6p21.32		0.1098	0.1336	0.0665	0.0634	0.0794	0.1148	0.0950	0.1426	0.1885	0.2102	0.1346	0.1678	0.0977	0.1421	0.2010	0.1759	rs71789649						
6	32714183	32714183	A	-	UTR3	HLA-DQA2	NM_020056:c.*12delA			0.00504406368032515	0.697612525457181	0.297343410862494	major histocompatibility complex, class II, DQ alpha 2	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. {ECO:0000269|PubMed:22407913}.; 	.	TISSUE SPECIFICITY: Restricted to skin Langerhans cells, although some expression at low levels may occur at the surface of B lymphoblastoid cells. {ECO:0000269|PubMed:22407913, ECO:0000269|PubMed:9036956}.; 	.	.	0.16449	.	1.216305531	93.13517339	883.96094	5.79012	6p21.32		0.5119	0.3687	0.5709	0.6780	0.5415	0.4718	0.5382	0.6104	0.4630	0.3649	0.5248	0.5345	0.7354	0.5141	0.4721	0.5198	rs28993557						
6	32724802	32724802	-	T	intronic	HLA-DQB2				0.00935592869459469	0.812895752209809	0.177748319095596	major histocompatibility complex, class II, DQ beta 2	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. {ECO:0000269|PubMed:22407913}.; 	.	TISSUE SPECIFICITY: Restricted to skin Langerhans cells (at protein level). {ECO:0000269|PubMed:22407913}.; 	.	.	0.13783	.	.	.	221.62626	3.21955	6p21.32										0.2014	0.2056	0.1273	0.2222	0.1010	0.2390	0.2069	0.2066	rs71536155						
6	32724802	32724802	-	TT	intronic	HLA-DQB2				0.00935592869459469	0.812895752209809	0.177748319095596	major histocompatibility complex, class II, DQ beta 2	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. {ECO:0000269|PubMed:22407913}.; 	.	TISSUE SPECIFICITY: Restricted to skin Langerhans cells (at protein level). {ECO:0000269|PubMed:22407913}.; 	.	.	0.13783	.	.	.	221.62626	3.21955	6p21.32										0.4869	0.5645	0.5383	0.5111	0.5164	0.3892	0.4524	0.4645	rs71536155						
6	32948598	32948598	-	C	UTR3	BRD2	NM_005104:c.*103_*104insC;NM_001291986:c.*103_*104insC;NM_001113182:c.*103_*104insC;NM_001199455:c.*103_*104insC;NM_001199456:c.*103_*104insC			0.999530880243209	0.000469119418252866	3.38538338591965e-10	bromodomain containing 2	FUNCTION: May play a role in spermatogenesis or folliculogenesis (By similarity). Binds hyperacetylated chromatin and plays a role in the regulation of transcription, probably by chromatin remodeling. Regulates transcription of the CCND1 gene. Plays a role in nucleosome assembly. {ECO:0000250, ECO:0000269|PubMed:18406326}.; 	.	.	.	.	0.41159	0.54184	-0.020150552	52.25288983	1065.99604	6.26213	6p21.32										0.0230	0.0135	0.0157	0.0068	0.0332	0.0085	0.0309	0.0213	rs28986268						
6	33035992	33035992	-	T	intronic	HLA-DPA1				0.000185717032888532	0.469215738907011	0.530598544060101	major histocompatibility complex, class II, DP alpha 1	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.; 	.	.	.	.	0.12228	.	3.285765937	99.40434065	7603.77264	18.69721	6p21.32										0.2806	0.4932	0.1930	0.1633	0.7281	0.1139	0.1617	0.1930	rs148889828						
6	33036399	33036399	-	T	intronic	HLA-DPA1				0.000185717032888532	0.469215738907011	0.530598544060101	major histocompatibility complex, class II, DP alpha 1	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.; 	.	.	.	.	0.12228	.	3.285765937	99.40434065	7603.77264	18.69721	6p21.32		0.2398	0.4880	0.1526	0.6452	0.0970	0.1623	0.2037	0.3227	0.2810	0.4924	0.1918	0.1689	0.7300	0.1139	0.1623	0.1947	rs111559071						
6	33054014	33054014	A	-	exonic	HLA-DPB1		nonframeshift deletion	HLA-DPB1:NM_002121:exon5:c.776delA:p.X259X	7.18465788950328e-09	0.075619220558398	0.924380772256944	major histocompatibility complex, class II, DP beta 1	FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.; 	.	.	.	.	0.05183	0.18779	3.396108778	99.44562397	17883.2969	28.14203	6p21.32		0.0441	0.0956	0.0349	0.0787	0.0033	0.0327	0.0441	0.0625	0.0472	0.0898	0.0347	0.0099	0.0877	0.0029	0.0308	0.0337	rs67523850						
6	33262444	33262445	AC	-	intronic	RGL2				0.0747682997961984	0.925211043750604	2.0656453197212e-05	ral guanine nucleotide dissociation stimulator like 2	FUNCTION: Probable guanine nucleotide exchange factor. Putative effector of Ras and/or Rap. Associates with the GTP-bound form of Rap 1A and H-Ras in vitro (By similarity). {ECO:0000250}.; 	.	.	.	.	0.22656	.	-0.686998355	15.26893135	1320.97393	6.83655	6p21.32		0.0378	0.0339	0.0328	0.0460	0.0323	0.0364	0.0295	0.0483	0	0	0	0	0	0	0	0	rs202228744						
6	33269395	33269395	A	-	UTR3	TAPBP	NM_172209:c.*142delT;NM_003190:c.*142delT			0.000393581688587975	0.957605434969596	0.0420009833418159	TAP binding protein (tapasin)	FUNCTION: Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading). {ECO:0000269|PubMed:10636848}.; 	.	TISSUE SPECIFICITY: Neutrophils, mostly in fully differentiated cells.; 	.	.	0.06907	.	0.132352165	63.48785091	104.57314	2.21028	6p21.32										0.0046	0.0016	0.0254	0.0088	0	0.0349	0.0032	0.0094							
6	33408466	33408467	TC	-	intronic	SYNGAP1				0.999998449747972	1.55025202789228e-06	3.06418087674641e-16	synaptic Ras GTPase activating protein 1	FUNCTION: Major constituent of the PSD essential for postsynaptic signaling. Inhibitory regulator of the Ras-cAMP pathway. Member of the NMDAR signaling complex in excitatory synapses, it may play a role in NMDAR-dependent control of AMPAR potentiation, AMPAR membrane trafficking and synaptic plasticity. Regulates AMPAR- mediated miniature excitatory postsynaptic currents. Exhibits dual GTPase-activating specificity for Ras and Rap. May be involved in certain forms of brain injury, leading to long-term learning and memory deficits (By similarity). {ECO:0000250}.; 	DISEASE: Mental retardation, autosomal dominant 5 (MRD5) [MIM:612621]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD5 patients show global developmental delay with delayed motor development, hypotonia, moderate-to- severe mental retardation, and severe language impairment. Epilepsy and autism can be present in some patients. {ECO:0000269|PubMed:19196676, ECO:0000269|PubMed:21076407, ECO:0000269|PubMed:21237447, ECO:0000269|PubMed:23161826}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;salivary gland;adrenal medulla;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;larynx;bone;testis;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;pharynx;blood;lens;breast;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.44861	0.11578	-1.153638777	6.233781552	1373.91556	6.95167	6p21.32		0.3760	0.2494	0.2792	0.2688	0.1273	0.3011	0.3883	0.4875	0.0098	0.0025	0.0281	0.0192	0	0.0709	0.0074	0.0218	rs138475712						
6	34934997	34934997	T	-	intronic	ANKS1A				0.84685967793139	0.153140282920134	3.91484761176882e-08	ankyrin repeat and sterile alpha motif domain containing 1A	FUNCTION: Regulator of different signaling pathways. Regulates EPHA8 receptor tyrosine kinase signaling to control cell migration and neurite retraction (By similarity). {ECO:0000250, ECO:0000269|PubMed:17875921}.; 	.	TISSUE SPECIFICITY: Widely expressed (at protein level).; 	ovary;salivary gland;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;adrenal cortex;pharynx;blood;lens;breast;lung;placenta;macula lutea;visual apparatus;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;cerebellum;thymus;	dorsal root ganglion;superior cervical ganglion;olfactory bulb;placenta;testis;atrioventricular node;	0.44722	0.11641	-1.254821849	5.355036565	700.58074	5.26551	6p21.31		0.0338	0.0291	0.0262	0.0288	0.0147	0.0346	0.0273	0.0535	0.0002	0.0001	0	0	0	0.0017	0	0	rs758057996						
6	35216592	35216592	A	-	UTR3	SCUBE3	NM_001303136:c.*110delA;NM_152753:c.*110delA			0.9999837065276	1.62934723807016e-05	1.90934895654898e-14	signal peptide, CUB domain and EGF like domain containing 3	FUNCTION: Binds to TGFBR2 and activates TGFB signaling. In lung cancer cells, could serve as an endogenous autocrine and paracrine ligand of TGFBR2, which could regulate TGFBR2 signaling and hence modulate epithelial-mesenchymal transition and cancer progression. {ECO:0000269|PubMed:21441952}.; 	.	TISSUE SPECIFICITY: Highly expressed in osteoblasts. In normal lung, mainly expressed in bronchial epithelial cells. Tends to be up-regulated in lung cancer cells. {ECO:0000269|PubMed:15234972, ECO:0000269|PubMed:21441952}.; 	unclassifiable (Anatomical System);ovary;colon;skin;breast;prostate;whole body;lung;adrenal gland;bone;placenta;thyroid;visual apparatus;testis;artery;aorta;	dorsal root ganglion;uterus corpus;superior cervical ganglion;subthalamic nucleus;temporal lobe;liver;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;parietal lobe;	0.24617	0.09100	-0.21856543	37.66218448	216.97195	3.18474	6p21.31										7.349e-05	0	0	0	0.0006	0	7.576e-05	0							
6	35262831	35262831	A	-	intronic	ZNF76				5.07288621916122e-16	0.00645354583959637	0.993546454160403	zinc finger protein 76	FUNCTION: May be involved in transcriptional regulation.; 	.	TISSUE SPECIFICITY: Testis.; 	colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;pituitary gland;testis;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;urinary;blood;lens;skeletal muscle;lung;epididymis;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	6p21.31										0.0056	0.0015	0.0097	0.0382	0	0.0060	0.0079	0.0041	rs113114842						
6	35541421	35541421	T	-	UTR3	FKBP5	NM_001145776:c.*2191delA;NM_004117:c.*2191delA;NM_001145775:c.*2191delA			0.498849476622916	0.500257970282122	0.000892553094961795	FK506 binding protein 5	FUNCTION: Immunophilin protein with PPIase and co-chaperone activities. Component of unligated steroid receptors heterocomplexes through interaction with heat-shock protein 90 (HSP90). Plays a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors maintaining the complex into the cytoplasm when unliganded.; 	.	TISSUE SPECIFICITY: Widely expressed, enriched in testis compared to other tissues.; 	lymphoreticular;ovary;substantia nigra;skin;retina;bone marrow;prostate;frontal lobe;endometrium;thyroid;iris;germinal center;ciliary body;bladder;brain;gall bladder;heart;cartilage;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;colon;parathyroid;uterus;whole body;cerebral cortex;bone;testis;artery;pineal gland;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;placenta;hippocampus;head and neck;kidney;stomach;aorta;	adipose tissue;white blood cells;atrioventricular node;skeletal muscle;	0.56735	0.09512	-0.025608647	51.91672564	44.99636	1.28850	6p21.31										0.0726	0.1971	0.0314	0.0606	0	0.0200	0.0221	0.0264	rs66957944						
6	35543220	35543220	T	-	UTR3	FKBP5	NM_001145776:c.*392delA;NM_004117:c.*392delA;NM_001145775:c.*392delA			0.498849476622916	0.500257970282122	0.000892553094961795	FK506 binding protein 5	FUNCTION: Immunophilin protein with PPIase and co-chaperone activities. Component of unligated steroid receptors heterocomplexes through interaction with heat-shock protein 90 (HSP90). Plays a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors maintaining the complex into the cytoplasm when unliganded.; 	.	TISSUE SPECIFICITY: Widely expressed, enriched in testis compared to other tissues.; 	lymphoreticular;ovary;substantia nigra;skin;retina;bone marrow;prostate;frontal lobe;endometrium;thyroid;iris;germinal center;ciliary body;bladder;brain;gall bladder;heart;cartilage;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;colon;parathyroid;uterus;whole body;cerebral cortex;bone;testis;artery;pineal gland;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;placenta;hippocampus;head and neck;kidney;stomach;aorta;	adipose tissue;white blood cells;atrioventricular node;skeletal muscle;	0.56735	0.09512	-0.025608647	51.91672564	44.99636	1.28850	6p21.31										0.0706	0.1923	0.0334	0.0567	0	0.0174	0.0233	0.0259	rs111803919						
6	36078920	36078920	-	A	UTR3	MAPK14	NM_001315:c.*2696_*2697insA;NM_139012:c.*2696_*2697insA;NM_139014:c.*2776_*2777insA			0.997467188213903	0.00253270979371188	1.01992385401025e-07	mitogen-activated protein kinase 14	FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF- induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14- mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF- kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113'. {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:10747897, ECO:0000269|PubMed:10943842, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:11333986, ECO:0000269|PubMed:15905572, ECO:0000269|PubMed:16932740, ECO:0000269|PubMed:17003045, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:19893488, ECO:0000269|PubMed:20188673, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9792677, ECO:0000269|PubMed:9858528}.; 	.	TISSUE SPECIFICITY: Brain, heart, placenta, pancreas and skeletal muscle. Expressed to a lesser extent in lung, liver and kidney.; 	myocardium;smooth muscle;ovary;colon;skin;bone marrow;uterus;prostate;whole body;cochlea;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;lacrimal gland;islets of Langerhans;hypothalamus;blood;skeletal muscle;breast;pancreas;lung;epididymis;placenta;visual apparatus;alveolus;liver;spleen;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;whole blood;trigeminal ganglion;skeletal muscle;bone marrow;	0.94805	0.91733	-0.161524709	41.6430762	22.88461	0.76322	6p21.31										0.9652	0.9930	0.9889	0.9694	1	0.9431	0.9485	0.9609	rs11399714						
6	36355495	36355502	GCCCGGGT	-	UTR5	ETV7	NM_001207035:c.-177_-184delACCCGGGC;NM_001207039:c.-177_-184delACCCGGGC;NM_001207036:c.-177_-184delACCCGGGC;NM_001207038:c.-177_-184delACCCGGGC;NM_001207041:c.-16178_-16185delACCCGGGC;NM_016135:c.-177_-184delACCCGGGC;NM_001207040:c.-11784_-11791delACCCGGGC;NM_001207037:c.-11759_-11766delACCCGGGC			2.00672826880885e-08	0.245599352476762	0.754400627455955	ETS variant 7	FUNCTION: Transcriptional repressor; binds to the DNA sequence 5'- CCGGAAGT-3'. Isoform A does not seem to have a repressor activity. Isoform C does not seem to have a repressor activity.; 	.	TISSUE SPECIFICITY: Expressed in hematopoietic tissues.; 	unclassifiable (Anatomical System);lung;islets of Langerhans;adrenal cortex;colon;blood;germinal center;brain;skeletal muscle;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.70881	.	1.243805243	93.41825902	433.45398	4.34535	6p21.31										0.4320	0.2561	0.3600	0.6007	0.4072	0.4655	0.5284	0.4652	rs3833927						
6	36569712	36569712	G	-	intronic	SRSF3				0.976175209668048	0.0238001260124275	2.46643195241527e-05	serine/arginine-rich splicing factor 3	FUNCTION: May be involved in RNA processing in relation with cellular proliferation and/or maturation. May function as export adapter involved in mRNA nuclear export such as of histone H2A. Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NXF1 pathway); enhances NXF1-NXT1 RNA- binding activity. RNA-binding is semi-sequence specific. {ECO:0000269|PubMed:11336712, ECO:0000269|PubMed:18364396}.; 	.	.	lymphoreticular;ovary;colon;skin;bone marrow;prostate;whole body;frontal lobe;endometrium;larynx;thyroid;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;blood;skeletal muscle;bile duct;breast;lung;nasopharynx;placenta;visual apparatus;duodenum;liver;head and neck;kidney;stomach;cerebellum;	occipital lobe;fetal liver;ciliary ganglion;atrioventricular node;cingulate cortex;	0.79279	0.13588	0.035072054	56.2514744	.	.	6p21.31		7.613e-05	0.0001	0	0	0	0.0001	0	6.101e-05									rs372672113						
6	36570854	36570854	T	-	UTR3	SRSF3	NM_003017:c.*1088delT			0.976175209668048	0.0238001260124275	2.46643195241527e-05	serine/arginine-rich splicing factor 3	FUNCTION: May be involved in RNA processing in relation with cellular proliferation and/or maturation. May function as export adapter involved in mRNA nuclear export such as of histone H2A. Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NXF1 pathway); enhances NXF1-NXT1 RNA- binding activity. RNA-binding is semi-sequence specific. {ECO:0000269|PubMed:11336712, ECO:0000269|PubMed:18364396}.; 	.	.	lymphoreticular;ovary;colon;skin;bone marrow;prostate;whole body;frontal lobe;endometrium;larynx;thyroid;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;blood;skeletal muscle;bile duct;breast;lung;nasopharynx;placenta;visual apparatus;duodenum;liver;head and neck;kidney;stomach;cerebellum;	occipital lobe;fetal liver;ciliary ganglion;atrioventricular node;cingulate cortex;	0.79279	0.13588	0.035072054	56.2514744	.	.	6p21.31										0.0267	0.0085	0.0975	0.0551	0.0051	0.1526	0.0251	0.0401	rs766825656						
6	37600959	37600960	AC	-	UTR3	MDGA1	NM_153487:c.*4185_*4184delGT			0.995236956713737	0.00476303933821579	3.94804666932354e-09	MAM domain containing glycosylphosphatidylinositol anchor 1	FUNCTION: Required for radial migration of cortical neurons in the superficial layer of the neocortex (By similarity). Plays a role in the formation or maintenance of inhibitory synapses. May function by inhibiting the activity of NLGN2. {ECO:0000250, ECO:0000269|PubMed:23248271}.; 	.	TISSUE SPECIFICITY: Has been found in brain, heart, skeletal muscle and kidney. Found to be overexpressed in tumor tissues.; 	unclassifiable (Anatomical System);heart;colon;fovea centralis;choroid;lens;skin;retina;uterus;prostate;optic nerve;lung;frontal lobe;macula lutea;iris;testis;germinal center;kidney;brain;cerebellum;thymus;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;uterus corpus;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;parietal lobe;skin;	0.15426	.	-1.126142808	6.564048125	1105.28503	6.35226	6p21.2										0.0042	0.0063	0.0033	0.0192	0.0012	0.0085	0.0025	0.0049	rs138772362						
6	38520531	38520531	A	-	intronic	BTBD9				0.00573299396733052	0.993286178262532	0.000980827770137838	BTB domain containing 9	.	.	TISSUE SPECIFICITY: Highly expressed in kidney and moderately expressed in all other adult and fetal tissues. Moderately expressed in all specific brain regions examined. {ECO:0000269|PubMed:11572484}.; 	unclassifiable (Anatomical System);lung;nasopharynx;placenta;testis;skeletal muscle;	superior cervical ganglion;subthalamic nucleus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.31062	0.12220	-0.957024976	9.088228356	18.76686	0.64776	6p21.2										0.0087	0.0028	0.0157	0	0	0.0890	0.0058	0.0204	rs201496890						
6	41032649	41032649	-	T	downstream	APOBEC2	dist=19			0.132007272868405	0.780162685562718	0.0878300415688774	apolipoprotein B mRNA editing enzyme catalytic subunit 2	FUNCTION: Probable C to U editing enzyme whose physiological substrate is not yet known. Does not display detectable apoB mRNA editing. Has a low intrinsic cytidine deaminase activity. May play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation. {ECO:0000269|PubMed:17187054, ECO:0000269|PubMed:21496894}.; 	.	TISSUE SPECIFICITY: Expressed exclusively in heart and skeletal muscle.; 	unclassifiable (Anatomical System);myocardium;heart;ovary;islets of Langerhans;muscle;parathyroid;skeletal muscle;prostate;whole body;lung;placenta;visual apparatus;liver;testis;brain;	superior cervical ganglion;tongue;ciliary ganglion;pons;atrioventricular node;skeletal muscle;	0.70533	0.12032	0.549415813	81.38122199	1216.14196	6.59779	6p21.1										0.0020	0.0020	0.0063	0	0	0.0135	0.0008	0.0026							
6	41067456	41067456	T	-	UTR3	NFYA	NM_002505:c.*2307delT;NM_021705:c.*2307delT			0.0220592707694253	0.974636289016496	0.00330444021407863	nuclear transcription factor Y subunit alpha	FUNCTION: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'- CCAAT-3' box motif found in the promoters of its target genes. NF- Y can function as both an activator and a repressor, depending on its interacting cofactors. NF-YA positively regulates the transcription of the core clock component ARNTL/BMAL1. {ECO:0000269|PubMed:12741956}.; 	.	.	medulla oblongata;ovary;sympathetic chain;colon;skin;retina;bone marrow;uterus;prostate;frontal lobe;thyroid;testis;germinal center;bladder;brain;unclassifiable (Anatomical System);heart;lacrimal gland;hypothalamus;blood;breast;lung;placenta;visual apparatus;duodenum;cervix;kidney;stomach;	superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.98942	0.19444	-0.207437529	38.2814343	18.86158	0.65137	6p21.1										0.1000	0.0238	0.1455	0.1410	0.0083	0.3169	0.1424	0.1337	rs201876868						
6	41158590	41158593	TGTC	-	UTR3	TREML2	NM_024807:c.*1575_*1572delGACA			1.29204332519966e-07	0.110103456906203	0.889896413889464	triggering receptor expressed on myeloid cells like 2	FUNCTION: Cell surface receptor that may play a role in the innate and adaptive immune response. Acts as a counter-receptor for CD276 and interaction with CD276 on T-cells enhances T-cell activation. {ECO:0000269|PubMed:12645956, ECO:0000269|PubMed:18650384}.; 	.	TISSUE SPECIFICITY: Detected in cultured B-cells, T-cell leukemia and monocyte leukemia. Expressed constitutively on CD8 T-cells and induced on CD4 T-cells after activation. {ECO:0000269|PubMed:12645956, ECO:0000269|PubMed:18650384}.; 	.	.	0.03616	0.05941	1.728918179	96.55579146	640.99926	5.08852	6p21.1										0.0115	0.0117	0.0048	0.0068	0.0267	0.0063	0.0114	0.0114	rs755054449						
6	42048928	42048928	-	GC	downstream	TAF8	dist=284			3.04223621180909e-09	0.0873447649963109	0.912655231961453	TATA-box binding protein associated factor 8	FUNCTION: Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. Mediates both basal and activator-dependent transcription. Plays a role in the differentiation of preadipocyte fibroblasts to adipocytes, however, does not seem to play a role in differentiation of myoblasts. Required for the integration of TAF10 in the TAF complex. May be important for survival of cells of the inner cell mass which constitute the pluripotent cell population of the early embryo (By similarity). {ECO:0000250, ECO:0000269|PubMed:14580349}.; 	.	.	.	.	0.31114	0.25991	-0.381986487	27.68931352	21.02525	0.71190	6p21.1										0.0020	0.0017	0	0	0.0006	0.0003	0.0030	0							
6	42048928	42048928	-	GTGC	downstream	TAF8	dist=284			3.04223621180909e-09	0.0873447649963109	0.912655231961453	TATA-box binding protein associated factor 8	FUNCTION: Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. Mediates both basal and activator-dependent transcription. Plays a role in the differentiation of preadipocyte fibroblasts to adipocytes, however, does not seem to play a role in differentiation of myoblasts. Required for the integration of TAF10 in the TAF complex. May be important for survival of cells of the inner cell mass which constitute the pluripotent cell population of the early embryo (By similarity). {ECO:0000250, ECO:0000269|PubMed:14580349}.; 	.	.	.	.	0.31114	0.25991	-0.381986487	27.68931352	21.02525	0.71190	6p21.1										0.2914	0.3674	0.2074	0.1871	0.4755	0.2633	0.2415	0.2739	rs138805514						
6	42094136	42094136	T	-	intronic	C6orf132				.	.	.	chromosome 6 open reading frame 132	.	.	.	prostate;lung;tongue;visual apparatus;colon;head and neck;stomach;	dorsal root ganglion;superior cervical ganglion;pons;trigeminal ganglion;	0.20222	.	.	.	2239.84233	8.73355	6p21.1										0.3100	0.3272	0.3073	0.3808	0.2549	0.3401	0.3011	0.3093	rs112193945						
6	42194278	42194278	-	C	UTR3	TRERF1	NM_001297573:c.*1804_*1805insG;NM_033502:c.*1804_*1805insG			0.999595776775278	0.000404223215078359	9.64370785934456e-12	transcriptional regulating factor 1	FUNCTION: Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1. {ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:16371131}.; 	.	TISSUE SPECIFICITY: Highest expression was seen in thymus, testis and adrenal cortex, expressed also in the adrenal medulla, thyroid, and stomach. Highly expressed in steroidogenic JEG-3 and MCF-7 cells, low expression was seen in non-steroidogenic Hep-G2 and HEK293 cells. {ECO:0000269|PubMed:11349124}.; 	unclassifiable (Anatomical System);medulla oblongata;cartilage;ovary;colon;blood;skeletal muscle;retina;bone marrow;breast;lung;cochlea;nasopharynx;placenta;thyroid;bone;testis;germinal center;kidney;brain;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.81063	0.16220	0.745828079	86.38240151	1197.75907	6.56545	6p21.1										0.8550	0.8179	0.9104	0.8079	0.9175	0.9200	0.8516	0.8691	rs56887552						
6	42194279	42194279	-	CT	UTR3	TRERF1	NM_001297573:c.*1803_*1804insAG;NM_033502:c.*1803_*1804insAG			0.999595776775278	0.000404223215078359	9.64370785934456e-12	transcriptional regulating factor 1	FUNCTION: Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1. {ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:16371131}.; 	.	TISSUE SPECIFICITY: Highest expression was seen in thymus, testis and adrenal cortex, expressed also in the adrenal medulla, thyroid, and stomach. Highly expressed in steroidogenic JEG-3 and MCF-7 cells, low expression was seen in non-steroidogenic Hep-G2 and HEK293 cells. {ECO:0000269|PubMed:11349124}.; 	unclassifiable (Anatomical System);medulla oblongata;cartilage;ovary;colon;blood;skeletal muscle;retina;bone marrow;breast;lung;cochlea;nasopharynx;placenta;thyroid;bone;testis;germinal center;kidney;brain;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.81063	0.16220	0.745828079	86.38240151	1197.75907	6.56545	6p21.1																		rs56887552						
6	42611936	42611936	-	A	intronic	UBR2				0.999999880132158	1.19867842240771e-07	8.33763066000186e-24	ubiquitin protein ligase E3 component n-recognin 2	FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Plays a critical role in chromatin inactivation and chromosome-wide transcriptional silencing during meiosis via ubiquitination of histone H2A. Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth. {ECO:0000269|PubMed:15548684, ECO:0000269|PubMed:20298436, ECO:0000269|PubMed:20835242}.; 	.	TISSUE SPECIFICITY: Broadly expressed, with highest levels in skeletal muscle, kidney and pancreas. Present in acinar cells of the pancreas (at protein level). {ECO:0000269|PubMed:15548684, ECO:0000269|PubMed:16311597}.; 	.	.	0.72806	0.25871	-1.365077992	4.5175749	3342.51324	11.07201	6p21.1		0.1832	0.2648	0.1668	0.2790	0.2512	0.1577	0.1821	0.1702	0.0504	0.0969	0.0824	0.0045	0.0303	0.1920	0.0113	0.0512	rs764057494						
6	42896948	42896948	-	CTC	UTR5	CNPY3;CNPY3-GNMT	NM_001318845:c.-504_-503insCTC;NM_001318842:c.-361_-360insCTC;NM_001318847:c.-361_-360insCTC;NM_001318848:c.-361_-360insCTC;NM_006586:c.-361_-360insCTC;NM_001318856:c.-504_-503insCTC;NM_001318857:c.-361_-360insCTC;NM_001318858:c.-361_-360insCTC																		6p21.1										0.5724	0.8886	0.4125	0.4503	0.4292	0.4148	0.4576	0.4877	rs1160867						
6	43538502	43538502	A	-	intronic	XPO5				0.999999368728011	6.31271989099294e-07	1.4062762331945e-18	exportin 5	FUNCTION: Mediates the nuclear export of proteins bearing a double-stranded RNA binding domain (dsRBD) and double-stranded RNAs (cargos). XPO5 in the nucleus binds cooperatively to the RNA and to the GTPase Ran in its active GTP-bound form. Proteins containing dsRBDs can associate with this trimeric complex through the RNA. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause disassembly of the complex and release of the cargo from the export receptor. XPO5 then returns to the nuclear compartment by diffusion through the nuclear pore complex, to mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Overexpression may in some circumstances enhance RNA-mediated gene silencing (RNAi). Mediates nuclear export of isoform 5 of ADAR/ADAR1 in a RanGTP-dependent manner.; 	.	TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:11777942}.; 	lymphoreticular;medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;cerebellum cortex;islets of Langerhans;muscle;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;placenta;macula lutea;visual apparatus;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	testis - seminiferous tubule;testis;ciliary ganglion;	0.86468	0.23456	-0.815648973	12.01344657	487.6193	4.54621	6p21.1										0.0707	0.1311	0.0390	0.0726	0.0383	0.0912	0.0371	0.0571	rs202021212						
6	43753881	43753882	TA	-	UTR3	VEGFA	NM_001204384:c.*1582_*1583delTA;NM_001171623:c.*1582_*1583delTA;NM_001204385:c.*1582_*1583delTA;NM_001171627:c.*1598_*1599delTA;NM_001171626:c.*1582_*1583delTA;NM_001171625:c.*1582_*1583delTA;NM_001171624:c.*1582_*1583delTA;NM_001171622:c.*1582_*1583delTA;NM_001317010:c.*1516_*1517delTA;NM_001171628:c.*1582_*1583delTA;NM_003376:c.*1582_*1583delTA;NM_001025367:c.*1582_*1583delTA;NM_001025366:c.*1582_*1583delTA;NM_001171630:c.*1582_*1583delTA;NM_001171629:c.*1516_*1517delTA;NM_001033756:c.*1516_*1517delTA;NM_001025370:c.*1582_*1583delTA;NM_001025369:c.*1598_*1599delTA;NM_001025368:c.*1582_*1583delTA;NM_001287044:c.*1582_*1583delTA			.	.	.	vascular endothelial growth factor A	FUNCTION: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. {ECO:0000269|PubMed:11427521, ECO:0000269|PubMed:16489009}.; 	DISEASE: Microvascular complications of diabetes 1 (MVCD1) [MIM:603933]: Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end- stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. {ECO:0000269|PubMed:11978667}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed. A higher level expression seen in pituitary tumors as compared to the pituitary gland. {ECO:0000269|PubMed:22009797}.; 	smooth muscle;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;synovium;larynx;bone;thyroid;iris;pituitary gland;testis;brain;amygdala;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;hypothalamus;urinary;adrenal cortex;blood;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;cerebellum;	superior cervical ganglion;prostate;thyroid;trigeminal ganglion;skeletal muscle;	0.27201	0.09418	.	.	95.26537	2.10662	6p21.1										0.0020	0.0010	0.0132	0	0	0.0110	0.0010	0.0036	rs370654536						
6	43754177	43754177	A	-	UTR3	VEGFA	NM_001204384:c.*1878delA;NM_001171623:c.*1878delA;NM_001204385:c.*1878delA;NM_001171627:c.*1894delA;NM_001171626:c.*1878delA;NM_001171625:c.*1878delA;NM_001171624:c.*1878delA;NM_001171622:c.*1878delA;NM_001317010:c.*1812delA;NM_001171628:c.*1878delA;NM_003376:c.*1878delA;NM_001025367:c.*1878delA;NM_001025366:c.*1878delA;NM_001171630:c.*1878delA;NM_001171629:c.*1812delA;NM_001033756:c.*1812delA;NM_001025370:c.*1878delA;NM_001025369:c.*1894delA;NM_001025368:c.*1878delA;NM_001287044:c.*1878delA			.	.	.	vascular endothelial growth factor A	FUNCTION: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. {ECO:0000269|PubMed:11427521, ECO:0000269|PubMed:16489009}.; 	DISEASE: Microvascular complications of diabetes 1 (MVCD1) [MIM:603933]: Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end- stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. {ECO:0000269|PubMed:11978667}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed. A higher level expression seen in pituitary tumors as compared to the pituitary gland. {ECO:0000269|PubMed:22009797}.; 	smooth muscle;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;synovium;larynx;bone;thyroid;iris;pituitary gland;testis;brain;amygdala;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;hypothalamus;urinary;adrenal cortex;blood;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;cerebellum;	superior cervical ganglion;prostate;thyroid;trigeminal ganglion;skeletal muscle;	0.27201	0.09418	.	.	95.26537	2.10662	6p21.1										0.0174	0.0329	0.0211	0.0242	0.0019	0.0569	0.0053	0.0135	rs869136464						
6	44221385	44221385	G	-	UTR3	HSP90AB1	NM_001271970:c.*50delG;NM_007355:c.*50delG;NM_001271971:c.*50delG;NM_001271972:c.*50delG;NM_001271969:c.*50delG			0.99529931563779	0.00470059099397846	9.33682314406571e-08	heat shock protein 90kDa alpha family class B member 1	FUNCTION: Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:19696785}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;skin;retina;uterus;prostate;frontal lobe;endometrium;larynx;bone;iris;testis;brain;artery;bladder;tonsil;unclassifiable (Anatomical System);lymph node;heart;tongue;spinal cord;muscle;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	medulla oblongata;thalamus;subthalamic nucleus;occipital lobe;cerebellum peduncles;temporal lobe;globus pallidus;pons;parietal lobe;skeletal muscle;cingulate cortex;cerebellum;	0.17451	0.26816	-1.265702118	5.237084218	20.0367	0.68400	6p21.1		0.0305	0.0178	0.0262	0.0149	0.0256	0.0330	0.0348	0.0420	6.544e-05	0	0	0	0	0	0.0001	0	rs769984219						
6	44246607	44246607	-	AC	UTR3	TMEM151B	NM_001137560:c.*2343_*2344insAC			.	.	.	transmembrane protein 151B	.	.	.	.	.	0.21974	.	.	.	55.52583	1.49718	6p21.1										0.0209	0.0241	0.1153	0.0189	0.0120	0.0327	0.0144	0.02	rs56308139						
6	44246607	44246607	-	ACAC	UTR3	TMEM151B	NM_001137560:c.*2343_*2344insACAC			.	.	.	transmembrane protein 151B	.	.	.	.	.	0.21974	.	.	.	55.52583	1.49718	6p21.1										0.7574	0.4647	0.7593	0.7955	0.9276	0.8380	0.8971	0.8541	rs397770041						
6	45871000	45871001	AG	-	intronic	CLIC5				0.00187685115916181	0.724933929762025	0.273189219078813	chloride intracellular channel 5	FUNCTION: Required for normal hearing (PubMed:24781754). It is necessary for the formation of stereocilia in the inner ear and normal development of the organ of Corti (By similarity). Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. May play a role in the regulation of transepithelial ion absorption and secretion. Is required for the development and/or maintenance of the proper glomerular endothelial cell and podocyte architecture (PubMed:15184393, PubMed:18028448, PubMed:20335315). {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393, ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	DISEASE: Deafness, autosomal recessive, 103 (DFNB103) [MIM:616042]: A form of sensorineural deafness with onset in early childhood. Hearing impairment progresses from mild to severe or even profound before the second decade, and is accompanied by vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed in both fetal and adult human tissues (PubMed:24781754). Isoform 1 is expressed in renal glomeruli endothelial cells and podocytes (at protein level). {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	unclassifiable (Anatomical System);ovary;spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;lung;optic nerve;whole body;placenta;macula lutea;liver;testis;kidney;brain;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.25637	0.09418	1.019682101	90.97664544	213.77513	3.15479	6p21.1		0.3593	0.2618	0.2007	0.4565	0.3824	0.3790	0.3848	0.4109	0.3356	0.2606	0.2422	0.36	0.4497	0.3723	0.3626	0.3450	rs35735653	496577	not_specified	MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
6	46128911	46128912	TG	-	UTR3	ENPP5	NM_001290072:c.*152_*151delCA;NM_021572:c.*152_*151delCA;NM_001290073:c.*152_*151delCA			1.91660634387746e-05	0.4600736700562	0.539907163880361	ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)	FUNCTION: May play a role in neuronal cell communication. Lacks nucleotide pyrophosphatase and lysopholipase D activity (By similarity). {ECO:0000250|UniProtKB:P84039}.; 	.	.	unclassifiable (Anatomical System);cartilage;heart;colon;parathyroid;fovea centralis;skin;skeletal muscle;pancreas;prostate;optic nerve;lung;endometrium;macula lutea;hippocampus;liver;pituitary gland;testis;kidney;brain;mammary gland;aorta;	.	0.09518	0.08781	0.176444282	66.07100731	6521.86997	16.95828	6p21.1										0.0005	0.0001	0.0027	0	0	0.0010	0.0005	0.0022							
6	46968042	46968042	A	-	intronic	ADGRF1				.	.	.	adhesion G protein-coupled receptor F1	FUNCTION: Orphan receptor.; 	.	TISSUE SPECIFICITY: Mainly expressed in the kidney. Up-regulated in lung adenocarcinomas and prostate cancers. {ECO:0000269|PubMed:20149256}.; 	.	.	0.06533	.	0.698081425	85.30313753	.	.	6p12.3		0.0051	0.0338	0.0040	0.0047	0.0005	0.0024	0.0048	0.0015	0.0091	0.0300	0.0012	0	0.0025	0	0.0001	0	rs538324513						
6	50681661	50681661	T	-	UTR5	TFAP2D	NM_172238:c.-108del-			0.981586998492109	0.0183999281899187	1.30733179728064e-05	transcription factor AP-2 delta (activating enhancer binding protein 2 delta)	FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Highly expressed in brain, placenta, skeletal muscle, thymus, small intestine, and prostate, and expressed at lower levels in leukocyte, spleen, testis, ovary and colon. Barely detectable in heart, kidney, liver, lung or pancreas. {ECO:0000269|PubMed:11733187}.; 	macula lutea;visual apparatus;fovea centralis;	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	6p12.3										0.3841	0.3894	0.2717	0.2603	0.4325	0.3340	0.3949	0.3860	rs35537220						
6	51481325	51481325	-	T	UTR3	PKHD1	NM_138694:c.*2553_*2554insA			2.88608936958615e-23	0.999999999976766	2.32335774448585e-11	polycystic kidney and hepatic disease 1 (autosomal recessive)	FUNCTION: May be required for correct bipolar cell division through the regulation of centrosome duplication and mitotic spindle assembly. May be a receptor protein that acts in collecting-duct and biliary differentiation. {ECO:0000269|PubMed:20554582}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in fetal and adult kidney. In the kidney, it is found in the cortical and medullary collecting ducts. Also present in the adult pancreas, but at much lower levels. Detectable in fetal and adult liver. Rather indistinct signal in fetal brain. {ECO:0000269|PubMed:14978161, ECO:0000269|PubMed:15458427}.; 	unclassifiable (Anatomical System);liver;kidney;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.08201	0.25544	0.37824847	75.51309271	3737.47294	11.94762	6p12.3										0.1108	0.1043	0.0930	0.1281	0.1664	0.1720	0.1014	0.1136	rs113144792	303537	Autosomal_recessive_polycystic_kidney_disease	MedGen:C0085548,OMIM:263200,Orphanet:ORPHA731,SNOMED_CT:28770003	criteria_provided,_single_submitter	Uncertain_significance	
6	56974102	56974102	T	-	UTR3	ZNF451	NM_001257273:c.*7208delT			1.98298362859696e-06	0.998711287306639	0.00128672970973219	zinc finger protein 451	FUNCTION: May be involved in transcriptional regulation. Coactivator for steroid receptors.; 	.	.	umbilical cord;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;hypothalamus;urinary;blood;lens;skeletal muscle;breast;lung;adrenal gland;epididymis;placenta;macula lutea;visual apparatus;liver;amnion;spleen;head and neck;kidney;mammary gland;stomach;aorta;cerebellum;	dorsal root ganglion;amygdala;superior cervical ganglion;subthalamic nucleus;occipital lobe;hypothalamus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.32090	0.09754	-0.775187015	13.05142722	58.96781	1.55810	6p12.1										0.0799	0.0929	0.3513	0.0116	0.3801	0.1667	0.0123	0.0852	rs34845247						
6	56974102	56974103	TT	-	UTR3	ZNF451	NM_001257273:c.*7208_*7209delTT			1.98298362859696e-06	0.998711287306639	0.00128672970973219	zinc finger protein 451	FUNCTION: May be involved in transcriptional regulation. Coactivator for steroid receptors.; 	.	.	umbilical cord;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;hypothalamus;urinary;blood;lens;skeletal muscle;breast;lung;adrenal gland;epididymis;placenta;macula lutea;visual apparatus;liver;amnion;spleen;head and neck;kidney;mammary gland;stomach;aorta;cerebellum;	dorsal root ganglion;amygdala;superior cervical ganglion;subthalamic nucleus;occipital lobe;hypothalamus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.32090	0.09754	-0.775187015	13.05142722	58.96781	1.55810	6p12.1										0.0001	0.0002	0.0016	0	0	0	0	0							
6	57433570	57433573	TGTT	-	intronic	PRIM2				5.14707916843554e-08	0.39171956986701	0.608280378662199	primase (DNA) subunit 2	FUNCTION: DNA primase is the polymerase that synthesizes small RNA primers for the Okazaki fragments made during discontinuous DNA replication.; 	.	.	unclassifiable (Anatomical System);uterus;prostate;lymph node;lung;heart;placenta;visual apparatus;cervix;spleen;skin;stomach;	dorsal root ganglion;superior cervical ganglion;uterus corpus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.89222	0.08308	.	.	55.84911	1.50063	6p11.2																								
6	63989792	63989792	A	-	UTR3	LGSN	NM_001143940:c.*616delT;NM_016571:c.*134delT			2.5899855281394e-07	0.291169715194655	0.708830025806793	lengsin, lens protein with glutamine synthetase domain	FUNCTION: May act as a component of the cytoskeleton or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens. Does not seem to have enzymatic activity (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Abundantly expressed in lens. {ECO:0000269|PubMed:12107413, ECO:0000269|PubMed:17010935}.; 	.	.	0.06929	0.14121	0.622829232	83.47487615	267.72084	3.50957	6q12										0.0002	0	0	0	0	0.0011	0.0002	0							
6	64290634	64290634	T	-	UTR3	PTP4A1	NM_003463:c.*555delT			0.889900786451036	0.108953620944541	0.00114559260442328	protein tyrosine phosphatase type IVA, member 1	FUNCTION: Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. May play a role in the development and maintenance of differentiating epithelial tissues. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis. {ECO:0000269|PubMed:12235145, ECO:0000269|PubMed:12782572, ECO:0000269|PubMed:14643450}.; 	.	TISSUE SPECIFICITY: Expressed in bone marrow, lymph nodes, T lymphocytes, spleen, thymus and tonsil. Overexpressed in tumor cell lines. {ECO:0000269|PubMed:10940933, ECO:0000269|PubMed:12235145}.; 	.	.	0.21134	.	-0.075159878	47.78839349	6.0286	0.22793	6q12										0.0160	0.0113	0.0558	0.0172	0.0260	0.0675	0.0095	0.0222	rs202116148						
6	70918738	70918738	T	-	UTR3	COL19A1	NM_001858:c.*1760delT			5.55032017757713e-17	0.999008905415671	0.000991094584329417	collagen type XIX alpha 1	FUNCTION: May act as a cross-bridge between fibrils and other extracellular matrix molecules. Involved in skeletal myogenesis in the developing esophagus. May play a role in organization of the pericellular matrix or the sphinteric smooth muscle. {ECO:0000269|PubMed:12788917}.; 	.	TISSUE SPECIFICITY: Localized to vascular, neuronal, mesenchymal, and some epithelial basement membrane zones in umbilical cord. {ECO:0000269|PubMed:12788917}.; 	lung;nasopharynx;testis;kidney;germinal center;skeletal muscle;retina;	cerebellum peduncles;globus pallidus;ciliary ganglion;	.	0.12613	-0.121287852	44.12007549	3154.15403	10.69128	6q13										0.0091	0.0190	0.0188	0.0038	0.0020	0.0091	0.0040	0.0063	rs760355898						
6	70966422	70966422	A	-	intronic	COL9A1				4.77422931673328e-15	0.977172691861338	0.0228273081386574	collagen type IX alpha 1	FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.; 	DISEASE: Multiple epiphyseal dysplasia 6 (EDM6) [MIM:614135]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:11565064}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stickler syndrome 4 (STL4) [MIM:614134]: An autosomal recessive form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:16909383}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;whole body;optic nerve;endometrium;cochlea;bone;amniotic fluid;middle ear;bladder;brain;unclassifiable (Anatomical System);cartilage;heart;hypothalamus;spinal cord;lens;lung;placenta;internal ear;visual apparatus;macula lutea;head and neck;kidney;mammary gland;	superior cervical ganglion;hypothalamus;ciliary ganglion;caudate nucleus;trigeminal ganglion;skeletal muscle;cingulate cortex;skin;	0.49846	0.17535	-0.856118029	10.95777306	7049.10534	17.93014	6q13		0.2428	0.3564	0.2984	0.3509	0.1484	0.1862	0.2358	0.3458	0.0704	0.1774	0.0605	0.032	0.0077	0.0447	0.0174	0.0415	rs58271754						
6	72596571	72596573	CTG	-	UTR5	RIMS1	NM_014989:c.-156_-154del-;NM_001350411:c.-156_-154del-;NM_001350412:c.-156_-154del-;NM_001350413:c.-156_-154del-			0.0292114494347639	0.970788550514326	5.0909783156634e-11	regulating synaptic membrane exocytosis 1	FUNCTION: Rab effector involved in exocytosis (By similarity). May act as scaffold protein that regulates neurotransmitter release at the active zone. Essential for maintaining normal probability of neurotransmitter release and for regulating release during short- term synaptic plasticity (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000250|UniProtKB:Q99NE5, ECO:0000269|PubMed:23999003}.; 	DISEASE: Cone-rod dystrophy 7 (CORD7) [MIM:603649]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:12659814}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in melanocytes (PubMed:23999003). Detected in brain and retina (PubMed:23999003). {ECO:0000269|PubMed:23999003}.; 	unclassifiable (Anatomical System);frontal lobe;cerebellum cortex;liver;brain;skeletal muscle;	superior cervical ganglion;subthalamic nucleus;cerebellum peduncles;temporal lobe;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skin;skeletal muscle;cerebellum;	0.52106	0.15134	-1.543300564	3.320358575	440.01281	4.37079	6q13										0.0001	0.0001	0	0	0	0.0006	6.714e-05	0							
6	73110712	73110713	CA	-	UTR3	RIMS1	NM_014989:c.*296_*297delCA;NM_001168408:c.*296_*297delCA;NM_001168407:c.*296_*297delCA;NM_001350414:c.*296_*297delCA;NM_001350415:c.*296_*297delCA;NM_001350416:c.*296_*297delCA;NM_001350417:c.*296_*297delCA;NM_001350418:c.*296_*297delCA;NM_001350419:c.*296_*297delCA;NM_001350420:c.*296_*297delCA;NM_001350421:c.*296_*297delCA;NM_001350422:c.*296_*297delCA;NM_001350423:c.*296_*297delCA;NM_001350424:c.*296_*297delCA;NM_001350425:c.*296_*297delCA;NM_001350426:c.*296_*297delCA;NM_001350427:c.*296_*297delCA;NM_001350428:c.*296_*297delCA;NM_001350429:c.*296_*297delCA;NM_001350430:c.*296_*297delCA;NM_001350431:c.*296_*297delCA;NM_001350432:c.*296_*297delCA;NM_001350433:c.*296_*297delCA;NM_001350434:c.*296_*297delCA;NM_001350435:c.*296_*297delCA;NM_001350436:c.*296_*297delCA;NM_001350437:c.*296_*297delCA;NM_001350438:c.*296_*297delCA;NM_001350439:c.*296_*297delCA;NM_001350440:c.*296_*297delCA;NM_001350441:c.*296_*297delCA;NM_001350442:c.*296_*297delCA;NM_001350443:c.*296_*297delCA;NM_001350444:c.*296_*297delCA;NM_001350445:c.*296_*297delCA;NM_001350446:c.*296_*297delCA;NM_001350447:c.*296_*297delCA;NM_001350448:c.*296_*297delCA;NM_001350449:c.*296_*297delCA;NM_001350450:c.*296_*297delCA;NM_001350454:c.*296_*297delCA;NM_001350455:c.*296_*297delCA;NM_001350456:c.*296_*297delCA;NM_001350457:c.*296_*297delCA;NM_001350458:c.*296_*297delCA;NM_001350459:c.*296_*297delCA;NM_001350460:c.*296_*297delCA;NM_001168409:c.*296_*297delCA;NM_001350462:c.*296_*297delCA;NM_001350463:c.*296_*297delCA;NM_001350464:c.*296_*297delCA;NM_001350465:c.*296_*297delCA;NM_001350466:c.*296_*297delCA;NM_001350467:c.*296_*297delCA;NM_001350468:c.*296_*297delCA;NM_001350469:c.*296_*297delCA;NM_001350461:c.*296_*297delCA;NM_001168410:c.*296_*297delCA;NM_001350470:c.*296_*297delCA;NM_001350471:c.*296_*297delCA;NM_001350472:c.*296_*297delCA;NM_001350473:c.*296_*297delCA;NM_001350474:c.*296_*297delCA;NM_001168411:c.*296_*297delCA			0.0292114494347639	0.970788550514326	5.0909783156634e-11	regulating synaptic membrane exocytosis 1	FUNCTION: Rab effector involved in exocytosis (By similarity). May act as scaffold protein that regulates neurotransmitter release at the active zone. Essential for maintaining normal probability of neurotransmitter release and for regulating release during short- term synaptic plasticity (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000250|UniProtKB:Q99NE5, ECO:0000269|PubMed:23999003}.; 	DISEASE: Cone-rod dystrophy 7 (CORD7) [MIM:603649]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:12659814}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in melanocytes (PubMed:23999003). Detected in brain and retina (PubMed:23999003). {ECO:0000269|PubMed:23999003}.; 	unclassifiable (Anatomical System);frontal lobe;cerebellum cortex;liver;brain;skeletal muscle;	superior cervical ganglion;subthalamic nucleus;cerebellum peduncles;temporal lobe;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skin;skeletal muscle;cerebellum;	0.52106	0.15134	-1.543300564	3.320358575	440.01281	4.37079	6q13										9.928e-05	0	0.0013	0	0	0	6.801e-05	0.0011	rs143889624						
6	75795122	75795122	-	CA	UTR3	COL12A1	NM_080645:c.*1140_*1141insTG;NM_004370:c.*1140_*1141insTG			0.999999611399328	3.88600671497958e-07	8.31932542843415e-29	collagen type XII alpha 1	FUNCTION: Type XII collagen interacts with type I collagen- containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix. {ECO:0000250}.; 	DISEASE: Ullrich congenital muscular dystrophy 2 (UCMD2) [MIM:616470]: A form of Ullrich muscular dystrophy, a congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:24334604}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bethlem myopathy 2 (BTHLM2) [MIM:616471]: A form of Bethlem myopathy, a benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:24334604, ECO:0000269|PubMed:24334769}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in collagen I-containing tissues: both isoform 1 and isoform 2 appear in amnion, chorion, skeletal muscle, small intestine, and in cell culture of dermal fibroblasts, keratinocytes and endothelial cells. Only isoform 2 is found in lung, placenta, kidney and a squamous cell carcinoma cell line. Isoform 1 is also present in the corneal epithelial Bowman's membrane (BM) and the interfibrillar matrix of the corneal stroma, but it is not detected in the limbal BM. {ECO:0000269|PubMed:9344363}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;cerebral cortex;endometrium;oesophagus;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;pharynx;blood;breast;pancreas;lung;cornea;placenta;visual apparatus;alveolus;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;adipose tissue;ciliary ganglion;atrioventricular node;	0.92484	0.14383	-1.625040811	2.88393489	1491.01427	7.18337	6q13		0.1956	0.0292	0.2217	0.3128	0.1127	0.2194	0.1905	0.2021	0.0171	0.0028	0.0556	0.0352	0.1947	0.0101	0.0051	0.0137	rs112607771						
6	75795122	75795122	-	CACA	UTR3	COL12A1	NM_080645:c.*1140_*1141insTGTG;NM_004370:c.*1140_*1141insTGTG			0.999999611399328	3.88600671497958e-07	8.31932542843415e-29	collagen type XII alpha 1	FUNCTION: Type XII collagen interacts with type I collagen- containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix. {ECO:0000250}.; 	DISEASE: Ullrich congenital muscular dystrophy 2 (UCMD2) [MIM:616470]: A form of Ullrich muscular dystrophy, a congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:24334604}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bethlem myopathy 2 (BTHLM2) [MIM:616471]: A form of Bethlem myopathy, a benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:24334604, ECO:0000269|PubMed:24334769}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in collagen I-containing tissues: both isoform 1 and isoform 2 appear in amnion, chorion, skeletal muscle, small intestine, and in cell culture of dermal fibroblasts, keratinocytes and endothelial cells. Only isoform 2 is found in lung, placenta, kidney and a squamous cell carcinoma cell line. Isoform 1 is also present in the corneal epithelial Bowman's membrane (BM) and the interfibrillar matrix of the corneal stroma, but it is not detected in the limbal BM. {ECO:0000269|PubMed:9344363}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;cerebral cortex;endometrium;oesophagus;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;pharynx;blood;breast;pancreas;lung;cornea;placenta;visual apparatus;alveolus;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;adipose tissue;ciliary ganglion;atrioventricular node;	0.92484	0.14383	-1.625040811	2.88393489	1491.01427	7.18337	6q13		0.5805	0.3265	0.6217	0.4953	0.6512	0.6082	0.6270	0.5881	0.6370	0.2395	0.7485	0.8125	0.6482	0.7512	0.8346	0.7945	rs112607771						
6	75795273	75795273	A	-	UTR3	COL12A1	NM_080645:c.*990delT;NM_004370:c.*990delT			0.999999611399328	3.88600671497958e-07	8.31932542843415e-29	collagen type XII alpha 1	FUNCTION: Type XII collagen interacts with type I collagen- containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix. {ECO:0000250}.; 	DISEASE: Ullrich congenital muscular dystrophy 2 (UCMD2) [MIM:616470]: A form of Ullrich muscular dystrophy, a congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:24334604}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bethlem myopathy 2 (BTHLM2) [MIM:616471]: A form of Bethlem myopathy, a benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:24334604, ECO:0000269|PubMed:24334769}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in collagen I-containing tissues: both isoform 1 and isoform 2 appear in amnion, chorion, skeletal muscle, small intestine, and in cell culture of dermal fibroblasts, keratinocytes and endothelial cells. Only isoform 2 is found in lung, placenta, kidney and a squamous cell carcinoma cell line. Isoform 1 is also present in the corneal epithelial Bowman's membrane (BM) and the interfibrillar matrix of the corneal stroma, but it is not detected in the limbal BM. {ECO:0000269|PubMed:9344363}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;cerebral cortex;endometrium;oesophagus;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;pharynx;blood;breast;pancreas;lung;cornea;placenta;visual apparatus;alveolus;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;adipose tissue;ciliary ganglion;atrioventricular node;	0.92484	0.14383	-1.625040811	2.88393489	1491.01427	7.18337	6q13										0.0752	0.2361	0.035	0	0	0.0024	0.0010	0.0142	rs533772339						
6	75796998	75796998	A	-	intronic	COL12A1				0.999999611399328	3.88600671497958e-07	8.31932542843415e-29	collagen type XII alpha 1	FUNCTION: Type XII collagen interacts with type I collagen- containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix. {ECO:0000250}.; 	DISEASE: Ullrich congenital muscular dystrophy 2 (UCMD2) [MIM:616470]: A form of Ullrich muscular dystrophy, a congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:24334604}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bethlem myopathy 2 (BTHLM2) [MIM:616471]: A form of Bethlem myopathy, a benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:24334604, ECO:0000269|PubMed:24334769}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in collagen I-containing tissues: both isoform 1 and isoform 2 appear in amnion, chorion, skeletal muscle, small intestine, and in cell culture of dermal fibroblasts, keratinocytes and endothelial cells. Only isoform 2 is found in lung, placenta, kidney and a squamous cell carcinoma cell line. Isoform 1 is also present in the corneal epithelial Bowman's membrane (BM) and the interfibrillar matrix of the corneal stroma, but it is not detected in the limbal BM. {ECO:0000269|PubMed:9344363}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;cerebral cortex;endometrium;oesophagus;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;pharynx;blood;breast;pancreas;lung;cornea;placenta;visual apparatus;alveolus;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;adipose tissue;ciliary ganglion;atrioventricular node;	0.92484	0.14383	-1.625040811	2.88393489	1491.01427	7.18337	6q13										0.9750	0.9937	0.9849	0.9615	0.9994	0.9570	0.9653	0.9662	rs11289042						
6	76138146	76138146	-	AG	ncRNA_exonic	MIR4463				.	.	.	microRNA 4463	.	.	.	.	.	.	.	.	.	.	.	6q14.1		0.75	.	.	.	.	0.75	.	.	0.6970	0.8562	0.5108	0.6424	0.5835	0.6024	0.6547	0.6237	rs398110299						
6	76728583	76728583	-	A	intronic	IMPG1				6.13186468480682e-13	0.35464184454479	0.645358155454597	interphotoreceptor matrix proteoglycan 1	FUNCTION: May interact with hyaluronan which may serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix. {ECO:0000269|PubMed:9813076}.; 	DISEASE: Macular dystrophy, vitelliform, 4 (VMD4) [MIM:616151]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD4 features include late- onset moderate visual impairment, small satellite drusen-like lesions in the foveal area, and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:23993198}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Abundantly expressed in retina where it is specifically expressed by cone and rod photoreceptor cells. Localizes to cone and rod photoreceptor cells surrounding the interphotoreceptor matrix of the retina. {ECO:0000269|PubMed:10601738, ECO:0000269|PubMed:9719680, ECO:0000269|PubMed:9813076}.; 	.	.	0.26878	0.09179	0.694433477	85.28544468	2205.13484	8.64488	6q14.1		0.0158	0.0112	0.0276	0.0758	0.0106	0.0077	0.0095	0.0140	0.0096	0.0016	0.0382	0	0.1005	0.0123	0.0018	0.0094	rs773740599						
6	79656601	79656601	A	-	intronic	PHIP				0.999999947701654	5.22983462395004e-08	1.10565889843483e-24	pleckstrin homology domain interacting protein	FUNCTION: Probable regulator of the insulin and insulin-like growth factor signaling pathways. Stimulates cell proliferation through regulation of cyclin transcription and has an anti- apoptotic activity through AKT1 phosphorylation and activation. Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:12242307, ECO:0000269|PubMed:21834987}.; 	.	TISSUE SPECIFICITY: Expressed in myeloma and epidermoid carcinoma cell lines. {ECO:0000269|PubMed:11018022}.; 	lymphoreticular;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;germinal center;bladder;brain;amygdala;heart;cartilage;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;alveolus;spleen;mammary gland;peripheral nerve;salivary gland;intestine;colon;parathyroid;choroid;fovea centralis;uterus;whole body;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;bile duct;lung;nasopharynx;placenta;duodenum;kidney;stomach;aorta;	superior cervical ganglion;skeletal muscle;	0.94541	0.10571	-1.238203625	5.490681765	2589.70314	9.52072	6q14.1	ID=COSM1723222;OCCURENCE=1(NS)	0.0870	0.1153	0.0719	0.0944	0.0721	0.0852	0.1003	0.0904	0.0083	0.0266	0.0013	0	0	0.0005	0.0003	0.0013	rs569725196						
6	80411339	80411339	G	-	UTR3	SH3BGRL2	NM_031469:c.*2113delG			7.16872263567788e-06	0.160301960201695	0.839690871075669	SH3 domain binding glutamate rich protein like 2	.	.	TISSUE SPECIFICITY: Highly expressed in brain, placenta, liver and kidney. Expressed in retina. {ECO:0000269|PubMed:12095696}.; 	.	.	0.16852	.	0.147123112	64.11299835	18.93269	0.65369	6q14.1										0.0050	0.0014	0.0148	0	0.0033	0.0088	0.0058	0.0087							
6	80910623	80910623	T	-	intronic	BCKDHB				2.91008815830628e-06	0.767207619382806	0.232789470529036	branched chain keto acid dehydrogenase E1, beta polypeptide	FUNCTION: The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).; 	DISEASE: Maple syrup urine disease 1B (MSUD1B) [MIM:248600]: A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. {ECO:0000269|PubMed:11509994, ECO:0000269|PubMed:22326532, ECO:0000269|PubMed:8161368}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	medulla oblongata;ovary;sympathetic chain;colon;parathyroid;skin;retina;uterus;prostate;whole body;cochlea;endometrium;synovium;bone;pituitary gland;testis;spinal ganglion;brain;unclassifiable (Anatomical System);amygdala;lymph node;heart;cartilage;tongue;hypothalamus;urinary;lung;mesenchyma;placenta;liver;spleen;kidney;stomach;	superior cervical ganglion;subthalamic nucleus;liver;testis;atrioventricular node;skeletal muscle;	0.21382	0.37665	-0.449946534	24.00330267	37.41729	1.11457	6q14.1		0.4438	0.4290	0.4334	0.4451	0.4032	0.4490	0.4259	0.4537	0.0635	0.0185	0.0453	0.1142	0.0089	0.1404	0.0847	0.0850	rs374325532						
6	83878180	83878180	T	-	UTR3	DOPEY1;PGM3	NM_001199942:c.*294delT;NM_015018:c.*294delT;NM_015599:c.*773delA;NM_001199918:c.*837delA;NM_001199917:c.*773delA																		6q14.1										0.0004	0.0011	0	0	0	0	7.143e-05	0							
6	86298944	86298946	TTT	-	intronic	SNX14				6.79995024969682e-10	0.998315053847262	0.00168494547274319	sorting nexin 14	FUNCTION: Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25848753, PubMed:25148684). {ECO:0000250|UniProtKB:Q8BHY8, ECO:0000269|PubMed:25148684, ECO:0000269|PubMed:25848753, ECO:0000305|PubMed:25848753}.; 	.	TISSUE SPECIFICITY: Widely expressed both in fetal and adult tissues. {ECO:0000269|PubMed:25848753}.; 	lymphoreticular;smooth muscle;ovary;salivary gland;sympathetic chain;intestine;colon;skin;retina;bone marrow;uterus;prostate;whole body;endometrium;larynx;bone;thyroid;pituitary gland;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;pineal body;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;placenta;visual apparatus;hippocampus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.16810	0.10829	-0.488577883	22.64685067	150.07757	2.67167	6q14.3										9.922e-05	0	0	0	0	0.0014	0	0.0018							
6	87157612	87157612	T	-	intergenic	SNHG5;HTR1E	dist=769161;dist=489412																		6q14.3										0.0005	0.0006	0.0027	0	0.0006	0.0016	0.0001	0							
6	88221097	88221097	-	T	intronic	SLC35A1				0.208304140627799	0.78239924166844	0.0092966177037602	solute carrier family 35 member A1	FUNCTION: Transports CMP-sialic acid from the cytosol into Golgi vesicles where glycosyltransferases function.; 	DISEASE: Congenital disorder of glycosylation 2F (CDG2F) [MIM:603585]: CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:15576474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.53767	.	0.12689526	63.00424628	165.54342	2.81406	6q15		0.0193	0.0174	0.0242	0.0151	0.0063	0.0192	0.0315	0.0257	0.0019	0.0037	0.0015	0.0036	0	0.0048	0.0006	0	rs771553100						
6	88850692	88850692	-	A	UTR3	CNR1	NM_016083:c.*2882_*2883insT;NM_001160258:c.*2882_*2883insT;NM_001160259:c.*2882_*2883insT;NM_033181:c.*2882_*2883insT;NM_001160226:c.*2882_*2883insT			0.155072221772085	0.776107848886241	0.0688199293416741	cannabinoid receptor 1 (brain)	FUNCTION: Involved in cannabinoid-induced CNS effects. Acts by inhibiting adenylate cyclase. Could be a receptor for anandamide. Inhibits L-type Ca(2+) channel current. Isoform 2 and isoform 3 have altered ligand binding. {ECO:0000269|PubMed:15620723}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15620723}.; 	.	.	0.44350	0.20297	-0.957024976	9.088228356	11.91527	0.43204	6q15										0.6320	0.5905	0.5762	0.5993	0.5647	0.6638	0.6608	0.6322	rs34669085						
6	89320668	89320668	T	-	UTR3	RNGTT	NM_001286428:c.*1770delA;NM_003800:c.*1770delA;NM_001286426:c.*1770delA			0.763456431133887	0.236540369185524	3.19968058895243e-06	RNA guanylyltransferase and 5'-phosphatase	FUNCTION: Bifunctional mRNA-capping enzyme exhibiting RNA 5'- triphosphatase activity in the N-terminal part and mRNA guanylyltransferase activity in the C-terminal part. Catalyzes the first two steps of cap formation: by removing the gamma-phosphate from the 5'-triphosphate end of nascent mRNA to yield a diphosphate end, and by transferring the gmp moiety of GTP to the 5'-diphosphate terminus. {ECO:0000269|PubMed:21636784, ECO:0000269|PubMed:9473487, ECO:0000269|PubMed:9512541}.; 	.	TISSUE SPECIFICITY: Isoform 1 and isoform 4 (at a lesser extent) are expressed in cerebrum, cerebellum, thyroid, lung, heart, liver, kidney, spleen, large intestine, testis, skin and muscle.; 	ovary;colon;fovea centralis;choroid;skin;bone marrow;retina;optic nerve;whole body;bone;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);cerebellum cortex;islets of Langerhans;lens;skeletal muscle;pancreas;lung;placenta;hippocampus;macula lutea;liver;spleen;head and neck;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.84113	0.19698	-0.558357437	19.54470394	54.7413	1.48185	6q15										0.0196	0.0644	0.0082	0	0.0044	0.0003	0.0004	0.0055	rs148635671						
6	89511255	89511256	AC	-	intronic	RNGTT				0.763456431133887	0.236540369185524	3.19968058895243e-06	RNA guanylyltransferase and 5'-phosphatase	FUNCTION: Bifunctional mRNA-capping enzyme exhibiting RNA 5'- triphosphatase activity in the N-terminal part and mRNA guanylyltransferase activity in the C-terminal part. Catalyzes the first two steps of cap formation: by removing the gamma-phosphate from the 5'-triphosphate end of nascent mRNA to yield a diphosphate end, and by transferring the gmp moiety of GTP to the 5'-diphosphate terminus. {ECO:0000269|PubMed:21636784, ECO:0000269|PubMed:9473487, ECO:0000269|PubMed:9512541}.; 	.	TISSUE SPECIFICITY: Isoform 1 and isoform 4 (at a lesser extent) are expressed in cerebrum, cerebellum, thyroid, lung, heart, liver, kidney, spleen, large intestine, testis, skin and muscle.; 	ovary;colon;fovea centralis;choroid;skin;bone marrow;retina;optic nerve;whole body;bone;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);cerebellum cortex;islets of Langerhans;lens;skeletal muscle;pancreas;lung;placenta;hippocampus;macula lutea;liver;spleen;head and neck;	dorsal root ganglion;superior cervical ganglion;appendix;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.84113	0.19698	-0.558357437	19.54470394	54.7413	1.48185	6q15		0.0681	0.0535	0.0788	0.0931	0.0650	0.0671	0.0706	0.0623	3.284e-05	0.0001	0	0	0	0	0	0	rs143372586						
6	89874657	89874657	-	AAG	UTR3	PM20D2	NM_001010853:c.*2675_*2676insAAG			0.00116674345055796	0.84152454110507	0.157308715444372	peptidase M20 domain containing 2	.	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;bone;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;blood;lens;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;cervix;kidney;mammary gland;stomach;aorta;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	0.11411	0.10228	.	.	210.24582	3.12916	6q15																								
6	90077648	90077648	T	-	UTR3	RRAGD	NM_021244:c.*127delA			0.812902090860283	0.186125075449519	0.000972833690197695	Ras related GTP binding D	FUNCTION: Guanine nucleotide-binding protein forming heterodimeric Rag complexes required for the amino acid-induced relocalization of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB. This is a crucial step in the activation of the TOR signaling cascade by amino acids. {ECO:0000269|PubMed:20381137}.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;thyroid;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;alveolus;spleen;kidney;stomach;cerebellum;	tongue;kidney;skeletal muscle;	0.21118	0.10528	-0.05129383	49.75819769	34.1959	1.04707	6q15										0.0177	0.0445	0.0062	0.0185	0.0056	0.0078	0.0058	0.0106	rs142744016						
6	90344156	90344156	C	-	UTR3	LYRM2	NM_020466:c.*2836delG			0.0596813347506901	0.716876796857066	0.223441868392244	LYR motif containing 2	.	.	.	.	.	0.10963	.	0.391453969	75.87284737	1719.30322	7.64598	6q15										0.0024	0.0009	0.0029	0.0041	0	0.0089	0.0019	0.0059	rs201140638						
6	91263310	91263310	A	-	intronic	MAP3K7				0.998336232242865	0.00166376625853662	1.49859858138454e-09	mitogen-activated protein kinase kinase kinase 7	FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2- induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity. {ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.; 	.	TISSUE SPECIFICITY: Isoform 1A is the most abundant in ovary, skeletal muscle, spleen and blood mononuclear cells. Isoform 1B is highly expressed in brain, kidney and small intestine. Isoform 1C is the major form in prostate. Isoform 1D is the less abundant form. {ECO:0000269|PubMed:11118615}.; 	.	.	0.79955	0.33817	-0.427900189	25.14744043	14.73281	0.53078	6q15		0.0147	0.0142	0.0072	0.0135	0.0018	0.0176	0.0175	0.0147	8.016e-05	0	0	0	0	0	8.075e-05	0.0014	rs200692753						
6	97000342	97000342	T	-	intronic	UFL1				1.9081642881261e-12	0.580335844923436	0.419664155074656	UFM1 specific ligase 1	FUNCTION: E3 protein ligase that mediates ufmylation, the covalent attachment of the ubiquitin-like modifier UFM1 to substrate proteins, a post-translational modification on lysine residues of proteins that may play a crucial role in a number of cellular processes. Mediates DDRGK1 ufmylation and may regulate the proteasomal degradation of DDRGK1 and CDK5RAP3 thereby modulating NF-kappa-B signaling (PubMed:20018847, PubMed:20164180, PubMed:20228063, PubMed:25219498). May also through TRIP4 ufmylation play a role in nuclear receptors-mediated transcription (PubMed:25219498). May play a role in the unfolded protein response, mediating the ufmylation of multiple proteins in response to endoplasmic reticulum stress (PubMed:23152784). {ECO:0000269|PubMed:20018847, ECO:0000269|PubMed:20164180, ECO:0000269|PubMed:20228063, ECO:0000269|PubMed:23152784, ECO:0000269|PubMed:25219498}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed, with a high expression in liver (at protein level). Low expression in several invasive hepatocellular carcinomas, such Hep-G2, Hep 3B2.1-7, HLE and PLC. {ECO:0000269|PubMed:20018847}.; 	.	.	0.75716	0.10429	-0.775187015	13.05142722	216.74364	3.18197	6q16.1		0.3706	0.3615	0.3892	0.3663	0.3147	0.3713	0.3777	0.3922	0.0166	0.0096	0.0769	0.0372	0.0007	0.1463	0.0103	0.0353	rs780528158						
6	99321800	99321800	T	-	UTR3	FBXL4	NM_001278716:c.*354delA;NM_012160:c.*354delA			0.0079087988593491	0.989068653586563	0.00302254755408758	F-box and leucine-rich repeat protein 4	.	.	TISSUE SPECIFICITY: Expressed in heart, kidney, liver, lung, pancreas, and placenta, but not in skeletal muscle. {ECO:0000269|PubMed:10531037}.; 	smooth muscle;ovary;parathyroid;skin;retina;bone marrow;uterus;prostate;thyroid;bone;germinal center;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;urinary;blood;pancreas;lung;placenta;visual apparatus;liver;spleen;cervix;kidney;stomach;	superior cervical ganglion;	0.42917	0.09922	-0.933156985	9.54824251	139.80195	2.57820	6q16.1										0.0001	0.0002	0	0	0	0.0003	6.845e-05	0							
6	99848036	99848036	A	-	UTR3	PNISR	NM_032870:c.*380delT;NM_001322413:c.*121delT;NM_001322405:c.*380delT;NM_001322416:c.*114delT;NM_001322408:c.*380delT;NM_001322406:c.*380delT;NM_001322410:c.*121delT;NM_001322412:c.*121delT;NM_001322415:c.*380delT;NM_001322414:c.*380delT;NM_015491:c.*380delT			0.999085487307753	0.000914512621740111	7.05067232963529e-11	PNN-interacting serine/arginine-rich protein	.	.	TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, thymus, spleen, kidney, liver, placenta and leukocytes. {ECO:0000269|PubMed:14578391}.; 	.	.	0.95992	0.10958	0.068033485	59.0351498	139.81381	2.57901	6q16.2										0.0055	0.0016	0.0216	0.0119	0	0.0507	0.0030	0.0132							
6	102130411	102130411	T	-	intronic	GRIK2				0.994567954112697	0.0054320447859458	1.10135670037754e-09	glutamate ionotropic receptor kainate type subunit 2	FUNCTION: Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L- glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. May be involved in the transmission of light information from the retina to the hypothalamus. Modulates cell surface expression of NETO2 (By similarity). {ECO:0000250}.; 	DISEASE: Mental retardation, autosomal recessive 6 (MRT6) [MIM:611092]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic mental retardation. MRT6 patients display mild to severe mental retardation and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal. {ECO:0000269|PubMed:17847003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expression is higher in cerebellum than in cerebral cortex.; 	unclassifiable (Anatomical System);ovary;placenta;parathyroid;brain;skeletal muscle;cerebellum;	amygdala;dorsal root ganglion;whole brain;medulla oblongata;occipital lobe;superior cervical ganglion;thalamus;cerebellum peduncles;hypothalamus;pons;caudate nucleus;skeletal muscle;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.53627	.	-1.131590109	6.481481481	129.48869	2.48041	6q16.3		0.0572	0.0426	0.0491	0.0443	0.0144	0.0596	0.0509	0.0940	0.0053	0.0162	0.0061	0	0.0013	0.0012	0.0002	0.0034	rs764346409	207293	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
6	106557172	106557172	T	-	UTR3	PRDM1	NM_001198:c.*1811delT;NM_182907:c.*1811delT			0.980264413149198	0.0197324443076129	3.1425431894302e-06	PR domain 1	FUNCTION: Transcriptional repressor that binds specifically to the PRDI element in the promoter of the beta-interferon gene (PubMed:1851123). Drives the maturation of B-lymphocytes into Ig secreting cells (PubMed:12626569). {ECO:0000269|PubMed:12626569, ECO:0000269|PubMed:1851123}.; 	.	.	.	.	0.75728	0.34838	0.824892996	88.06912008	1937.8398	8.09882	6q21										0.0013	0.0006	0	0	0.0044	0.0032	0.0012	0.0011							
6	107231882	107231883	TC	-	ncRNA_intronic	LOC100422737																			6q21										0.0041	0.0013	0.0167	0.0039	0	0.0238	0.0026	0.0084	rs782711583						
6	108189877	108189877	A	-	UTR3	SEC63	NM_007214:c.*3031delT			1.24261908060209e-05	0.999895027797944	9.254601125033e-05	SEC63 homolog, protein translocation regulator	FUNCTION: Required for integral membrane and secreted preprotein translocation across the endoplasmic reticulum membrane.; 	.	TISSUE SPECIFICITY: Widely expressed, with high levels in the liver. {ECO:0000269|PubMed:15133510}.; 	.	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	6q21										0.0367	0.0466	0.0939	0.0664	0	0.2252	0.0162	0.0519	rs34250899	305349	Polycystic_liver_disease_1	MedGen:C0887850,OMIM:174050	criteria_provided,_single_submitter	Uncertain_significance	
6	108214755	108214755	T	-	exonic	SEC63		frameshift deletion	SEC63:NM_007214:exon16:c.1605delA:p.K535Nfs*28	1.24261908060209e-05	0.999895027797944	9.254601125033e-05	SEC63 homolog, protein translocation regulator	FUNCTION: Required for integral membrane and secreted preprotein translocation across the endoplasmic reticulum membrane.; 	.	TISSUE SPECIFICITY: Widely expressed, with high levels in the liver. {ECO:0000269|PubMed:15133510}.; 	.	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	6q21	ID=COSM111632;OCCURENCE=6(large_intestine),1(ovary)	0.0044	0.0038	0.0010	0.0042	0.0009	0.0064	0.0045	0.0007									rs752868449						
6	108224600	108224600	A	-	intronic	SEC63				1.24261908060209e-05	0.999895027797944	9.254601125033e-05	SEC63 homolog, protein translocation regulator	FUNCTION: Required for integral membrane and secreted preprotein translocation across the endoplasmic reticulum membrane.; 	.	TISSUE SPECIFICITY: Widely expressed, with high levels in the liver. {ECO:0000269|PubMed:15133510}.; 	.	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	6q21										0.0096	0.0021	0.0273	0.0263	0	0.0878	0.0078	0.0230	rs750531944						
6	109752563	109752563	-	A	intronic	PPIL6				6.30258336517342e-08	0.137211733497767	0.862788203476399	peptidylprolyl isomerase like 6	FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.; 	.	.	.	.	0.14477	0.10138	-0.249709319	35.74545883	263.88766	3.48573	6q21		0.1210	0.1270	0.1663	0.1855	0.1568	0.0974	0.1239	0.1485	0.0082	0.0075	0.0156	0.0256	0.0085	0.0201	0.0075	0.0030	rs374703340						
6	109850200	109850201	AC	-	intronic	AK9				7.09554971028093e-12	0.956487530817953	0.0435124691749514	adenylate kinase 9	FUNCTION: Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has both nucleoside monophosphate and diphosphate kinase activities. Catalyzes the phosphorylation of AMP, dAMP, CMP and dCMP with ATP as phosphate donor and of CMP with GTP as phosphate donor. Also catalyzes the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and TTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor. Shows substrate preference of CDP > UDP > ADP > GDP > TDP. {ECO:0000269|PubMed:23416111}.; 	.	.	.	.	0.20706	0.07112	1.723305156	96.49681529	9574.37609	21.15233	6q21	ID=COSM1732834;OCCURENCE=1(pancreas)	0.4744	0.2987	0.5061	0.5292	0.5022	0.4723	0.5098	0.5350	0.5368	0.3432	0.6383	0.6929	0.8431	0.5468	0.6044	0.6215	rs560850105						
6	109850201	109850201	C	-	intronic	AK9				7.09554971028093e-12	0.956487530817953	0.0435124691749514	adenylate kinase 9	FUNCTION: Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has both nucleoside monophosphate and diphosphate kinase activities. Catalyzes the phosphorylation of AMP, dAMP, CMP and dCMP with ATP as phosphate donor and of CMP with GTP as phosphate donor. Also catalyzes the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and TTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor. Shows substrate preference of CDP > UDP > ADP > GDP > TDP. {ECO:0000269|PubMed:23416111}.; 	.	.	.	.	0.20706	0.07112	1.723305156	96.49681529	9574.37609	21.15233	6q21		0.2321	0.0557	0.2988	0.3283	0.1674	0.2049	0.2341	0.3824	0.0064	0.0012	0.0329	0.0110	0	0.0348	0.0034	0.0147	rs577355457						
6	111499761	111499761	A	-	intronic	SLC16A10				0.0676070063771054	0.91840788200296	0.0139851116199349	solute carrier family 16 member 10	FUNCTION: Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity). {ECO:0000250, ECO:0000269|PubMed:11827462}.; 	.	TISSUE SPECIFICITY: Strongly expressed in kidney and skeletal muscle and at lower level in placenta and heart. {ECO:0000269|PubMed:11827462}.; 	.	.	0.08076	0.10491	-0.049474214	50.01179523	216.00513	3.17412	6q21										0.0061	0.0015	0.0187	0.0043	0.0006	0.0757	0.0030	0.0129	rs150694490						
6	112575549	112575550	CT	-	ncRNA_intronic	LOC101927640																			6q21										9.839e-05	0.0001	0	0	0.0006	0	6.756e-05	0							
6	114181915	114181915	T	-	UTR3	MARCKS	NM_002356:c.*160delT			0.266490060221299	0.636923987194479	0.0965859525842222	myristoylated alanine rich protein kinase C substrate	FUNCTION: MARCKS is the most prominent cellular substrate for protein kinase C. This protein binds calmodulin, actin, and synapsin. MARCKS is a filamentous (F) actin cross-linking protein.; 	.	.	.	.	0.57210	0.35330	.	.	121.70769	2.40288	6q21										0.0026	0.0004	0.0015	0	0.0032	0.0038	0.0036	0.0051							
6	114181914	114181914	-	T	UTR3	MARCKS	NM_002356:c.*159_*160insT			0.266490060221299	0.636923987194479	0.0965859525842222	myristoylated alanine rich protein kinase C substrate	FUNCTION: MARCKS is the most prominent cellular substrate for protein kinase C. This protein binds calmodulin, actin, and synapsin. MARCKS is a filamentous (F) actin cross-linking protein.; 	.	.	.	.	0.57210	0.35330	.	.	121.70769	2.40288	6q21										0.0020	0.0004	0.0030	0.0036	0	0.0028	0.0030	0.0038							
6	114182373	114182373	A	-	UTR3	MARCKS	NM_002356:c.*618delA			0.266490060221299	0.636923987194479	0.0965859525842222	myristoylated alanine rich protein kinase C substrate	FUNCTION: MARCKS is the most prominent cellular substrate for protein kinase C. This protein binds calmodulin, actin, and synapsin. MARCKS is a filamentous (F) actin cross-linking protein.; 	.	.	.	.	0.57210	0.35330	.	.	121.70769	2.40288	6q21										0.0039	0.0018	0.0142	0	0.0007	0.0388	0.0029	0.0087	rs752660224						
6	114183592	114183592	-	C	UTR3	MARCKS	NM_002356:c.*1837_*1838insC			0.266490060221299	0.636923987194479	0.0965859525842222	myristoylated alanine rich protein kinase C substrate	FUNCTION: MARCKS is the most prominent cellular substrate for protein kinase C. This protein binds calmodulin, actin, and synapsin. MARCKS is a filamentous (F) actin cross-linking protein.; 	.	.	.	.	0.57210	0.35330	.	.	121.70769	2.40288	6q21										0.4951	0.5877	0.2391	0.5196	0.4857	0.2472	0.4872	0.4970	rs145532268						
6	114292110	114292112	CTG	-	ncRNA_intronic	HDAC2-AS2																			6q21	ID=COSM1292187;OCCURENCE=1(breast),1(haematopoietic_and_lymphoid_tissue)	0.0362	0.0660	0.0519	0.0463	0.0298	0.0502	0.0282	0.0233	0.0146	0.0196	0.0025	0	0.0006	0.0082	0.0162	0.0063	rs777539281						
6	114378010	114378010	A	-	ncRNA_intronic	HDAC2-AS2																			6q21										0.0001	0.0002	0	0	0	0.0009	0	0							
6	114378234	114378234	T	-	ncRNA_intronic	HDAC2-AS2																			6q21										0.0014	0.0013	0.0066	0	0.0031	0.0018	0.0010	0.0012							
6	116782973	116782973	G	-	intronic	FAM26F				1.79931863021701e-05	0.1442218283755	0.855760178438198	family with sequence similarity 26 member F	FUNCTION: Pore-forming subunit of a voltage-gated ion channel. {ECO:0000250}.; 	.	.	.	.	0.05778	.	.	.	2565.4477	9.46343	6q22.1										0	0	0	0	0	0	0	0	rs758659750						
6	116842680	116842680	-	GA	UTR3	FAM26E	NM_153711:c.*5528_*5529insGA			0.00110838835995408	0.612647200395886	0.38624441124416	family with sequence similarity 26 member E	FUNCTION: Pore-forming subunit of a voltage-gated ion channel. {ECO:0000250}.; 	.	.	.	.	0.56443	.	0.328949044	73.41354093	64.66715	1.64998	6q22.1										0.0014	0.0031	0.0026	0	0	0.0006	0.0006	0.0021	rs150273405						
6	116842680	116842680	-	GAGA	UTR3	FAM26E	NM_153711:c.*5528_*5529insGAGA			0.00110838835995408	0.612647200395886	0.38624441124416	family with sequence similarity 26 member E	FUNCTION: Pore-forming subunit of a voltage-gated ion channel. {ECO:0000250}.; 	.	.	.	.	0.56443	.	0.328949044	73.41354093	64.66715	1.64998	6q22.1										0.3930	0.1830	0.5609	0.4545	0.5396	0.4555	0.4722	0.4541	rs150273405						
6	117735717	117735717	A	-	intronic	ROS1				1.78016845315113e-44	5.15188928587586e-06	0.999994848110714	ROS proto-oncogene 1 , receptor tyrosine kinase	FUNCTION: Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2. {ECO:0000269|PubMed:11094073, ECO:0000269|PubMed:16885344}.; 	DISEASE: Note=A chromosomal aberration involving ROS1 is found in a glioblastoma multiforme sample. An intra-chromosomal deletion del(6)(q21q21) is responsible for the formation of GOPC-ROS1 chimeric protein which is localized to the Golgi and has a constitutive receptor tyrosine kinase activity. A SLC34A2-ROS1 chimeric protein produced in non-small cell lung cancer cells also retains a constitutive kinase activity. A third type of chimeric protein CD74-ROS1 was also identified in those cells. {ECO:0000269|PubMed:12661006}.; 	TISSUE SPECIFICITY: Expressed in brain. Expression is increased in primary gliomas. {ECO:0000269|PubMed:8143271}.; 	.	.	0.60171	0.24685	-0.02786522	51.40953055	6571.55365	17.08126	6q22.1	ID=COSM1634454;OCCURENCE=1(liver)	0.3680	0.3409	0.3018	0.2815	0.3526	0.3875	0.3656	0.3895	0.2129	0.1614	0.125	0.1548	0.0315	0.3739	0.2443	0.2833	rs3836983						
6	119135551	119135551	T	-	UTR3	MCM9	NM_017696:c.*436delA			0.0039178276020221	0.958174024708846	0.0379081476891314	minichromosome maintenance 9 homologous recombination repair factor	FUNCTION: Component of the MCM8-MCM9 complex, a complex involved in homologous recombination repair following DNA interstrand cross-links and plays a key role during gametogenesis. The MCM8- MCM9 complex probably acts as a hexameric helicase downstream of the Fanconi anemia proteins BRCA2 and RAD51 and is required to process aberrant forks into homologous recombination substrates and to orchestrate homologous recombination with resection, fork stabilization and fork restart. {ECO:0000269|PubMed:22771115}.; 	DISEASE: Ovarian dysgenesis 4 (ODG4) [MIM:616185]: A disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as a result of streak gonads. {ECO:0000269|PubMed:25480036}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);breast;lung;hypothalamus;thyroid;testis;germinal center;brain;stomach;retina;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;cerebellum;	0.24948	.	.	.	657.30492	5.13970	6q22.31										3.362e-05	0	0	0	0	0.0003	0	0							
6	119501610	119501610	A	-	intronic	MAN1A1				0.803866877079253	0.196123819610013	9.30331073416279e-06	mannosidase alpha class 1A member 1	FUNCTION: Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2).; 	.	.	.	.	0.03949	0.10316	-0.468351206	23.42533616	52.98086	1.44514	6q22.31	ID=COSN169006;OCCURENCE=1(large_intestine)	0.0160	0.0056	0.0189	0.0144	0.0077	0.0192	0.0145	0.0132	3.815e-05	0	0	0	0.0006	0	0	0	rs553091066						
6	121769905	121769905	-	T	UTR3	GJA1	NM_000165:c.*763_*764insT			0.215546849622465	0.775782971111432	0.00867017926610283	gap junction protein alpha 1	FUNCTION: Gap junction protein that acts as a regulator of bladder capacity. A gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph. Negative regulator of bladder functional capacity: acts by enhancing intercellular electrical and chemical transmission, thus sensitizing bladder muscles to cholinergic neural stimuli and causing them to contract (By similarity). May play a role in cell growth inhibition through the regulation of NOV expression and localization. Plays an essential role in gap junction communication in the ventricles (By similarity). {ECO:0000250|UniProtKB:P08050, ECO:0000250|UniProtKB:P23242}.; 	DISEASE: Oculodentodigital dysplasia (ODDD) [MIM:164200]: A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances. {ECO:0000269|PubMed:12457340, ECO:0000269|PubMed:14729836, ECO:0000269|PubMed:15108203, ECO:0000269|PubMed:15637728, ECO:0000269|PubMed:16219735, ECO:0000269|PubMed:16222672, ECO:0000269|PubMed:16378922, ECO:0000269|PubMed:16709485, ECO:0000269|PubMed:16813608, ECO:0000269|PubMed:16816024, ECO:0000269|PubMed:17509830, ECO:0000269|PubMed:18161618, ECO:0000269|PubMed:19338053, ECO:0000269|PubMed:21670345, ECO:0000269|PubMed:23550541, ECO:0000269|PubMed:24508941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Oculodentodigital dysplasia, autosomal recessive (ODDD- AR) [MIM:257850]: A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances. {ECO:0000269|PubMed:16816024}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Syndactyly 3 (SDTY3) [MIM:186100]: A form of syndactyly, a congenital anomaly of the hand or foot marked by persistence of the webbing between adjacent digits that are more or less completely attached. In SDTY3, there is usually complete and bilateral syndactyly between the fourth and fifth fingers. Usually it is soft tissue syndactyly but occasionally the distal phalanges are fused. The fifth finger is short with absent or rudimentary middle phalanx. The feet are not affected. {ECO:0000269|PubMed:14729836}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Hypoplastic left heart syndrome 1 (HLHS1) [MIM:241550]: A syndrome due to defective development of the aorta proximal to the entrance of the ductus arteriosus, and hypoplasia of the left ventricle and mitral valve. As a result of the abnormal circulation, the ductus arteriosus and foramen ovale are patent and the right atrium, right ventricle, and pulmonary artery are enlarged. {ECO:0000269|PubMed:11470490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hallermann-Streiff syndrome (HSS) [MIM:234100]: A disorder characterized by a typical skull shape (brachycephaly with frontal bossing), hypotrichosis, microphthalmia, cataracts, beaked nose, micrognathia, skin atrophy, dental anomalies and proportionate short stature. Mental retardation is present in a minority of cases. {ECO:0000269|PubMed:14974090}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrioventricular septal defect 3 (AVSD3) [MIM:600309]: A congenital heart malformation characterized by a common atrioventricular junction coexisting with deficient atrioventricular septation. The complete form involves underdevelopment of the lower part of the atrial septum and the upper part of the ventricular septum; the valve itself is also shared. A less severe form, known as ostium primum atrial septal defect, is characterized by separate atrioventricular valvar orifices despite a common junction. {ECO:0000269|PubMed:11470490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Craniometaphyseal dysplasia, autosomal recessive (CMDR) [MIM:218400]: An osteochondrodysplasia characterized by hyperostosis and sclerosis of the craniofacial bones associated with abnormal modeling of the metaphyses. Sclerosis of the skull may lead to asymmetry of the mandible, as well as to cranial nerve compression, that may finally result in hearing loss and facial palsy. {ECO:0000269|PubMed:23951358}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in the heart and fetal cochlea. {ECO:0000269|PubMed:11741837}.; 	smooth muscle;ovary;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;larynx;bone;thyroid;testis;dura mater;spinal ganglion;brain;artery;unclassifiable (Anatomical System);amygdala;meninges;heart;islets of Langerhans;hypothalamus;adrenal cortex;lens;skeletal muscle;breast;pia mater;lung;adrenal gland;mesenchyma;trabecular meshwork;placenta;visual apparatus;hippocampus;hypopharynx;liver;amnion;head and neck;mammary gland;stomach;aorta;	amygdala;adrenal gland;hypothalamus;spinal cord;prefrontal cortex;caudate nucleus;	0.95221	0.36533	-0.271755481	34.31823543	29.87324	0.95342	6q22.31										0.4379	0.7440	0.224	0.2379	0.2332	0.3793	0.3135	0.3497	rs34370179	301331	Syndactyly|Oculodentodigital_dysplasia|Hypoplastic_left_heart_syndrome_1	Human_Phenotype_Ontology:HP:0001159,MedGen:C0039075,Orphanet:ORPHA90025|MedGen:C0812437,OMIM:164200|MedGen:C4551854,OMIM:241550	criteria_provided,_single_submitter	Benign	
6	123958210	123958210	T	-	UTR5	TRDN	NM_006073:c.-290delA;NM_001251987:c.-290delA;NM_001256020:c.-290delA;NM_001256021:c.-290delA;NM_001256022:c.-290delA			1.81677623808329e-10	0.826941440119538	0.173058559698784	triadin	FUNCTION: Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation- contraction coupling in the heart and in regulating the rate of heart beats. {ECO:0000250|UniProtKB:E9Q9K5, ECO:0000269|PubMed:22422768}.; 	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);lung;whole body;macula lutea;developmental;liver;testis;fovea centralis;skeletal muscle;retina;	subthalamic nucleus;superior cervical ganglion;tongue;thyroid;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.18235	0.15914	1.976952171	97.61146497	4408.1144	13.27537	6q22.31										0.0001	0.0002	0	0	0	0.0006	0	0							
6	124759038	124759038	C	-	intronic	NKAIN2				0.00783238533852385	0.928062091303548	0.0641055233579282	Na+/K+ transporting ATPase interacting 2	.	.	TISSUE SPECIFICITY: Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined. {ECO:0000269|PubMed:11979551}.; 	.	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	6q22.31		0.0198	0.0686	0.0380	0.0172	0	0.0135	0.0083	0.0196									rs761275079						
6	125144526	125144527	AC	-	UTR3	NKAIN2	NM_153355:c.*151_*152delAC;NM_001300737:c.*151_*152delAC;NM_001300738:c.*151_*152delAC;NM_001040214:c.*151_*152delAC;NM_001300740:c.*151_*152delAC			0.00783238533852385	0.928062091303548	0.0641055233579282	Na+/K+ transporting ATPase interacting 2	.	.	TISSUE SPECIFICITY: Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined. {ECO:0000269|PubMed:11979551}.; 	.	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	6q22.31										0.6320	0.6588	0.5899	0.5868	0.4298	0.6451	0.6386	0.6326	rs3831017						
6	125144526	125144529	ACAC	-	UTR3	NKAIN2	NM_153355:c.*151_*154delACAC;NM_001300737:c.*151_*154delACAC;NM_001300738:c.*151_*154delACAC;NM_001040214:c.*151_*154delACAC;NM_001300740:c.*151_*154delACAC			0.00783238533852385	0.928062091303548	0.0641055233579282	Na+/K+ transporting ATPase interacting 2	.	.	TISSUE SPECIFICITY: Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined. {ECO:0000269|PubMed:11979551}.; 	.	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	6q22.31										0.0005	0.0002	0	0	0	0	0.0009	0.0011	rs553425388						
6	125146685	125146685	T	-	UTR3	NKAIN2	NM_153355:c.*2310delT;NM_001300737:c.*2310delT;NM_001300738:c.*2310delT;NM_001040214:c.*2310delT;NM_001300740:c.*2310delT			0.00783238533852385	0.928062091303548	0.0641055233579282	Na+/K+ transporting ATPase interacting 2	.	.	TISSUE SPECIFICITY: Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined. {ECO:0000269|PubMed:11979551}.; 	.	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	6q22.31										0.0003	0.0001	0.0013	0	0	0.0003	0.0003	0							
6	126081693	126081693	T	-	UTR3	HEY2	NM_012259:c.*745delT			0.444357733397612	0.54910741369535	0.00653485290703815	hes related family bHLH transcription factor with YRPW motif 2	FUNCTION: Downstream effector of Notch signaling which may be required for cardiovascular development. Transcriptional repressor which binds preferentially to the canonical E box sequence 5'- CACGTG-3'. Represses transcription by the cardiac transcriptional activators GATA4 and GATA6. {ECO:0000269|PubMed:10692439, ECO:0000269|PubMed:11095750, ECO:0000269|PubMed:15485867, ECO:0000269|PubMed:16293227}.; 	.	.	.	.	0.37195	0.17951	-0.404032746	26.53338051	218.50627	3.19585	6q22.31										0.0004	0.0001	0	0	0	0.0023	0.0004	0	rs532641564						
6	127762555	127762556	AC	-	UTR3	KIAA0408;SOGA3	NM_014702:c.*2699_*2698delGT;NM_001012279:c.*5105_*5104delGT																		6q22.33										0.0068	0.0044	0.0265	0.0116	0	0.0279	0.0053	0.0049	rs139335520						
6	128297951	128297951	A	-	intronic	PTPRK				0.980388546226756	0.0196114537728881	3.56130428132296e-13	protein tyrosine phosphatase, receptor type K	FUNCTION: Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}.; 	.	TISSUE SPECIFICITY: High levels in lung, brain and colon; less in liver, pancreas, stomach, kidney, placenta and mammary carcinoma.; 	.	.	0.39459	.	-1.723336008	2.465204058	177.34828	2.89418	6q22.33		0.2760	0.4085	0.1850	0.1527	0.2710	0.2850	0.2482	0.2486	0.2119	0.3149	0.1076	0.1172	0.0347	0.2702	0.1669	0.2003	rs376302219						
6	128321487	128321487	A	-	intronic	PTPRK				0.980388546226756	0.0196114537728881	3.56130428132296e-13	protein tyrosine phosphatase, receptor type K	FUNCTION: Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}.; 	.	TISSUE SPECIFICITY: High levels in lung, brain and colon; less in liver, pancreas, stomach, kidney, placenta and mammary carcinoma.; 	.	.	0.39459	.	-1.723336008	2.465204058	177.34828	2.89418	6q22.33		0.0566	0.0518	0.0727	0.0661	0.0202	0.0585	0.0444	0.0660	0.0003	0.0004	0	0	0	0.0010	0.0002	0	rs113113294						
6	128330424	128330424	A	-	intronic	PTPRK				0.980388546226756	0.0196114537728881	3.56130428132296e-13	protein tyrosine phosphatase, receptor type K	FUNCTION: Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}.; 	.	TISSUE SPECIFICITY: High levels in lung, brain and colon; less in liver, pancreas, stomach, kidney, placenta and mammary carcinoma.; 	.	.	0.39459	.	-1.723336008	2.465204058	177.34828	2.89418	6q22.33		0.0786	0.0739	0.1114	0.0790	0.0157	0.0672	0.0875	0.1448	0.0133	0.0306	0.0503	0.0042	0.0190	0.0070	0.0010	0.0061	rs576466042						
6	129898732	129898732	A	-	UTR3	ARHGAP18	NM_033515:c.*926delT			2.45958437535249e-06	0.995368002982463	0.00462953743316131	Rho GTPase activating protein 18	FUNCTION: Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;blood;skeletal muscle;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;head and neck;kidney;stomach;thymus;	ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.09701	0.11308	-0.797234383	12.48525596	144.42294	2.61697	6q22.33										0.0017	0.0010	0.0016	0.0078	0.0056	0.0071	0.0007	0.0051	rs200125362						
6	129905036	129905036	A	-	intronic	ARHGAP18				2.45958437535249e-06	0.995368002982463	0.00462953743316131	Rho GTPase activating protein 18	FUNCTION: Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;blood;skeletal muscle;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;head and neck;kidney;stomach;thymus;	ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.09701	0.11308	-0.797234383	12.48525596	144.42294	2.61697	6q22.33										0.0483	0.0706	0.1	0.0430	0.0537	0.1922	0.0166	0.0524							
6	129905074	129905075	GA	-	intronic	ARHGAP18				2.45958437535249e-06	0.995368002982463	0.00462953743316131	Rho GTPase activating protein 18	FUNCTION: Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;blood;skeletal muscle;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;head and neck;kidney;stomach;thymus;	ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.09701	0.11308	-0.797234383	12.48525596	144.42294	2.61697	6q22.33										0.0001	0	0	0	0	0.0010	6.818e-05	0	rs142019329						
6	129955152	129955152	A	-	intronic	ARHGAP18				2.45958437535249e-06	0.995368002982463	0.00462953743316131	Rho GTPase activating protein 18	FUNCTION: Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;blood;skeletal muscle;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;head and neck;kidney;stomach;thymus;	ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.09701	0.11308	-0.797234383	12.48525596	144.42294	2.61697	6q22.33		0.0746	0.0654	0.1788	0.1207	0.0672	0.0587	0.0634	0.0459	0.0114	0.0031	0.0765	0.0040	0.0311	0.0365	0.0086	0.0139	rs752215245						
6	130761533	130761533	T	-	intronic	TMEM200A				0.835246151685534	0.161481988041995	0.00327186027247132	transmembrane protein 200A	.	.	TISSUE SPECIFICITY: Expressed in cerebellum. {ECO:0000269|PubMed:16000565}.; 	unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;adrenal cortex;colon;fovea centralis;choroid;lens;skin;retina;uterus;optic nerve;lung;cochlea;endometrium;bone;macula lutea;visual apparatus;liver;pituitary gland;testis;kidney;stomach;	.	0.15425	0.10111	-0.843147538	11.2762444	50.13238	1.39097	6q23.1		0.0218	0.0204	0.0151	0.0217	0.0074	0.0243	0.0213	0.0252	0.0003	0.0004	0	0	0	0.0017	0	0	rs760191096						
6	131919846	131919846	T	-	exonic	MED23		frameshift deletion	MED23:NM_001270521:exon19:c.2276delA:p.N759Mfs*12,MED23:NM_001270522:exon19:c.2276delA:p.N759Mfs*12,MED23:NM_004830:exon19:c.2276delA:p.N759Mfs*12,MED23:NM_015979:exon20:c.2294delA:p.N765Mfs*12	0.150657691204943	0.849342306714803	2.08025487697261e-09	mediator complex subunit 23	FUNCTION: Required for transcriptional activation subsequent to the assembly of the pre-initiation complex (By similarity). Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcription factors. Required for transcriptional activation by adenovirus E1A protein. Required for ELK1-dependent transcriptional activation in response to activated Ras signaling. {ECO:0000250, ECO:0000269|PubMed:10353252, ECO:0000269|PubMed:14759369, ECO:0000269|PubMed:16595664}.; 	DISEASE: Mental retardation, autosomal recessive 18 (MRT18) [MIM:614249]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:21868677}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;sympathetic chain;colon;skin;uterus;prostate;frontal lobe;cerebral cortex;larynx;bone;testis;amniotic fluid;germinal center;brain;gall bladder;unclassifiable (Anatomical System);heart;adrenal cortex;skeletal muscle;breast;lung;trabecular meshwork;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;stomach;cerebellum;	superior cervical ganglion;trigeminal ganglion;skeletal muscle;parietal lobe;	0.12285	0.15367	-1.131590109	6.481481481	64.0853	1.64122	6q23.2	ID=COSM1440487,COSM1440486;OCCURENCE=1(large_intestine)																							
6	132712800	132712804	TTTAT	-	intronic	MOXD1				8.99118348991882e-11	0.266204625717657	0.733795374192431	monooxygenase, DBH-like 1	.	.	TISSUE SPECIFICITY: Highly expressed in lung, kidney, brain and spinal cord. {ECO:0000269|PubMed:15337741, ECO:0000269|PubMed:9751809}.; 	ovary;parathyroid;skin;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;cochlea;thyroid;bone;testis;spinal ganglion;pineal gland;brain;unclassifiable (Anatomical System);heart;cartilage;adrenal cortex;pancreas;lung;adrenal gland;placenta;spleen;stomach;	amygdala;superior cervical ganglion;atrioventricular node;	0.12508	0.23100	-0.799052816	12.45576787	155.89106	2.72832	6q23.2										0.0959	0.1462	0.1878	0.1040	0.4035	0.0313	0.0466	0.0531	rs71674009						
6	133850670	133850670	A	-	ncRNA_intronic	TARID				.	.	.	TCF21 antisense RNA inducing promoter demethylation	.	.	.	.	.	.	.	.	.	.	.	6q23.2										0.0028	0.0075	0.0060	0	0.0007	0.0015	0.0003	0.0015							
6	134210498	134210499	TC	-	UTR5	TCF21	NM_198392:c.-38_-37del-;NM_003206:c.-38_-37del-			0.80536994429277	0.189537107862187	0.00509294784504338	transcription factor 21	FUNCTION: Involved in epithelial-mesenchymal interactions in kidney and lung morphogenesis that include epithelial differentiation and branching morphogenesis. May play a role in the specification or differentiation of one or more subsets of epicardial cell types.; 	.	.	unclassifiable (Anatomical System);cartilage;heart;ovary;colon;parathyroid;skin;uterus;pancreas;prostate;lung;synovium;epididymis;placenta;liver;testis;spleen;kidney;stomach;	heart;placenta;fetal lung;kidney;	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	6q23.2		0.1961	0.1389	0.2678	0.3736	0.1093	0.1671	0.1782	0.2549	3.354e-05	0	0	0	0	0	6.914e-05	0	rs34718376						
6	134216151	134216152	CT	-	UTR3	TCF21	NM_198392:c.*1867_*1868delCT			0.80536994429277	0.189537107862187	0.00509294784504338	transcription factor 21	FUNCTION: Involved in epithelial-mesenchymal interactions in kidney and lung morphogenesis that include epithelial differentiation and branching morphogenesis. May play a role in the specification or differentiation of one or more subsets of epicardial cell types.; 	.	.	unclassifiable (Anatomical System);cartilage;heart;ovary;colon;parathyroid;skin;uterus;pancreas;prostate;lung;synovium;epididymis;placenta;liver;testis;spleen;kidney;stomach;	heart;placenta;fetal lung;kidney;	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	6q23.2										0.1635	0.0539	0.1814	0.2576	0.0863	0.2634	0.2159	0.1924	rs796370193						
6	134312046	134312046	T	-	UTR3	SLC2A12	NM_145176:c.*247delA			0.0194084110413465	0.961598580402219	0.0189930085564348	solute carrier family 2 member 12	FUNCTION: Facilitative glucose transporter. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in skeletal muscle, heart and prostate, with lower levels in brain, placenta and kidney. {ECO:0000269|PubMed:11832379}.; 	medulla oblongata;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;whole body;frontal lobe;endometrium;larynx;thyroid;testis;dura mater;germinal center;brain;unclassifiable (Anatomical System);amygdala;meninges;islets of Langerhans;hypothalamus;urinary;lens;skeletal muscle;pancreas;pia mater;lung;adrenal gland;placenta;macula lutea;visual apparatus;liver;head and neck;kidney;mammary gland;stomach;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.51083	0.13755	-1.153638777	6.233781552	134.73204	2.52307	6q23.2										0.0006	0.0004	0.0016	0	0	0.0022	0.0004	0.0024	rs368176248						
6	134490614	134490614	A	-	UTR3	SGK1	NM_001143678:c.*792delT;NM_005627:c.*792delT;NM_001291995:c.*792delT;NM_001143677:c.*792delT;NM_001143676:c.*792delT			0.986448162634836	0.0135515850482105	2.52316953736295e-07	serum/glucocorticoid regulated kinase 1	FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na+ retention, renal K+ elimination, salt appetite, gastric acid secretion, intestinal Na+/H+ exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na+ channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K+ channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na+/dicarboxylate cotransporter: SLC13A2/NADC1, Na+-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na+/K+ ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca+2 entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na+ transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.; 	.	TISSUE SPECIFICITY: Expressed in most tissues with highest levels in the pancreas, followed by placenta, kidney and lung. Isoform 2 is strongly expressed in brain and pancreas, weaker in heart, placenta, lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.; 	ovary;sympathetic chain;substantia nigra;skin;retina;bone marrow;prostate;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;gall bladder;tonsil;heart;cartilage;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;dura mater;pineal gland;unclassifiable (Anatomical System);meninges;lymph node;small intestine;lacrimal gland;islets of Langerhans;hypothalamus;pancreas;pia mater;lung;adrenal gland;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;	adrenal gland;adrenal cortex;	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	6q23.2										0.1084	0.0906	0.1181	0.2016	0	0.1797	0.1232	0.125	rs55984236						
6	134494709	134494709	A	-	intronic	SGK1				0.986448162634836	0.0135515850482105	2.52316953736295e-07	serum/glucocorticoid regulated kinase 1	FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na+ retention, renal K+ elimination, salt appetite, gastric acid secretion, intestinal Na+/H+ exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na+ channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K+ channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na+/dicarboxylate cotransporter: SLC13A2/NADC1, Na+-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na+/K+ ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca+2 entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na+ transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.; 	.	TISSUE SPECIFICITY: Expressed in most tissues with highest levels in the pancreas, followed by placenta, kidney and lung. Isoform 2 is strongly expressed in brain and pancreas, weaker in heart, placenta, lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.; 	ovary;sympathetic chain;substantia nigra;skin;retina;bone marrow;prostate;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;gall bladder;tonsil;heart;cartilage;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;dura mater;pineal gland;unclassifiable (Anatomical System);meninges;lymph node;small intestine;lacrimal gland;islets of Langerhans;hypothalamus;pancreas;pia mater;lung;adrenal gland;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;	adrenal gland;adrenal cortex;	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	6q23.2		0.2987	0.3036	0.2356	0.2612	0.2932	0.3164	0.3115	0.2955	0.0042	0.0019	0.0078	0	0	0.0560	0.0026	0.0094	rs113667538						
6	134581911	134581911	-	TCTTT	intronic	SGK1				0.986448162634836	0.0135515850482105	2.52316953736295e-07	serum/glucocorticoid regulated kinase 1	FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na+ retention, renal K+ elimination, salt appetite, gastric acid secretion, intestinal Na+/H+ exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na+ channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K+ channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na+/dicarboxylate cotransporter: SLC13A2/NADC1, Na+-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na+/K+ ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca+2 entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na+ transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.; 	.	TISSUE SPECIFICITY: Expressed in most tissues with highest levels in the pancreas, followed by placenta, kidney and lung. Isoform 2 is strongly expressed in brain and pancreas, weaker in heart, placenta, lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.; 	ovary;sympathetic chain;substantia nigra;skin;retina;bone marrow;prostate;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;gall bladder;tonsil;heart;cartilage;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;dura mater;pineal gland;unclassifiable (Anatomical System);meninges;lymph node;small intestine;lacrimal gland;islets of Langerhans;hypothalamus;pancreas;pia mater;lung;adrenal gland;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;	adrenal gland;adrenal cortex;	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	6q23.2										0.5178	0.3241	0.4132	0.5733	0.3752	0.6344	0.6208	0.5705	rs3069603						
6	135238908	135238908	T	-	UTR3	ALDH8A1	NM_170771:c.*645delA;NM_022568:c.*645delA;NM_001193480:c.*645delA			9.45631299959995e-06	0.544952328230336	0.455038215456665	aldehyde dehydrogenase 8 family member A1	FUNCTION: Converts 9-cis-retinal to 9-cis-retinoic acid. Has lower activity towards 13-cis-retinal. Has much lower activity towards all-trans-retinal. Has highest activity with benzaldehyde and decanal (in vitro). Has a preference for NAD, but shows considerable activity with NADP (in vitro). {ECO:0000269|PubMed:11007799}.; 	.	TISSUE SPECIFICITY: Highly expressed in adult kidney and liver. Detected at lower levels in fetal liver and kidney. {ECO:0000269|PubMed:11007799}.; 	unclassifiable (Anatomical System);breast;lung;bone;liver;testis;spleen;kidney;	fetal liver;liver;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.11265	0.10988	-0.574945567	18.90186365	68.72056	1.71673	6q23.3										0.0005	0.0001	0	0	0	0.0022	0.0005	0							
6	135303873	135303873	T	-	intronic	HBS1L				0.924522220570616	0.0754776289910087	1.50438375464264e-07	HBS1 like translational GTPase	.	.	TISSUE SPECIFICITY: Detected in heart, brain, placenta, liver, muscle, kidney and pancreas. {ECO:0000269|PubMed:9872408}.; 	unclassifiable (Anatomical System);prostate;lung;placenta;testis;germinal center;	superior cervical ganglion;medulla oblongata;occipital lobe;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;cingulate cortex;	0.41898	0.25241	1.225399457	93.24722812	375.67317	4.08629	6q23.3										0.0012	0.0009	0.0062	0	0	0.0072	0.0007	0.0027							
6	136847117	136847117	T	-	UTR5	MAP7	NM_001198609:c.-15delA;NM_001198611:c.-15delA;NM_001198608:c.-15delA			0.929880601613702	0.0701192736895609	1.24696736852857e-07	microtubule associated protein 7	FUNCTION: Microtubule-stabilizing protein that may play an important role during reorganization of microtubules during polarization and differentiation of epithelial cells. Associates with microtubules in a dynamic manner. May play a role in the formation of intercellular contacts. Colocalization with TRPV4 results in the redistribution of TRPV4 toward the membrane and may link cytoskeletal microfilaments. {ECO:0000269|PubMed:11719555, ECO:0000269|PubMed:8408219, ECO:0000269|PubMed:9989799}.; 	.	TISSUE SPECIFICITY: Expressed in the skin and cells of epithelial origin. Predominantly expressed in the suprabasal layers of the normal epidermis and relatively abundant in squamous cell carcinomas but barely detectable in basal cell carcinomas. {ECO:0000269|PubMed:8408219, ECO:0000269|PubMed:9989799}.; 	umbilical cord;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;bone;thyroid;pituitary gland;testis;brain;pineal gland;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;urinary;pharynx;blood;lens;skeletal muscle;breast;bile duct;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;head and neck;cervix;kidney;stomach;	whole brain;amygdala;medulla oblongata;testis - interstitial;occipital lobe;thalamus;testis - seminiferous tubule;hypothalamus;spinal cord;prefrontal cortex;testis;caudate nucleus;parietal lobe;	0.65344	0.12871	0.494191824	79.62373201	671.81801	5.17977	6q23.3		0.3564	0.4455	0.3611	0.4521	.	0.3498	0.3704	0.3444	0.1551	0.3517	0.25	0.0744	0.2641	0.0978	0.0228	0.0905	rs5880298						
6	136878751	136878751	-	T	UTR3	MAP3K5	NM_005923:c.*144_*145insA			0.995107743453563	0.00489225654500715	1.42967211593086e-12	mitogen-activated protein kinase kinase kinase 5	FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:12697749, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.; 	.	TISSUE SPECIFICITY: Abundantly expressed in heart and pancreas.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;bone;thyroid;testis;germinal center;brain;artery;bladder;unclassifiable (Anatomical System);amygdala;lymph node;heart;islets of Langerhans;urinary;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;epididymis;trabecular meshwork;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;aorta;stomach;cerebellum;	amygdala;superior cervical ganglion;subthalamic nucleus;occipital lobe;adrenal gland;spinal cord;adrenal cortex;prefrontal cortex;globus pallidus;caudate nucleus;	0.53784	0.55740	-0.705410796	14.77942911	272.93273	3.54158	6q23.3										0.0486	0.1295	0.0360	0.0089	0.0192	0.0681	0.0041	0.0216							
6	137151126	137151126	T	-	intronic	PEX7				6.86128307466037e-08	0.260872575902808	0.739127355484362	peroxisomal biogenesis factor 7	FUNCTION: Binds to the N-terminal PTS2-type peroxisomal targeting signal and plays an essential role in peroxisomal protein import.; 	DISEASE: Rhizomelic chondrodysplasia punctata 1 (RCDP1) [MIM:215100]: A peroxisome biogenesis disorder. It is characterized by rhizomelic shortening of femur and humerus, vertebral disorders, cataract, cutaneous lesions and severe mental retardation. {ECO:0000269|PubMed:9090381}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 9B (PBD9B) [MIM:614879]: A peroxisome biogenesis disorder with unusually mild clinical and biochemical manifestations. Affected individuals manifest a variable phenotype similar to, and in some cases indistinguishable from, classic Refsum disease. Variable features include ocular abnormalities, sensorimotor neuropathy, ichthyosis, deafness, chondrodysplasia punctata without rhizomelia or growth failure. {ECO:0000269|PubMed:12522768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Ubiquitous. Highest expression in pancreas, skeletal muscle and heart.; 	unclassifiable (Anatomical System);heart;tongue;hypothalamus;colon;fovea centralis;choroid;lens;skin;retina;uterus;prostate;optic nerve;lung;endometrium;bone;placenta;macula lutea;liver;testis;kidney;brain;stomach;	dorsal root ganglion;superior cervical ganglion;testis;pons;atrioventricular node;trigeminal ganglion;parietal lobe;	0.11254	0.19973	0.014844891	54.94810097	28.2424	0.90611	6q23.3		0.0871	0.1371	0.1349	0.1652	0.0355	0.1187	0.0929	0.0657	0.0034	0.0007	0.0057	0	0.0361	0.0006	0.0015	0.0052	rs369087463						
6	137518967	137518967	A	-	UTR3	IFNGR1	NM_000416:c.*201delT			0.327969027338138	0.668725776304575	0.00330519635728746	interferon gamma receptor 1	FUNCTION: Receptor for interferon gamma. Two receptors bind one interferon gamma dimer.; 	DISEASE: Immunodeficiency 27A (IMD27A) [MIM:209950]: A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. {ECO:0000269|PubMed:10811850, ECO:0000269|PubMed:9389728}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 27B (IMD27B) [MIM:615978]: A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. IMD27B commonly presents with recurrent, moderately severe infections with environmental mycobacteria or BCG. Salmonellosis is present in about 5% of patients. {ECO:0000269|PubMed:10192386}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.50087	0.51837	-0.200157416	39.11299835	429.70695	4.32908	6q23.3										0.0177	0.0158	0.0667	0.0297	0	0.1307	0.0088	0.0272							
6	138192325	138192325	T	-	intronic	TNFAIP3				0.999666684982313	0.000333314290102666	7.2758380374275e-10	TNF alpha induced protein 3	FUNCTION: Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS- induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages. {ECO:0000269|PubMed:14748687, ECO:0000269|PubMed:15258597, ECO:0000269|PubMed:16684768, ECO:0000269|PubMed:17961127, ECO:0000269|PubMed:18164316, ECO:0000269|PubMed:18952128, ECO:0000269|PubMed:19494296, ECO:0000269|PubMed:22099304, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:8692885, ECO:0000269|PubMed:9299557, ECO:0000269|PubMed:9882303}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;alveolus;hypopharynx;liver;cervix;spleen;head and neck;kidney;aorta;stomach;thymus;	superior cervical ganglion;smooth muscle;white blood cells;fetal lung;trigeminal ganglion;	0.31507	0.61057	-0.530852121	20.82448691	1191.30876	6.54436	6q23.3		0.3612	0.3582	0.3648	0.3746	0.2897	0.3625	0.3723	0.3847	0.0018	0.0006	0.0098	0.0039	0	0.0107	0.0008	0.0037	rs3214646						
6	138204004	138204004	A	-	UTR3	TNFAIP3	NM_001270508:c.*1548delA;NM_006290:c.*1548delA;NM_001270507:c.*1548delA			0.999666684982313	0.000333314290102666	7.2758380374275e-10	TNF alpha induced protein 3	FUNCTION: Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS- induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages. {ECO:0000269|PubMed:14748687, ECO:0000269|PubMed:15258597, ECO:0000269|PubMed:16684768, ECO:0000269|PubMed:17961127, ECO:0000269|PubMed:18164316, ECO:0000269|PubMed:18952128, ECO:0000269|PubMed:19494296, ECO:0000269|PubMed:22099304, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:8692885, ECO:0000269|PubMed:9299557, ECO:0000269|PubMed:9882303}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;alveolus;hypopharynx;liver;cervix;spleen;head and neck;kidney;aorta;stomach;thymus;	superior cervical ganglion;smooth muscle;white blood cells;fetal lung;trigeminal ganglion;	0.31507	0.61057	-0.530852121	20.82448691	1191.30876	6.54436	6q23.3										0.0039	0.0015	0.0132	0.0129	0	0.0674	0.0017	0.0018							
6	138744117	138744117	A	-	UTR3	NHSL1	NM_020464:c.*1101delT;NM_001144060:c.*1101delT			.	.	.	NHS like 1	.	.	TISSUE SPECIFICITY: Widely expressed. Expressed in adult and fetal brain, fetal eyes, adult lens, kidney, liver and intestine. {ECO:0000269|PubMed:15466011}.; 	ovary;rectum;colon;parathyroid;fovea centralis;choroid;skin;retina;optic nerve;frontal lobe;cochlea;endometrium;thyroid;bone;iris;testis;pineal gland;brain;unclassifiable (Anatomical System);small intestine;cartilage;hypothalamus;lens;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;kidney;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.16939	0.08813	1.534092314	95.56499174	516.80632	4.64861	6q23.3										3.794e-05	0	0	0	0.0006	0	0	0	rs199617704						
6	139094629	139094629	-	GG	intronic	GVQW2				.	.	.	GVQW motif containing 2	.	.	.	.	.	.	.	.	.	.	.	6q24.1		0.1578	0.2346	0.1773	0.1628	0.1235	0.1109	0.1325	0.1861	0.1674	0.2213	0.2837	0.1007	0.2003	0.1793	0.1277	0.1585	rs111500978						
6	143082717	143082717	A	-	intronic	HIVEP2				0.999999664252267	3.35747733176297e-07	7.37862086254662e-18	human immunodeficiency virus type I enhancer binding protein 2	FUNCTION: This protein specifically binds to the DNA sequence 5'- GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon- beta genes. It may act in T-cell activation.; 	.	TISSUE SPECIFICITY: Expressed in brain and skeletal muscle. {ECO:0000269|PubMed:10207097}.; 	ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;iris;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;lacrimal gland;hypothalamus;urinary;blood;lens;skeletal muscle;breast;pancreas;lung;epididymis;placenta;macula lutea;liver;alveolus;spleen;head and neck;kidney;mammary gland;	amygdala;whole brain;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;pons;caudate nucleus;atrioventricular node;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;trigeminal ganglion;cingulate cortex;parietal lobe;	0.57854	0.15610	-2.196075097	1.374144845	466.73466	4.47593	6q24.2		0.0180	0.0019	0.1397	0.0549	0	0.0006	0.0091	0.0001	0.0065	0.0014	0.0894	0	0.0545	0	0.0002	0.0101	rs3830758						
6	144758648	144758648	T	-	intronic	UTRN				2.96803315260187e-09	0.999999997031967	2.23662207392544e-20	utrophin	FUNCTION: May play a role in anchoring the cytoskeleton to the plasma membrane. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Isoform 1 has high expression in muscle. Isoforms Up70 and Up140 were found in all the adult and fetal tissues tested and relatively abundant in lung and kidney. {ECO:0000269|PubMed:10369873}.; 	.	.	0.17851	0.56056	-1.550042262	3.255484784	1957.13132	8.14203	6q24.2										0.0131	0.0021	0.0556	0.0205	0	0.1352	0.0075	0.0197							
6	145095544	145095544	-	T	intronic	UTRN				2.96803315260187e-09	0.999999997031967	2.23662207392544e-20	utrophin	FUNCTION: May play a role in anchoring the cytoskeleton to the plasma membrane. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Isoform 1 has high expression in muscle. Isoforms Up70 and Up140 were found in all the adult and fetal tissues tested and relatively abundant in lung and kidney. {ECO:0000269|PubMed:10369873}.; 	.	.	0.17851	0.56056	-1.550042262	3.255484784	1957.13132	8.14203	6q24.2		1.343e-05	0	0	0	0	2.217e-05	0	0									rs764853116						
6	146012112	146012112	-	A	intronic	EPM2A				3.58971451329325e-05	0.368559658109774	0.631404444745093	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)	.	.	.	unclassifiable (Anatomical System);cartilage;heart;ovary;colon;parathyroid;blood;fovea centralis;skin;skeletal muscle;retina;uterus;prostate;lung;endometrium;epididymis;placenta;macula lutea;pituitary gland;cervix;germinal center;kidney;brain;	superior cervical ganglion;globus pallidus;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.54907	0.32511	.	.	120.1533	2.38861	6q24.3										0.0205	0.0323	0.0328	0.025	0.0020	0.0761	0.0104	0.0228							
6	148710093	148710093	A	-	intronic	SASH1				0.00325444461467519	0.996741816786582	3.73859874266323e-06	SAM and SH3 domain containing 1	FUNCTION: May have a role in a signaling pathway. Could act as a tumor suppressor.; 	.	.	.	.	0.36890	0.11167	-0.562239385	19.06699693	3939.62918	12.40945	6q24.3										0.0391	0.0081	0.1567	0.088	0.0006	0.3510	0.0241	0.0682	rs753689475						
6	148761411	148761411	T	-	intronic	SASH1				0.00325444461467519	0.996741816786582	3.73859874266323e-06	SAM and SH3 domain containing 1	FUNCTION: May have a role in a signaling pathway. Could act as a tumor suppressor.; 	.	.	.	.	0.36890	0.11167	-0.562239385	19.06699693	3939.62918	12.40945	6q24.3		0.0690	0.0507	0.0656	0.0570	0.0173	0.0661	0.0828	0.1319	0.0008	0.0005	0.0014	0	0	0.0038	0.0005	0	rs34635991						
6	149397744	149397744	T	-	UTR3	UST	NM_005715:c.*2492delT			0.984203294606023	0.0157877362198489	8.96917412819243e-06	uronyl 2-sulfotransferase	FUNCTION: Sulfotransferase that catalyzes the transfer of sulfate to the position 2 of uronyl residues. Has mainly activity toward iduronyl residues in dermatan sulfate, and weaker activity toward glucuronyl residues of chondroitin sulfate. Has no activity toward desulfated N-resulfated heparin.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10187838}.; 	.	.	0.20757	0.12558	-0.514264485	21.41424864	224.05841	3.23683	6q25.1										0.2615	0.3207	0.2974	0.2781	0.1941	0.2297	0.2407	0.2412	rs11330840						
6	149398013	149398013	T	-	UTR3	UST	NM_005715:c.*2761delT			0.984203294606023	0.0157877362198489	8.96917412819243e-06	uronyl 2-sulfotransferase	FUNCTION: Sulfotransferase that catalyzes the transfer of sulfate to the position 2 of uronyl residues. Has mainly activity toward iduronyl residues in dermatan sulfate, and weaker activity toward glucuronyl residues of chondroitin sulfate. Has no activity toward desulfated N-resulfated heparin.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10187838}.; 	.	.	0.20757	0.12558	-0.514264485	21.41424864	224.05841	3.23683	6q25.1										0.0199	0.0242	0.0446	0.0126	0.0120	0.0811	0.0124	0.0175							
6	149846373	149846373	A	-	intronic	PPIL4				1.68093009893407e-05	0.992867370689602	0.00711582000940872	peptidylprolyl isomerase like 4	FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Abundantly expressed in kidney but has a ubiquitously low expression pattern in other adult tissues. {ECO:0000269|PubMed:11978968}.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;germinal center;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;hypothalamus;pharynx;blood;lens;skeletal muscle;bile duct;breast;pancreas;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	uterus;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.28458	0.11780	-0.159704656	41.90846898	84.52811	1.95737	6q25.1		0.3476	0.2786	0.3948	0.3444	0.2440	0.3467	0.3327	0.3977	0.0129	0.0045	0.0533	0.0442	0.0007	0.1329	0.0093	0.0317	rs749085585						
6	150123317	150123317	T	-	intronic	PCMT1				0.446383565895946	0.547179505232261	0.00643692887179311	protein-L-isoaspartate (D-aspartate) O-methyltransferase	FUNCTION: Catalyzes the methyl esterification of L-isoaspartyl and D-aspartyl residues in peptides and proteins that result from spontaneous decomposition of normal L-aspartyl and L-asparaginyl residues. It plays a role in the repair and/or degradation of damaged proteins. Acts on EIF4EBP2, microtubule-associated protein 2, calreticulin, clathrin light chains a and b, Ubiquitin carboxyl-terminal hydrolase isozyme L1, phosphatidylethanolamine- binding protein 1, stathmin, beta-synuclein and alpha-synuclein. {ECO:0000250|UniProtKB:P23506}.; 	.	.	.	.	0.40253	0.17705	0.03689118	56.64071715	36.69422	1.10081	6q25.1		0.5357	0.6229	0.5917	0.6271	0.5016	0.5098	0.5180	0.5189	0.5249	0.7643	0.6540	0.4078	0.8529	0.4366	0.3610	0.4472	rs11297063						
6	150123317	150123318	TT	-	intronic	PCMT1				0.446383565895946	0.547179505232261	0.00643692887179311	protein-L-isoaspartate (D-aspartate) O-methyltransferase	FUNCTION: Catalyzes the methyl esterification of L-isoaspartyl and D-aspartyl residues in peptides and proteins that result from spontaneous decomposition of normal L-aspartyl and L-asparaginyl residues. It plays a role in the repair and/or degradation of damaged proteins. Acts on EIF4EBP2, microtubule-associated protein 2, calreticulin, clathrin light chains a and b, Ubiquitin carboxyl-terminal hydrolase isozyme L1, phosphatidylethanolamine- binding protein 1, stathmin, beta-synuclein and alpha-synuclein. {ECO:0000250|UniProtKB:P23506}.; 	.	.	.	.	0.40253	0.17705	0.03689118	56.64071715	36.69422	1.10081	6q25.1		0.0626	0.1421	0.1215	0.1639	0.0290	0.0337	0.0503	0.0550	0.0002	0.0004	0	0	0	0.0012	7.182e-05	0	rs754913188						
6	150140830	150140831	TA	-	UTR3	LRP11	NM_032832:c.*855_*854delTA			0.100969715328085	0.891713144969226	0.00731713970268879	LDL receptor related protein 11	.	.	.	smooth muscle;ovary;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;bone;thyroid;pituitary gland;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;islets of Langerhans;hypothalamus;adrenal cortex;pharynx;lens;breast;pancreas;lung;placenta;head and neck;cervix;kidney;mammary gland;stomach;	.	0.24657	.	.	.	3182.89784	10.74631	6q25.1										0.1880	0.5975	0.0833	0.0333	0.0229	0.0009	0.0066	0.0544	rs59091269						
6	150209805	150209805	-	AA	splicing	RAET1E	NM_001243325:exon4:c.515-2->TT;NM_139165:exon4:c.623-2->TT			1.85957575867062e-05	0.45402575853045	0.545955645711964	retinoic acid early transcript 1E	FUNCTION: Ligand for the KLRK1 receptor. Delivers activating signals to NK cells and promotes tumor immune surveillance by inducing the expansion of anti-tumor cytotoxic lymphocytes.; 	.	TISSUE SPECIFICITY: Predominantly expressed in the skin, but also expressed in testis and trachea. Up-regulated in tumor cells of different origins. Expression progressively decreased after treatment of tumor cells with retinoic acid. {ECO:0000269|PubMed:12732206, ECO:0000269|PubMed:14508119}.; 	optic nerve;macula lutea;fovea centralis;choroid;lens;retina;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.03332	0.12047	2.149758993	97.97711724	1343.90882	6.88288	6q25.1		0.0510	0.0704	0.0872	0.2071	0.0539	0.0426	0.0471	0.0273	0.2354	0.2603	0.1276	0.1894	0.5934	0.0479	0.1752	0.1962	rs10671072						
6	150244217	150244231	GTCTGAATGCAGCCC	-	UTR5	RAET1G	NM_001001788:c.-71_-85delGGGCTGCATTCAGAC			0.00147072916271158	0.673933352093366	0.324595918743922	retinoic acid early transcript 1G	FUNCTION: Acts as a ligand for the KLRK1 receptor and mediates NK cell cytotoxicity via the receptor. {ECO:0000269|PubMed:15240696}.; 	.	TISSUE SPECIFICITY: Isoform 1 is highly expressed in colon and in a number of tumor cell lines and highly restricted in normal tissues. Both isoforms are frequently expressed in cell lines derived from epithelial cancers, and in primary breast cancers. {ECO:0000269|PubMed:15240696, ECO:0000269|PubMed:19223974}.; 	.	.	0.07649	0.05401	1.907156687	97.38145789	66.79305	1.68650	6q25.1										0.2155	0.3910	0.0981	0.1192	0.5247	0.1211	0.1156	0.1670	rs71656790						
6	151779421	151779422	AC	-	intronic	ARMT1				.	.	.	acidic residue methyltransferase 1	FUNCTION: O-methyltransferase that methylates glutamate residues of target proteins to form gamma-glutamyl methyl ester residues. Methylates PCNA, suggesting it is involved in the DNA damage response. {ECO:0000269|PubMed:25732820}.; 	.	.	.	.	0.62908	0.08819	0.284856336	71.40835103	.	.	6q25.1		0.2585	0.2666	0.2112	0.3212	0.2788	0.2538	0.2410	0.2638	6.546e-05	0	0.0012	0	0	0	6.723e-05	0	rs142167376						
6	152755214	152755214	A	-	intronic	SYNE1				3.75068139299055e-27	1	1.78073503849307e-40	spectrin repeat containing, nuclear envelope 1	FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. Component of SUN-protein- containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. May be involved in the maintenance of nuclear organization and structural integrity. Connects nuclei to the cytoskeleton by interacting with the nuclear envelope and with F- actin in the cytoplasm. May be required for centrosome migration to the apical cell surface during early ciliogenesis. {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:18396275}.; 	DISEASE: Spinocerebellar ataxia, autosomal recessive, 8 (SCAR8) [MIM:610743]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR8 is an autosomal recessive form. {ECO:0000269|PubMed:17159980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4) [MIM:612998]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in HeLa, A431, A172 and HaCaT cells (at protein level). Widely expressed. Highly expressed in skeletal and smooth muscles, heart, spleen, peripheral blood leukocytes, pancreas, cerebellum, stomach, kidney and placenta. Isoform GSRP- 56 is predominantly expressed in heart and skeletal muscle (at protein level). {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:11801724, ECO:0000269|PubMed:15093733, ECO:0000269|PubMed:16875688, ECO:0000269|PubMed:22518138}.; 	lymphoreticular;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;germinal center;brain;heart;cartilage;spinal cord;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;spleen;mammary gland;salivary gland;colon;parathyroid;choroid;fovea centralis;uterus;whole body;cerebral cortex;bone;testis;artery;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;muscle;lung;adrenal gland;nasopharynx;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;aorta;cerebellum;	dorsal root ganglion;superior cervical ganglion;medulla oblongata;cerebellum peduncles;atrioventricular node;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;appendix;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	0.46149	-0.160234117	41.64897381	10210.55056	22.01419	6q25.2										0.0003	0.0009	0	0	0	0.0004	0	0.0011							
6	152793575	152793575	-	G	intronic	SYNE1				3.75068139299055e-27	1	1.78073503849307e-40	spectrin repeat containing, nuclear envelope 1	FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. Component of SUN-protein- containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. May be involved in the maintenance of nuclear organization and structural integrity. Connects nuclei to the cytoskeleton by interacting with the nuclear envelope and with F- actin in the cytoplasm. May be required for centrosome migration to the apical cell surface during early ciliogenesis. {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:18396275}.; 	DISEASE: Spinocerebellar ataxia, autosomal recessive, 8 (SCAR8) [MIM:610743]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR8 is an autosomal recessive form. {ECO:0000269|PubMed:17159980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4) [MIM:612998]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in HeLa, A431, A172 and HaCaT cells (at protein level). Widely expressed. Highly expressed in skeletal and smooth muscles, heart, spleen, peripheral blood leukocytes, pancreas, cerebellum, stomach, kidney and placenta. Isoform GSRP- 56 is predominantly expressed in heart and skeletal muscle (at protein level). {ECO:0000269|PubMed:11792814, ECO:0000269|PubMed:11801724, ECO:0000269|PubMed:15093733, ECO:0000269|PubMed:16875688, ECO:0000269|PubMed:22518138}.; 	lymphoreticular;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;germinal center;brain;heart;cartilage;spinal cord;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;spleen;mammary gland;salivary gland;colon;parathyroid;choroid;fovea centralis;uterus;whole body;cerebral cortex;bone;testis;artery;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;muscle;lung;adrenal gland;nasopharynx;placenta;hippocampus;hypopharynx;head and neck;kidney;stomach;aorta;cerebellum;	dorsal root ganglion;superior cervical ganglion;medulla oblongata;cerebellum peduncles;atrioventricular node;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;appendix;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	0.46149	-0.160234117	41.64897381	10210.55056	22.01419	6q25.2		0.0025	0.0024	0.0009	0.0032	0.0003	0.0015	0.0023	0.0084	0.0002	0.0005	0	0	0	0.0003	6.763e-05	0	rs370960329						
6	153045367	153045367	A	-	UTR3	MYCT1	NM_025107:c.*1979delA			6.34322649393561e-05	0.477102325674928	0.522834242060133	myc target 1	FUNCTION: May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Down-regulated in gastric cancer tissues.; 	.	.	0.71820	0.09518	0.549415813	81.38122199	1709.96613	7.62536	6q25.2																								
6	154476150	154476150	A	-	UTR3	IPCEF1	NM_001130699:c.*4813delT;NM_015553:c.*4813delT;NM_001130700:c.*4813delT			0.399940590099527	0.59967368427699	0.000385725623483231	interaction protein for cytohesin exchange factors 1	FUNCTION: Enhances the promotion of guanine-nucleotide exchange by PSCD2 on ARF6 in a concentration-dependent manner. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);amygdala;lymph node;cartilage;colon;blood;skeletal muscle;bone marrow;pancreas;prostate;frontal lobe;endometrium;nasopharynx;placenta;thyroid;kidney;brain;aorta;	occipital lobe;subthalamic nucleus;medulla oblongata;thalamus;superior cervical ganglion;thyroid;temporal lobe;prefrontal cortex;globus pallidus;parietal lobe;cingulate cortex;	.	.	0.328949044	73.41354093	57.76721	1.53559	6q25.2										0.0027	0.0017	0.0033	0	0.0056	0.0142	0.0013	0.0065							
6	155109169	155109169	T	-	intronic	SCAF8				0.999999979124473	2.08755270838552e-08	4.20106177670743e-20	SR-related CTD associated factor 8	FUNCTION: May play a role in mRNA processing. {ECO:0000269|PubMed:11101529}.; 	.	.	.	.	0.19849	.	-0.947938165	9.341825902	330.90174	3.86879	6q25.2		0.3837	0.3728	0.3882	0.3993	0.3723	0.3929	0.3857	0.3424	0.0195	0.0099	0.0286	0.0354	0	0.0228	0.0260	0.0243	rs370598712						
6	157529244	157529244	T	-	UTR3	ARID1B	NM_001346813:c.*219delT;NM_017519:c.*219delT;NM_020732:c.*219delT			0.999949930200412	5.00697995874118e-05	4.93048584287307e-16	AT-rich interaction domain 1B	FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to post-mitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Binds DNA non-specifically. {ECO:0000250}.; 	DISEASE: Mental retardation, autosomal dominant 12 (MRD12) [MIM:614562]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD12 patients present with moderate to severe psychomotor retardation, and most show evidence of muscular hypotonia. In many patients, expressive speech is more severely affected than receptive function. Additional common findings include short stature, abnormal head shape and low-set, posteriorly rotated, and abnormally shaped ears, downslanting palpebral fissures, a bulbous nasal tip, a thin upper lip, minor teeth anomalies, and brachydactyly or single palmar creases. Autistic features are uncommon. {ECO:0000269|PubMed:22405089, ECO:0000269|PubMed:22426308, ECO:0000269|PubMed:22426309}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed with high levels in heart, skeletal muscle and kidney. {ECO:0000269|PubMed:11988099, ECO:0000269|PubMed:12200431, ECO:0000269|PubMed:12665591}.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;tongue;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;epididymis;placenta;hippocampus;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;thymus;cerebellum;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;cingulate cortex;cerebellum;	0.15152	0.12645	-2.622392448	0.802075961	623.55868	5.03581	6q25.3										0.0031	0.0101	0.0041	0	0	0.0003	0	0.0022	rs376411414						
6	157529844	157529844	C	-	UTR3	ARID1B	NM_001346813:c.*819delC;NM_017519:c.*819delC;NM_020732:c.*819delC			0.999949930200412	5.00697995874118e-05	4.93048584287307e-16	AT-rich interaction domain 1B	FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to post-mitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Binds DNA non-specifically. {ECO:0000250}.; 	DISEASE: Mental retardation, autosomal dominant 12 (MRD12) [MIM:614562]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD12 patients present with moderate to severe psychomotor retardation, and most show evidence of muscular hypotonia. In many patients, expressive speech is more severely affected than receptive function. Additional common findings include short stature, abnormal head shape and low-set, posteriorly rotated, and abnormally shaped ears, downslanting palpebral fissures, a bulbous nasal tip, a thin upper lip, minor teeth anomalies, and brachydactyly or single palmar creases. Autistic features are uncommon. {ECO:0000269|PubMed:22405089, ECO:0000269|PubMed:22426308, ECO:0000269|PubMed:22426309}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed with high levels in heart, skeletal muscle and kidney. {ECO:0000269|PubMed:11988099, ECO:0000269|PubMed:12200431, ECO:0000269|PubMed:12665591}.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;tongue;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;epididymis;placenta;hippocampus;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;thymus;cerebellum;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;cingulate cortex;cerebellum;	0.15152	0.12645	-2.622392448	0.802075961	623.55868	5.03581	6q25.3																								
6	158098377	158098377	T	-	intergenic	ZDHHC14;SNX9	dist=3400;dist=145826																		6q25.3										0.0334	0.0557	0.0186	0.0148	0.0191	0.0423	0.0220	0.0312							
6	158098972	158098972	A	-	intergenic	ZDHHC14;SNX9	dist=3995;dist=145231																		6q25.3										0.0028	0.0017	0.0187	0	0	0.0244	0.0011	0.0056							
6	158518876	158518876	A	-	UTR3	SYNJ2	NM_003898:c.*1480delA;NM_001178088:c.*1480delA			3.52295821798563e-05	0.999960575668203	4.19474961684895e-06	synaptojanin 2	FUNCTION: Inositol 5-phosphatase which may be involved in distinct membrane trafficking and signal transduction pathways. May mediate the inhibitory effect of Rac1 on endocytosis.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;cerebral cortex;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;pineal body;spinal cord;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;cervix;kidney;stomach;aorta;cerebellum;	dorsal root ganglion;amygdala;thalamus;medulla oblongata;superior cervical ganglion;hypothalamus;spinal cord;pons;caudate nucleus;atrioventricular node;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.23517	.	-1.902173	1.952111347	376.38515	4.09028	6q25.3																								
6	158519569	158519569	A	-	UTR3	SYNJ2	NM_003898:c.*2173delA;NM_001178088:c.*2173delA			3.52295821798563e-05	0.999960575668203	4.19474961684895e-06	synaptojanin 2	FUNCTION: Inositol 5-phosphatase which may be involved in distinct membrane trafficking and signal transduction pathways. May mediate the inhibitory effect of Rac1 on endocytosis.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;cerebral cortex;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;pineal body;spinal cord;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;cervix;kidney;stomach;aorta;cerebellum;	dorsal root ganglion;amygdala;thalamus;medulla oblongata;superior cervical ganglion;hypothalamus;spinal cord;pons;caudate nucleus;atrioventricular node;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.23517	.	-1.902173	1.952111347	376.38515	4.09028	6q25.3										0.0213	0.0222	0.0604	0.0333	0.0046	0.1297	0.0100	0.0280							
6	158613375	158613375	A	-	UTR3	GTF2H5	NM_207118:c.*186delA			0.0468099786233029	0.677353349051733	0.275836672324964	general transcription factor IIH subunit 5	FUNCTION: Component of the TFIIH basal transcription factor involved in nucleotide excision repair (NER) of DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. Necessary for the stability of the TFIIH complex and for the presence of normal levels of TFIIH in the cell. {ECO:0000269|PubMed:15220921}.; 	DISEASE: Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395]: A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non- photosensitive forms of the disorder. {ECO:0000269|PubMed:15220921}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.07711	0.18619	-0.075159878	47.78839349	4.78359	0.17398	6q25.3										0.1784	0.0510	0.4585	0.1875	0.4042	0.3707	0.1797	0.2507	rs3841147						
6	158613375	158613376	AA	-	UTR3	GTF2H5	NM_207118:c.*186_*187delAA			0.0468099786233029	0.677353349051733	0.275836672324964	general transcription factor IIH subunit 5	FUNCTION: Component of the TFIIH basal transcription factor involved in nucleotide excision repair (NER) of DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. Necessary for the stability of the TFIIH complex and for the presence of normal levels of TFIIH in the cell. {ECO:0000269|PubMed:15220921}.; 	DISEASE: Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395]: A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non- photosensitive forms of the disorder. {ECO:0000269|PubMed:15220921}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.07711	0.18619	-0.075159878	47.78839349	4.78359	0.17398	6q25.3										0.0008	0.0001	0.0046	0	0	0.0081	0.0002	0							
6	158614315	158614315	A	-	UTR3	GTF2H5	NM_207118:c.*1126delA			0.0468099786233029	0.677353349051733	0.275836672324964	general transcription factor IIH subunit 5	FUNCTION: Component of the TFIIH basal transcription factor involved in nucleotide excision repair (NER) of DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. Necessary for the stability of the TFIIH complex and for the presence of normal levels of TFIIH in the cell. {ECO:0000269|PubMed:15220921}.; 	DISEASE: Trichothiodystrophy 3, photosensitive (TTD3) [MIM:616395]: A form of trichothiodystrophy, an autosomal recessive disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non- photosensitive forms of the disorder. {ECO:0000269|PubMed:15220921}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.07711	0.18619	-0.075159878	47.78839349	4.78359	0.17398	6q25.3										0.0002	0	0.0030	0	0	0.0011	0.0002	0							
6	159056061	159056061	A	-	UTR3	TMEM181	NM_020823:c.*3141delA			0.468986734137893	0.530967098674931	4.61671871758581e-05	transmembrane protein 181	FUNCTION: Mediates action of cytolethal distending toxins (CDT), which are secreted by many pathogenic bacteria. Expression level of TMEM181 is rate-limiting for intoxication. {ECO:0000269|PubMed:19965467}.; 	.	.	ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;thyroid;bone;testis;amniotic fluid;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;islets of Langerhans;hypothalamus;skeletal muscle;breast;lung;placenta;liver;duodenum;hypopharynx;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;trigeminal ganglion;	0.11316	.	0.220536484	68.38287332	134.24863	2.51950	6q25.3										0.0109	0.0028	0.0139	0.0088	0	0.0730	0.0136	0.0088	rs530154982						
6	161556118	161556118	-	TTGTGC	UTR3	AGPAT4	NM_020133:c.*1453_*1454insGCACAA			0.674499951839515	0.325297171162999	0.000202876997485756	1-acylglycerol-3-phosphate O-acyltransferase 4	FUNCTION: Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. {ECO:0000269|PubMed:21173190}.; 	unclassifiable (Anatomical System);cartilage;islets of Langerhans;hypothalamus;muscle;colon;pancreas;whole body;lung;frontal lobe;placenta;bone;hippocampus;alveolus;testis;spleen;kidney;brain;stomach;	whole brain;amygdala;subthalamic nucleus;thalamus;occipital lobe;hypothalamus;spinal cord;caudate nucleus;	0.32335	0.10604	-0.514264485	21.41424864	13.17386	0.47964	6q26										0.2872	0.3884	0.4257	0.1490	0.2568	0.2112	0.2464	0.2597	rs111716475						
